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(RE)embodying Biotechnology: Towards the Democratization of 
Biotechnology Through Embodied Art Practices. 
Jennifer Willet, Ph.D. 
Concordia University, 2009 
Contemporary discourse surrounding biotechnology places great emphasis on 
digital metaphors in describing the biological sciences. In these discourses it is 
as if mankind's 'cumulative' technology - computation - performs the ultimate 
science, the dominion of man over nature through the application of numeric 
code to living organism. This general application of computational models to 
instances of biotechnology provides a sterilizing affect, removing all that is wet, 
bloody, unruly, and animal, from mass imaginations of the biotech future. As I 
argue this vision of biotechnology (as it is presented to non-specialists) may 
serve to nullify public engagement in the complex ethical dilemmas that arise 
from engaging in technologies of the body. 
(RE)embodying Biotechnology focuses on reuniting notions of embodiment with 
the language, analysis, practice, and representation of contemporary 
biotechnologies. With a social and political mandate that advocates informed 
public discourse, (RE)embodying Biotechnology complicates, rather than simplify 
our understanding of the biotech field. Methodologically, I propose artistic means 
for non-specialists to engage in biotechnology as an embodied practice through 
in 
the mobilization of a 'critical participatory methodology'. (RE)embodying 
Biotechnology is a research / creation thesis; comprised of the documentation of 
a body of work and a text that reflects on how artistic engagement in the 
biotechnological field may allow for non-specialists to engage critically with 
evolving biotechnologies. 
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1 | (RE)embodying Biotechnology: Introduction 
First day in the lab. Baptism by fire of sorts. We arrived in Australia two 
days ago. Still dizzy, jet lagged, and curiously upset by the location of the 
sun in the northern sky. Today we performed our first passaging on the 
3T3 Mouse Fibroblast cell line. Cell lines are very special cells developed 
for research purposes. They are immortal. The telomeres have been 
chemically treated with an enzyme so that the cells do not age, they do 
not experience cell death, they are able to divide infinitely. Sound 
Familiar? Creating an infinite cell line sounds a lot like creating a 
cancerous cell line. What is the difference? Possibly in order to deem 
uncontrollable cellular division cancerous the cells must inhabit and 
jeopardize a host organism. I immediately begin referring to our cells as 
'our little monsters'.1 
In May 2004,1 left my home and disabled cat in Montreal to travel to the opposite 
end of the earth (Perth, Australia) with my collaborator Shawn Bailey2 as part of 
our ongoing BIOTEKNICA research to study mammalian tissue culture (TC) and 
tissue engineering (TE) protocols at The University of Western Australia. Over a 
period of three months, we gained proficiency in antiseptic technique, freezing, 
1
 Jennifer Willet. BIOTEKNICA | ORGANIC TISSUE PROTOTYPES \ 
LABORATORY NOTES, unpublished manuscript, 2004. 
2
 Shawn Bailey now works under the name Jason Knight, though I refer to him as 
Shawn Bailey as this was his working name throughout the BIOTEKNICA project. 
I 
defrosting, feeding, and trypsinizing procedures — all working in chorus to 
support cellular life outside of the donor body. The skills we acquired during this 
time are rather basic in the specialized field of TC, which was established over a 
hundred years ago. However, what was unique about our first foray into the field 
was not the specialization of the knowledge obtained or the remote location of 
our instruction but instead the intentions, education, and background of 
ourselves, the willing students. We are artists. Together, we developed an 
interdisciplinary artist collective called BIOTEKNICA, investigating the ethics and 
aesthetics at the intersection of art and science. Our original training was in 
traditional forms of reproduction: printmaking, serigraphy, intaglio, lithography; 
these expanded to include digital imaging, internet authoring, installation and 
performance. In 2004, we went back to the classroom — this time to learn TC 
and TE techniques towards the production of contemporary art. 
We served as Honorary Research Fellows at SymbioticA: The Art and Science 
Collaborative Research Laboratory, giving us the same status and level of 
access as visiting scientific researchers working in the School of Anatomy and 
Human Biology at the UWA. It was at this time that (RE)Embodying 
Biotechnology was conceived — at the edge of life-altering, art-denaturing 
instances of real, hands-on knowledge of biotechnological protocols from a non-
specialist perspective. Here, for the first time, I experienced the 
instrumentalization of life as a scientific and technological tool and, 
simultaneously, as the object of scrutiny. I often look back at that time as an 
2 
induction — or a disillusionment — as it was the moment when the biosciences 
became a real embodied knowledge set rather than merely a textual topic of 
study. Though my research and production had centered on science, medicine, 
and the body for a decade, it was at SymbioticA that my work as an artist came 
to life. 
Biotechnology is arguably the most significant technological development of our 
time. Historically, humankind has harnessed the ability to produce and 
reproduce (in an industrial sense), as well as simulate (with computation), but 
with biotechnology we are able to breed, and indeed to birth, generational life 
forms that serve as tools and subjects — creating living, embodied technologies 
that, in turn, interact with and alter our bodies and the planet's ecology. We see 
ourselves facing an alarming threshold where humanity, as we understand it 
today, will be irrevocably changed by the technological trajectories that we 
choose. Biotechnology and, more specifically, projected cloning technologies are 
imagined as a kind of Pandora's box. Paradoxically, these technologies offer 
great humanitarian potential, particularly in the health care sector, yet 
simultaneously they ensure, a societal leap into a vast and possibly devastating 
unknown. In The Biotech Century, Jeremy Rifkin states that "The biotechnology 
revolution will affect each of us more directly, forcefully, and intimately than any 
other technology revolution in history."3 With such focus placed on predictions 
and forecasts (the hype and hysteria) surrounding biotechnology, we often 
3
 Jeremy Rifkin, The Biotech Century: Harnessing the Gene and Remaking the 
World, (New York: Tharcher/Putnam, 1998), p. 236. 
3 
overlook the bio-manipulations and bio-invasions of the physical and social body 
occurring each and every day. In vitro fertilization, plant hybridization, 
pasteurization, antibiotics, vaccines, and genetic testing, to name only a few, are 
all established and integrated technologies that/after corporeal existence in our 
society. Arguably, there is no impending biotechnological threshold — or, if there 
is, it has already been crossed. Quietly, and without pomp or circumstance, we 
have slipped into the biotech future. 
We are already immersed as a species, society, and ecology, in harnessing the 
natural world towards human ends. This process of life manipulation goes back 
thousands of years — humans have long been breeding, planting, culling, and 
affecting life forms towards survival and aesthetic ends. This process is easy to 
imagine as a one-way manipulation, particularly given our anthropocentric view 
that human beings are simply influencing the environment around us to suit our 
needs. However, I prefer to see this relationship as reciprocal; humanity is a 
component of the very ecology we intend to harness. In fact, I would argue that 
this process of manipulating our ecology (and, by extension, ourselves) is not 
restricted to the human race, although we understand biotechnology as 
inherently a cultural and unnatural act. If we distance our analysis from the 
specificities of this particular incursion, we can interpret biotechnology as an 
evolved relationship between species and environment: one of ecology. I am 
reminded of Richard Lewontin's description of a cyclical ecology: 
4 
Every species, not only Homo Sapiens, is in the process of destroying its 
own environment by using resources that are in short supply and 
transforming them into a form that cannot be used again by the individuals 
of the species. ... But every act of consumption is also an act of 
production. That is, living systems are the transformers of materials, 
taking in matter and energy in one form and passing it out in another that 
will be a resource for consumption for another species.4 
This life-manipulating drive has grown exponentially in the last hundred years. In 
this time, we have identified the constituent parts of life (atoms, cells, DNA) and 
manipulated these parts to the extent that organic chemistry and microbiology 
are no longer observational but experimental sciences. In his detailed 
investigation The Uses of Life: A History of Biotechnology, Robert Bud outlines, 
in great detail, a lineage of life manipulation, from the inception of agriculture to 
contemporary genetic manipulations. He provides a common definition of 
biotechnology; it is "...the application of scientific and engineering principles to 
the processing of materials by biological agents to provide goods and services."5 
Bud marks the 1980s as the birth of our contemporary conception of 
biotechnology, one dominated by genetics and genomics with great emphasis on 
the commercialization potential of these fields. He states, "Practically the entire 
period covered by this book so far could be considered as the 'prehistory' of 
4
 Richard Lewontin, The Triple Helix: Gene, Organism, and Environment, 
Cambridge: Harvard University Press, 2000. P.55. 
5
 Robert Bud, The Uses of Life: A History of Biotechnology, Cambridge: 
Cambridge University Press, 1993. P.1. 
5 
biotechnology, for only in the 1980s did biotechnology acquire internationally 
recognized significance. Certainly, it was then that the subject became an 
economic category, with careful measurements of national investments and 
outputs."6 
This incarnation of biotechnology as an economic entity draws my attention as an 
artist and activist to the field. On a fundamental level, I find it very disconcerting 
for life to be conceived of and mobilized as a commodity. Certainly, my concern 
for this situation is inherently flawed and hypocritical, as the commodification of 
life is as old as the economy itself. In addition, I have benefited directly from this 
basic premise, as has everyone else on this planet. Animal husbandry (to obtain 
food, byproducts, and domestic pets) is an industry deeply entrenched in our 
civilization and an excellent example of accepted life commodification. My fear in 
regard to biotechnology is more specific. I worry about allowing economic gain to 
determine the research trajectories, applications, and outcomes of this 
revolutionary means of harnessing generational life with little consideration of the 
long-term biological implications. Though subject to alarmist language, and 
espousing a didactic rejection of all things biotechnological, Jeremy Rifkin would 
certainly agree: 
Several of the largest life science companies are extending their 
commercial activities to virtually every bio-industrial field. ... The 
increasing consolidation of control is alarming, especially considering that 
6
 Robert Bud, The Uses of Life: A History of Biotechnology, Cambridge: 
Cambridge University Press, 1993. p. 189. 
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the biotech revolution will affect every aspect of our lives: the way we eat, 
the way we date and marry, the way we have our babies, the way our 
children are raised and educated, the way we work, the way we perceive 
the world around us and our place in it.7 
The biotechnology we perpetuate today involves multifarious processes and 
orders of life. While my area of specialty is tissue culture and tissue engineering 
(a segment of regenerative medicine), but we can also look to fields such as in 
vitro fertilization, biological warfare, biometrics, genomics, and pharmacology in 
order to understand the far-reaching boundaries of contemporary biotechnology. 
With these advancements, we are manipulating manifold orders of life; plant, 
animal, human, partial-life8 — cells, serums, bacteria, and plasmids — towards 
short-term economic gain. The market economy model, in a similar fashion as 
the scientific model, does not take into account those elements (such as 
irrationality or empathy) that reside outside of the systematic construct in which 
they are established and perpetuated. For example, human (or animal, plant, 
cell) indignity, pain, and suffering are not significant factors in reaching sound 
economic decisions. Also, if we look to more long-term considerations, economic 
gain is rarely judged against undefined ecological and humanitarian outcomes, 
as we clearly have little idea what will result from these invasive (and often 
7
 Jeremy Rifkin, "The Biotech Century: Genetic Commerce and the Dawn of a 
New Era." from LifeScience: Ars Electronica 99. Stocker, Gerfried and Christine 
Schopf. Edits, New York: Springer-Verlang, 1999. p. 48. 
s
 Oron Catts, and lonat Zurr "Growing Semi-Living Sculptures" from Leonardo 
Magazine, MIT Press, Issue 35:4, August 2002, p. 366. 
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multigenerational) manipulations of the body. We seem to exhibit little foresight 
in imagining the possible ramifications of our biotechnological actions. 
In addition to these general concerns linking life with economy, I am particularly 
focused on the lack of disclosure of biotechnological procedures and protocols to 
the general public. A culture of non-disclosure surrounds the biotechnological 
field, manifested by rampant over-specialization, instilled patent rights, and a 
competitive research community. Full communication of biotechnological 
procedures, protocols, and detailed risk-management reports is minimal. How 
can we, as a society, investigate, debate, and reach consensus about future 
biotechnological trajectories without full disclosure and general education? Or is 
it truly best to leave these decisions to businessmen, government officials, and 
scientists? It is my assertion that it is unethical to sever the general population 
from full knowledge of the products, legislation, and research that we are blindly 
and unconsciously supporting. 
Both over-specialization in the field, and the dominance of economic interests in 
regards to biotechnology, contribute significantly to undermining public 
engagement in biotechnological research trajectories and debates. However, I 
see another important factor, that will serve as a central theme of (RE)embodying 
Biotechnology, the perpetuation of digital metaphors mobilized in the description 
and representation of biotechnology in public discourse. As I will outline in 
greater detail in chapter 3, I see a long trajectory of understanding, describing, 
8 
and mobilizing life based on metaphors generated by the latest technological 
revolution, be it the industrial revolution that spurred mechanistic models for 
conceiving of life as described by Lewontin: 
Such an analytic mode of understanding and study of biological systems, 
appropriate to a machine, is implied in the very word organism, first used 
in the eighteenth century. The analogy is between the living body and the 
musical instrument composed of separate parts that work together to 
produce a variety of final functions.9 
Or perhaps the computational model that is applied in the description of all 
aspects of life, as elucidated by Gerfried Stocker: 
The post-human movement's pipe dream of soon being able to transform 
human beings into nomadic software entities takes an interesting turn in 
the emerging interpretation of the human body (or rather, all biological 
organisms) as wetware platform. Instead of the transformation of the 
human spirit into Os and 1s, it is now the gigantic operation of the Human 
Genome Project which it is hoped will produce the decoding of the 
genome as the human operating system. And because we have learned 
so well over the long years of the digital information revolution to dress up 
everything in computer parlance, terminology like "the software of life" and 
9
 Richard Lewontin, The Triple Helix: Gene, Organism, and Environment, 
Cambridge: Harvard University Press, 2000. P.72. 
9 
reference to the human genome as the "human being's operating system" 
are already solidly established.10 
Along with Stocker, it is* my fear that, with a continued investment in digital 
metaphors to describe biotechnology in public discourse, we are effectively 
undermining an ethical and reflective consideration of the various orders of life 
that function as the material basis of this technology. (RE)embodying 
Biotechnology undermines the use of these metaphors in describing biotech and, 
instead, propose and practice embodied language sets, embodied relationships, 
and moments of embodied reflexivity in the image, the representation, and the 
practice of contemporary biotechnology. 
As a result, (RE)embodying Biotechnology is a reciprocal and hopefully dialogic 
text, which conceives of biotechnology as a pluralistic, ongoing process of 
manipulating life and manipulating ourselves, with an emphasis on social and 
political criticism. My efforts are focused on the democratization of 
biotechnology. I am proposing an interdisciplinary research / creation strategy 
for achieving this goal. My process includes participation in real hands-on 
laboratory practices, the production of complex artworks, and critical theorization 
and reflection. I believe that by participating in the biological sciences individual 
non-specialists can become empowered because they gain a new understanding 
of their ethical relationship to biotechnology. I am proposing an embodied, 
10
 Gerfried Stocker and Christine Schopf. Edits. LifeScience: Ars Electronica 99. 
New York: Springer-Verlang, 1999. P.23. 
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empathetic, participatory, and populist-driven investment in analyzing proposed 
biotechnologies outside of primarily economic criteria. The intended outcome of 
my research / creation (my artistic practice, and (RE)embodying Biotechnology) 
is to allow you, the reader, to come to your own conclusions regarding the 
multiple ways biotechnological research is practiced today. My greatest criticism 
is not of biotechnology in general but of the poor and often misleading 
dissemination of information to the general public that effectively excludes 
individuals and communities from participating in determining the directionality of 
this significant technological revolution. 
This research is influenced greatly by a form of thinking about science and 
technology proposed by the artist group Critical Art Ensemble (CAE). The 
introduction to The Molecular Invasion explains how this model evaluates 
biotechnological processes on a case-by-case basis. 
Each product or process has to be taken on a case-bye-case basis. 
Some appear disastrous (primarily to the environment), while others seem 
soundly engineered and useful. The real question of GMOs is how to 
create models of risk assessment that are accessible to those not trained 
in biology so people can tell the difference between a product that 
amounts to little more than pollutants for profit and those which have a 
11 
practical and desirable function, while at the same time having no 
environmental impact.11 
Certainly, this specified investigation of each procedure and protocol amounts to 
a lot of work. But it is deeply important that we, as individuals and as a society, 
come to our own independent conclusions about the efficacy and ethics of 
biotechnological protocols. 
Here, I am reminded of the image of Noam Chomsky surrounded by stacks of 
newspapers as part of his daily reading and research in the documentary 
Manufacturing Consent: Noam Chomsky and the Media. He states: 
The point is that you have to work. And that's why the propaganda system 
is so successful. Very few people are going to have the time or the energy 
or the commitment to carry out the constant battle that's required to get 
outside of Lehrer, or Dan Rather, or somebody like that. The easy thing to 
do, you know, you come home from work, you're tired, you had a busy 
day, you're not going to spend the evening carrying out a research project. 
So you turn on the tube, you say it's probably right, or you look at the 
headlines in the paper, and then you're watching sports or something. 
That's basically the way the system of indoctrination works. Sure the other 
" Critical Art Ensemble. The Molecular Invasion. Brooklyn: Autonomedia, 2002. 
P.3-4. 
12 
stuff is there, but you're going to work to find it.12 
Chomsky's critical attitude, prevalent throughout his lectures and publications, 
proposes that individuals take responsibility for theirirves by doing their own 
research — outside of popular media, propaganda, and even his own assertions 
— to come to informed conclusions about social and political issues. The focus 
of (RE)embodying Biotechnology is to describe one enabling strategy that is akin 
to Chomsky's notion of 'work' to understand and arrive at independent 
conclusions about biotechnological protocols. Unlike Chomsky, my 'work' is not 
merely and analysis of news discourse. My 'work' is carried out from a hands-on 
perspective within the laboratory. 
This position advocates a critical, participatory approach for engaging with 
biotechnology. It is the central thrust of (RE)embodying Biotechnology and 
reflects my continued investment in bioart production. I present a research / 
creation project from at least three different standpoints: personal, political, and 
artistic. The results include a written text, three appendices ( including my 
personal lab notes), and documentation of my collaborative art practice over the 
past ten years. I mobilize a number of disciplinary perspectives (communication 
and media studies, anthropology, art history, creative writing, and contemporary 
12
 Mark Achbar and Peter Wintonick, Manufacturing Consent: Noam Chomsky 
and the Media,1992. 2:39:15 
13 
art production) towards an implicated ecological relationship with evolving 
biotechnologies. 
The structure of the text itself reflects the varying verisimilitudes of conflicting 
arguments, hindsight, and grey areas that erupt as complications when engaging 
critically with bodies in biotechnology (although, despite this chaos, rationality is 
still significant to this dialogue). Most often, I choose to maintain a collected 
distance from what some may perceive of as 'the horror'13 of life harnessed in the 
laboratory. This strategy of both breaking with the academic canon and 
strangely adhering to it is indicative of my general approach to research and 
production. With (RE)embodying Biotechnology, form assumes the qualities of 
subject or, more accurately, subjectivities. With the goal of educing Chomsky's 
'work' in the reader, I reveal my own 'work' for your consideration. 
Towards that end, let me provide a brief chapter outline. Chapter 2 provides an 
introduction into the gross over-specialization of the biological sciences, as well 
as the powerful significance of artists infiltrating the specialist class. In Chapter 
3, I address the incursion of digital metaphors in describing the biotechnological 
sphere to the general public and introduce the reader to alternative language 
sets, propagating more implicated and embodied language for describing 
scientific protocols. Chapter 4 details the actualities of bioart production, with a 
case study of the exhibition BIOTEKNICA: LiveLifeLab, authored by myself and 
13
 Joseph Conrad. Heart of Darkness. 1902; available online: URL: 
http://www.gutenberg.org/etext/526 [date of last access: 07/12/2008] 
14 
Shawn Bailey at the FOFA Gallery in Montreal in 2007. I have also included a 
copy of the video documentation from this installation, produced by Yen-Chao 
Lin, entitled BIOTEKNICA: LiveLifeLab. The concluding chapter discusses the 
results of this approach, as I have experienced and perceived them, and 
provides a more phenomenological understanding and engagement with 
biotechnology as an instance of implicated ecology. Lastly, I have chosen to 
include three appendices for further information and to better elucidate the 'work' 
involved in this kind of research. The appendices include: (1) my personal lab 
notes from the 2006 residency at SymbioticA, (2) a basic tissue culture protocol, 
and (3) a segment of the human research ethics application submitted by Shawn 
Bailey and myself to Concordia University in 2005. 
Having presented a clear introduction to the concerns of (RE)embodying 
Biotechnology I wish to define two central concepts, biotechnology and the body. 
I will then describe my collaborative research / creation project BIOTEKNICA. 
This undertaking serves as a catalyst and case study for the re-embodiment of 
biotechnology and is essential to the foundations of this text. 
Defining Biotechnology 
I want to establish a working definition of biotechnology through the intersection 
of multiple texts in order to formulate a temporally and materially plural 
15 
description of the field. Outside of the humanities, biotechnology is typically 
understood in three different ways: (1) as a function of the economy, (2) in terms 
of disciplinary boundaries established in science and engineering, and (3) in 
terms of its techniques and protocols. I wish to touch briefly on all three of these 
understandings and put them in dialogue with research in the humanities so as to 
provide a more contingent reading of this complex field. 
We have already encountered Robert Bud's contemporary definition of 
biotechnology, which links it to the economy: "...the application of scientific and 
engineering principles to the processing of materials by biological agents to 
provide goods and services."14 This fairly common definition is mirrored in texts 
which have been developed by organizations in the financial and investment 
sectors. Another good example of this understanding is found in a text by The 
Organization for Economic Co-operation and Development: "The application of 
science and technology to living organisms, as well as parts, products and 
models thereof, to alter living or non-living materials for the production of 
knowledge, goods and services."15 This definition captures some of the 
dominant ideologies that define biotechnology. However, I am critical of this 
economic reductionist understanding of bodies in biotechnology. 
14
 Robert Bud, The Uses of Life: A History of Biotechnology, Cambridge: 
Cambridge University Press, 1993. P.1. 
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 Organization for Economic Co-operation and Development, "Statistical 
Definition of Biotechnology." From OECD website; available online: URL: 
http://www.oecd.org/documentprint/0,3455,en_2649_34537_1933994_1_1_1_1, 
OO.html [date of last access: 10/10/2007] 
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From the perspective of science and engineering, definitions of biotechnology are 
often based on the boarders between the disciplines. For example, Health 
Canada relies on the definition of biotechnology proposed in the Canadian 
Environmental Protection Act of 1999. It describes biotechnology as "the 
application of science and engineering to the direct or indirect use of living 
organisms of parts or products of living organisms, in their natural or modified 
forms."16 This perspective is quite common — and not without historical 
significance, as Robert Bud illustrates in his process of tracing the origins of 
contemporary biotechnology during the industrial revolution. 
The concept of biotechnology would, by contrast, integrate the 
contemporary ideal of manufacturing with visions of humanity and its 
environment, and a faith in the privileged view of life. Though it is perhaps 
surprising to find the metaphor of the machine relevant even to organic 
philosophers, for them the machine became a symbol of the system that 
was more then the sum of its parts and has an irreducible character of its 
own. Thus, both the severely mechanistic models of biological organisms 
were endowed with some special organizing or developmental character 
not available to man-made systems, yielded concepts of biotechnics.17 
16
 Health Canada, "About Biotechnology." From Health Canada website; 
available online: URL: http://www.hc-sc.gc.ca/sr-sr/biotech/about-
apropos/indexe.html [date of last access: 10/10/2007] 
17
 Robert Bud, The Uses of Life: A History of Biotechnology, Cambridge: 
Cambridge University Press, 1993. P.52. 
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This perception of biotechnology reduces the biotechnological manipulation of life 
to a mechanical action, defined by the boundaries of established disciplines. 
The previous example comes from public policy documents, but this tendency 
also occurs in scientist's description of their own actions. In the book The 
Second Creation: Dolly and the age of Biological Control, Dr. Ian Wilmut18 
defines biotechnology in a similar fashion — as an intersection of disciplines with 
emphasis on the contribution made by the hard sciences. 
Technology without Science is, well technology: stone tools, windmills and 
mud huts. Technology with science is "high technology"; "high tech" is the 
technology that emerges from science. "Biotechnology" is high tech of a 
biological nature: genetic engineering and cloning are prime examples.19 
Wilmut's colloquial definition of biotechnology is likely intended for mass 
audiences. I would argue, however, that there is a distinctly partisan scientific 
viewpoint expressed in this quotation, simultaneously claiming biotechnology and 
. other 'high' technologies for the sciences and deploying highly optimistic, 
promotional language sets in persuading the general public of the intrinsic merits 
of biotech. 
(Head of the research consortium at The Roslin Institute responsible for 
generating the first cloned mammal Dolly the sheep in 1997) 
19
 Ian Whilmut, Keith Campbell, and Colin Tudge, The Second Creation: Dolly 
and the age of Biological Control. Cambridge: Harvard University Press, 2000. 
p. 10. 
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One other discursive tendency is to define biotechnology by its techniques, 
procedures, and protocols. For example, the Cartagena Protocol on Biosafety 
authored by the Convention on Biological Diversity (2004) relies heavily on the 
idea of technique in defining the field: 
(i) "Modern biotechnology" means the application of: 
a. In vitro nucleic acid techniques, including recombinant deoxyribonucleic 
acid (DNA) and direct injection of nucleic acid into cells or organelles, or 
b. Fusion of cells beyond the taxonomic family, 
that overcome natural physiological reproductive or recombination barriers 
and that are not techniques used in traditional breeding and selection;20 
Contemporary definitions of biotechnology such as these often prioritize genetic 
manipulation as a central component of the field. Another example of this type of 
technical emphasis is this rudimentary definition provided by Stephen Heuser in 
his article "What is Biotechnology?" published in the Boston Globe: 
In a strict sense, it means altering live cells and putting them to work. By 
20
 The Cartagena Protocol on Biosafety, "Article 3. Use of Terms." From The 
Convention of Biological Diversity website; available online: URL: 
http://www.cbd. int/biosafety/articles.shtml?a=cpb-03 
[date of last access: 10/10/2007] 
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splicing new genes into the DNA of bacteria or other organisms, scientists 
can program them to make drugs. They can also introduce new genes into 
crops and create microbes that produce industrial chemicals. 
More broadly, biotech embraces a spectrum of medical science, from 
sophisticated biochemistry to machines that can build new DNA. In the 
business world, the term "biotechnology company" is often shorthand for 
any small or start-up pharmaceutical firm.21 
Although these statements come from two very different types of documents, 
they are similar because of their reduction of biotechnology to technique alone. 
I am critical of this reductionism for two reasons. First, technique-based 
definitions of the biotechnological field often suffer from 'genohype,'22 which 
places overwhelming significance on genetics and genetic manipulation as the 
defining features of an otherwise very diversified field. Second, technique-based 
definitions tend to eliminate the social, political, and economic factors that also 
work to constitute biotechnology in its contemporary manifestation. 
21
 Stephen Heuser, "What is Biotechnology?" From The Boston Globe website; 
available online: URL: 
http://www.boston.eom/business/technology/biotechnology/articles/2007/05/06/w 
hat_is_biotechnology/ [date of last access: 10/10/2007], May 06, 2007. 
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If we look to the debates in the philosophy of science, we can find an alternative 
vision of biotechnology. In these discourses there is a tendency to explain the 
social and political factors that structure and influence the field. This perspective, 
for example, informs Paul Brodwin's introduction to Biotechnology and Culture: 
Bodies, Anxieties, Ethics: 
The word "biotechnology" denotes much more then material devices, 
designed for specific medical functions. It also includes the techniques for 
using them: the background practices and treatment rituals in which a 
given device acquires its meanings. The value and meaning of 
biotechnologies, like those of all manufactured objects, are not inherent 
properties but rather judgments made by people who use them 
(Appadurai). These judgments arise first among the laboratory 
researchers who fashion the technology and their colleagues and financial 
supporters (for example Rainbow). The judgments continue in the clinic 
as people gradually master a new instrument or machine, routinize it as a 
standard therapy, and embed it in the complex negotiations among health 
care workers, patients, their families, insurers and others. Finally, certain 
biotechnologies become powerful, public symbols even for those who 
never directly encounter them.23 
I am very interested in the perspective offered by Brodwin, as it allows for 
individual and community contributions to an otherwise 'technical field.' 
23
 Paul E. Brodwin, (edt) Biotechnology and Culture: Bodies, Anxieties, Ethics, 
Bloomington and Indianapolis: Indiana University Press, 2000. P.2. 
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In other contemporary critical circles biotechnology is often read with an 
emphasis on the intersection of the biological sciences with computation. In The 
Biotech Century: Harnessing the Gene and Remaking the World, Jeremy Rifkin 
argues for the importance of the conjunction of "the genetic revolution and the 
computer revolution"24 with molecular biology, as well as the expanding field of 
bioinformatics, as central to his definition of biotechnology. Another noted critic, 
Eugene Thacker, places similar significance on digital technologies in his 
definition of biotechnology in Data Made Flesh: Biotechnology and the Discourse 
of the Post Human. He states, "When we consider advances in these fields, it 
becomes apparent that what characterizes biotech is a unique relationship 
between the biological and the informatic."25 I would certainly agree that the 
conjunction of genetics with computation in molecular biology is of cornerstone 
significance; Thacker and Rifkin (amongst others) provide insightful descriptions 
and analysis of this important intersection. However, I am concerned by the 
overarching dominance of bioinformatics in defining the entire field of 
biotechnology, as well as the prioritization of only the most contemporary 
incarnations of biotech in describing a set of practices that have evolved over 
hundreds of years. As was the case for mechanical models during the height of 
industrialization, I see us applying our most recent technological paradigm, 
Jeremy Rifkin. The Biotech Century: Harnessing the Gene and Remaking the 
World. New York: Tharcher/Putnam, 1998.p. xv. 
25
 Eugene Thacker. "Data Made Flesh: Biotechnology & the Discourse of the 
Posthuman", Cultural Critique 53 Available online: URL: 
http://www.upress.umn.edu/journals/cc53.html [date of last access: 08/01/2005] 
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computation, to the description of the nature of all things — including living 
systems — in the present, past, and future. 
I advocate for an understanding of biotechnology that reflects the long history of 
biotechnological experimentation that has been conducted by humankind. If we 
look to the example established in A Feeling for the Organism: The Life and 
Work of Barbara McClintoch, Evelyn Fox-Keller reminds us that the biological 
sciences — specifically, the field of genetics — proved successful in explaining 
complex natural phenomena like heredity, mutation, and transposition, by 
utilizing pre-digital observational methodologies of inquiry.26 I suggest we look to 
other instances in the history of the instrumentalization of biology prior to the 
advent of mass computation in the sciences — for example, tissue engineering, 
in vitro fertilization, selective breeding, pasteurization — before we embrace 
biotechnology as the intersection of computation with biology. Although we see 
that the digital is indispensable for recording, documenting, and modeling such 
experiments, I propose that we look to contemporary practices of 
biotechnological research where laboratory protocols are not dictated by 
computation but rather by biological practices that are practical, tangible, and 
accessible. 
I am interested in applying the theoretical understanding of technology proposed 
by Jennifer Daryl Slack in Rethinking Communication Vol. 2 Paradigm Exemplars 
26
 Evelyn Fox-Keller. A Feeling for the Organism: The Life and Work of Barbara 
McClintock. New York: Henry Holt and Company, 1983. p. 181. 
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in order to better describe this complex field. In the chapter, "Contextualizing 
Technology," she states: 
-t: that a technology is not simply an object connected in various ways to 
the institutional and organizational structures from within which it emerges 
to be reconnected in a new context, but that it is always an articulated 
moment of interconnections among the range of social practices, 
discursive statements, ideological positions, social forces, and social 
groups within which the object moves.27 
Taking this definition of technology into consideration, my overarching definition 
of biotechnology becomes far more contingent and temporal; it becomes less 
focused on a description of the techniques involved and more focused on 
understanding biotechnology as an intersection between a variety of interests 
and agents. This understanding, in conjunction with the methodology proposed 
by Critical Art Ensemble (from the general to the very specific analysis and 
understanding of biotech), opens up the possibility for a dialogic or complexity-
driven engagement with the pluralism that constitutes biotechnology today. 
Slack's definition can be expanded further to develop a description of 
biotechnology. Here, the 'so called' object of biotechnology is not a stable entity 
27
 Jennifer Daryl Slack. "Contextualizing Technology" from Rethinking 
Communication vol. 2 Paradigm Exemplars. Brenda Dervin, Lawrence 
Grossberg, Barbara J. O'Keefe, and Ellen Wartella edts. Bervily Hills: Sage 
Publications, 1989. p.339. 
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— it is not only moving but growing, pulsating, living, and dying as it moves 
through other forces. Thacker draws our attention to this very point. He says, 
"Biotech research is unique in that, on the one hand it employs the technologies 
common to other posthuman fields (principally, computer/information 
technologies), but on the other hand, its constant 'object' of study is the domain 
of the biological (a domain traditionally set apart from the technological)."28 His 
work with the notion of biomedia will prove to be of great value in this regard, but 
requires tweaking to suit my purposes. The understanding of biotechnology that 
I propose resides at a shifting intersection of life forms with time, place, 
ideologies, and intentionalities in perpetuating a technology of living systems: a 
techno-ecology. 
Understanding the Body 
Ironically, one of the first step towards re-embodying biotechnology must begin 
with language. From my perspective, we need to reconceptualize biotechnology 
as a technology of living systems — a technology of bodies. For this definition to 
operate successfully, we must expand our understanding of a body to include 
multiplicities of bodies — the human body, the animal body, a body of water, 
bodies within the body, even antibodies. This expanded definition of the body 
has echoes in the work of Elizabeth Grosz. 
Eugene Thacker. "Data Made Flesh: Biotechnology & the Discourse of the 
Posthuman", Cultural Critique 53 Available online: URL: 
http://www.upress.umn.edu/journals/cc53.html [date of last access: 08/01/2005] 
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In Volatile Bodies: Towards a Corporeal Feminism she argues that the mind/body 
dualism prevalent throughout philosophy must be refigured for feminist purposes. 
She states, "misogynist thought confines women to the biological requirements of 
reproduction on the assumption that because of particular biological, 
physiological, and endocrinological transformations, women are somehow more 
biological, more corporeal, and more natural than men."29 She proposes that we 
mobilize the body through a range of desperate discourses that are not restricted 
to naturalist and scientific models. She suggests, "A plural, multiple field of 
possible body "types", no one of which functions as the delegate or 
representative of the others, must be created, a "field" of body types - young and 
old, black and white, male and female, animal and human, inanimate and 
animate - which, in being recognized in their specificity, cannot take on the 
coercive role of singular norm or ideals for all the others."30 Grosz's philosophy is 
convincing. With a shift in the definition of the body towards a plural and multiple 
field of possible bodies, we can begin to imagine animal bodies, chimera bodies, 
bacterial bodies, even scientist and non-specialist bodies as key participants in 
biotechnology. Additionally, she doesn't see the body as just flesh, but as a 
semiotic factor - a body of language. 
I am also interested in Donna Haraway's critical conceptualization of the cyborg 
likewise incorporates bioinformatics into the biotechnological body fold. Haraway 
Elizabeth Grosz, Volatile Bodies: Towards a Corporeal Feminism. Australia: 
Allen &Unwin 1994. p.15. 
30
 ibid. p.22. 
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is important because she understands the implications of bioinformatics in 
current conceptions of the body. Just as I am arguing that it is a great oversight 
to conceive of the bodies in biotechnology as primarily informatic and therefore 
virtualized, I maintain that it would also prove a grave oversight not to 
acknowledge the power of computational and technological components of the 
bodies in biotechnology. Haraway defines the cyborg as such: 
A cyborg is a hybrid creature, composed of organism and machine. But, 
cyborgs are compounded of special kinds of machines and special kinds 
of organisms appropriate to the late twentieth century. Cyborgs are post-
Second World War hybrid entities made of, first, ourselves and other 
organic creatures in our unchosen 'high-technological' guise as 
information systems, texts, and ergonomically controlled labouring, 
desiring, and reproducing systems.31 
Like Haraway, I am focused on developing a plural field of bodies - animal, 
human, semi-living, cellular, and even hybrid bodies, operating in the 
biotechnological domain. As Haraway argues, "Cyborg imagery can suggest a 
way out of the maze of dualisms in which we have explained our bodies and our 
31
 Donna Haraway, Simians, Cyborgs, and Women: The Reinvention of Nature. 
Routiedge: New York, 1991. P.1. 
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tools to ourselves. This is a dream not of common language, but of a powerful 
infidel heteroglossia."32 
Though a deeply important task, shifting the language surrounding biotechnology 
in the media, classrooms, and hospitals from one of pure programming to a 
language of plural embodiment may also prove damaging to progress in other 
areas of ethics and human rights — particularly for women, in regard to abortion. 
In arguing for a widespread acknowledgement of the bodies in biotechnology, I 
may be inadvertently contributing to pro-life arguments in the public debate about 
abortion and reproductive technologies. If my argument for a plural field of 
bodies is misinterpreted as a 'vitalist' assertion, then one might assume that I am 
also arguing against the death or termination of all orders of life — against 
actions such as abortion. Rather than 'vitalism,' I see my arguments as more 
closely aligned with a sort of 'organicism.' 
Donna Haraway aptly outlines the distinguishing factors between these 
conceptualizations of life in Crystals, Fabrics, and Fields: Metaphors that Shape 
Embryos: 
Vitalism and organicism share basic questions and positions. From a 
negative point of view, both maintain that the study of parts does not 
suffice to explain the study of the whole. The methods and conclusions of 
other sciences, in particular physics and chemistry, are held to be 
nibid. P. 181. 
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applicable to organisms but radically insufficient. Second, the form of the 
whole is important in embryological development, animal behavior, 
reproduction, and physiology. By whatever means, the properties of the 
whole are essential in determining the nature and behavior of the parts at 
each stage in the life cycle as vice versa. Last, both organicists and 
vitalists stress the teleological behavior of organisms: there is at least the 
appearance of goal-directedness and design in biological phenomena.33 
She continues, 
Nevertheless, organicists and vitalists differ fundamentally on where they 
locate the root of wholeness and consequent regulative behavior of 
organisms. Vitalists of all hues assert some non-physical entity - either a 
nonquantifiable vital force like Driesch's entelechy or some basic 
difference between "vital substance" and ordinary matter. Organicists 
insists on wholeness, directedness, and regulation can be explained fully 
without such notions.34 
The distinction between vitalism and organicism is important to my argument. 
Though I am suggesting that we embrace a wide notion of possible bodies within 
the laboratory site, I am not suggesting that we in turn apply the notion of a 'vital 
force' or 'soul' in our understanding of these bodies. 
33
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My intention is to acknowledge and draw public attention to these issues so that 
they may be viewed outside of didactic models and anthropocentrism in order to 
illustrate the significance of all the bodies intersecting at the site of 
biotechnology. I wish to consider each cell, plant, ecosystem, and animal (and, 
by extension, each patient and fetus) an emergent body of varying verisimilitudes 
in interaction with other bodies; I wish to consider each body — sometimes 
growing, sometimes dying — as life. In addition, the end of life should not be 
seen as an intrinsic failure, or as something to be avoided at all costs, but as a 
significant and acceptable component of the life cycle. I am arguing that we 
need to truly embrace the murky, messy, and sometimes violent processes of 
living. I am suggesting that we take a moment to 'look our meat in the eye'. I am 
suggesting that we create a site, and a body of language, that invites the public 
to formulate their own complex opinions and understandings about each specific 
technological practice in the field of biotechnology. If we can adopt this notion of 
an embodied technology, we are more likely, as a society, to formulate 
responsible, informed, and grateful attitudes to the consequences resulting from 
our choices. 
In Beyond the Body of Bioethics: Challenging the Convention, Margrit Shildrick 
challenges conventional bioethical strategies. She argues that we need to 
embrace increasingly fluid and contingent strategies of interpreting the ethics of 
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the body. The first component of her argument suggests that, with evolving 
models for understanding the body in humanities-based circles, we have already 
relinquished an oversimplified, fixed definition of the body, that is central to 
conventionahethical (and often moral) evaluation. 
The second important point she makes is in regards to interpreting the ethic of 
biotechnologies, the very locus of interpretation — biotech — is itself producing 
contingent and multiple incarnations of the body and therefore requires pluralistic 
treatment. Shildrick suggests: 
The problem with - and, I would argue, the relative limitations of mainstream 
bioethics is that its concentration on issues such as choice and consent, 
property interests, rational decision making, and equality of access still relies 
on the traditional ethical model in which the ultimate determinants of moral 
agency are individuality and rationality. It is not that these things are 
unimportant, but that they are rooted in a world that is being radically 
transformed by the capacities of bioscience to very and extend the hitherto 
limited things of which bodies seem capable. Where once the material body 
could be taken as relatively stable and predictable (although postmodernists 
would argue that has always been an illusion), the technological possibilities 
of a postmodern age - and this is especially clear in the area of reproduction 
and genetics - continually disrupt humanist certainties.35 
Margrit Shildrick, "Beyond the Body of Bioethics: Challenging the 
Conventions." From Ethics of the Body: Postconventional Challenges, M. 
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Shildrick argues that traditional notions of ethics are based on liberal humanist 
beliefs, such as liberty and equality, that rely on binary notions: the division 
between mind and body; subject and object, right and wrong.36 In the process of 
introducing an array of papers analyzing ethics and the body in the 
biotechnological age, Shildrick instead proposes a multifold (and sometimes 
contradictory) approach to bioethics in order to better reflect the transient nature 
of the body in the biotechnological age. I am particularly interested in her work 
for its dialogical model of engaging in bioethics as it applies to biotechnological 
bodies and its relevance to my ongoing collaborative art/research project, 
BIOTEKNICA. 
BIOTEKNICA" 
From 2000 until 2007, Shawn Bailey and I developed a collaborative research / 
creation project called BIOTEKNICA.38 Our initial focus was an artistic and 
Shildrick and R. Mykitiuk Edts. Cambridge and London: The MIT Press. 2005 
p.9. 
36
 ibid p.5. 
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 A large portion of the following BIOTEKNICA description is taken from various 
papers published collaboratively by myself and Shawn Bailey between 2000-
2007. All other portions of this thesis are singularly authored by myself, Jennifer 
Willet. 
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 BIOTEKNICA was a two-person artist collective that produced a variety of 
performances, artworks, and academic papers and lectures. Our collaborative 
research was funded by The Canada Council for the Arts, the Conseil des arts et 
des lettres du Quebec, and Hexagram, amongst others. Most notably, we 
received three year funding from The Social Science and Humanities Research 
Council of Canada in 2005 (S.Bailey principle researcher, J.Willet collaborator) 
for BIOTEKNICA: Organic Tissue Prototypes. All works produced by 
BIOTEKNICA members are 50% co-authored by both parties. BIOTEKNICA 
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academic investigation of the corporate representation of biotechnology in the 
public sphere, with the application of media studies as well as methodologies of 
social and political criticism. We began by looking at a number of biotech 
websites, advertisirrg^campaigns, and printed material. It became immediately 
clear to us that the representation of biotechnological research as propagated by 
most biotech firms provided the general public with generalized, sterilized, 
technologized, and sometimes even euphemistic images of biotechnology, often 
overlooking or even misrepresenting the specific nature of the procedures and 
protocols which make use of living systems. In other words, we saw a great 
disparity between the public representation of biotechnology and the actual 
nature of the various biotech research trajectories. We sought to rectify this 
schism through the development of our own artistic and theoretical practice, 
where we created a fictitious corporation called BIOTEKNICA in order to house a 
variety of avant-garde art actions, research trajectories, and an extensive 
photographic archive, all of which provided alternative representations of the 
bodies in biotechnology outside of the prescribed corporate dictum. 
has been exhibited in various forms including the EnterMultimediale festival, 
Prague (2007), FOFA Gallery, Montreal (2007), ISEA San Jose, USA (2006), 
Biennial Electronic Arts Perth Perth, Australia (2004), The European Media Arts 
Festival Osnabruck , Germany (2003), La Societe des arts et technologiques 
(SAT) Montreal, Canada (2005), and The Forest City Gallery London, Canada 
(2004), amongst others. In addition BIOTEKNICA has been presented in 
interviews and conferences at multiple venues across Canada, and in France, 
Australia, Scotland, Germany, Czech Republic, Serbia, Bulgaria, Turkey, 
Slovenia, Australia and Spain. BIOTEKNICA research has been conducted 
during residencies at The Banff Centre for the Arts Banff, Canada (2002, 2007), 
and SymbioticA, The University of Western Australia, Perth, Australia (2004, 
2006). 
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We sought an imaginary biotechnological product that would serve as a locus for 
a subjective (and sometimes ironic) vision of the biotechnological body. This 
desire led us to a particularly important and grotesque object of biotechnological 
study: the teratomas (ffg.1.) A teratoma is an abnormal and monstrous tumor, 
quite often cancerous and metastasizing in the body of a host organism (whether 
human or animal). It is also an important site of numerous biotechnological 
investigations conducted by governments and corporations. The teratoma is a 
pluripotent germinal cell tumor, in that its cells differentiate as they divide and 
proliferate, much like a fetus. However, the teratoma differs from a fetus in many 
ways. A teratoma requires no instance of fertilization to commence growth. 
Though most often found in the reproductive organs, a teratoma can manifest 
itself throughout the body, whether fetal or adult. As well, the appearance of a 
teratoma differs significantly from a healthy fetus in its irrational and grotesque 
construction. Though a teratoma is almost genetically identical to its host 
organism, and contains an assortment of 'normal' tissues such as skin, nails, 
hair, and teeth, its structure is confused, asymmetrical, and dysfunctional. One 
of our viewers once described the teratoma as having the appearance of a "baby 
in a blender." 
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(FigA.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA: Teratoma Anatomy 
Digitally Generated Duratrans 
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In her insightful book Teratologies; A Cultural Study of Cancer, Jackie Stacey 
equates these irregular cysts with little monsters — a virgin conception of sorts, 
deep within the bowels of the human body.39 Stacey looks to films like The Fly, 
Rosemary's Baby, and Aliens to understand how the little-known teratoma is 
interpreted outside of its clinical setting. Her interest in the teratoma lies in its 
metaphoric qualities in terms of the grotesque, the slippage between traditional 
self/other distinctions, notions of disease, and the healthy human body. On a 
more personal level, the teratoma holds great significance for Stacey as she had 
one removed from her ovary in 1991. 
Jackie Stacey, Teratologies: A Cultural Study of Cancer. New York: 
Routledge, 1997. P.60. 
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In some scientific circles, the teratoma is interpreted as an instance of cloning in 
nature, however non-viable, that has the potential to provide valuable information 
towards understanding and instrumentalizing parthenogenesis (the development 
of a fetus from an unfertilized egg).40 In addition, there is great interest in 
teratomatic tumors that form outside of the reproductive organs, as their location 
suggests that a process of reverse cellular differentiation has occurred in order to 
provide an otherwise differentiated cell with capabilities similar to those of a stem 
cell. Other people, particularly a growing number of fundamentalist Christian 
rights advocates, see the teratoma as a possible ethical source for harvesting 
stem cells for research. It is their argument that the teratoma, unlike a fetus, will 
never result in a live birth and thus does not possess a soul. Dr. William Hurlbut, 
a physician and consulting professor at Stanford University and a member of the 
U.S. President's Council on Bioethics, leads this proposition in American political 
debates.41 In May 2005, the council published the "White Paper: Alternative 
Sources of Pluripotent Stem Cells," which includes a section investigating the 
efficacy of Hurlbut's proposal to create 'biological artifacts' rather than organisms 
in order to harvest viable stem cells. The report states: 
ANT, the modified procedure proposed by Hurlbut, involves altering the 
Advanced Cell Technology, Press Release: Researchers Develop Specialized 
Cell Types From Embryonic Monkey Stem Cells, Advanced Cell Technology 
corporate website; no longer available online URL: 
http://www.advancedcell.com/press.htm [date of last access 02/05/2002] 
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somatic cell nucleus before its transfer to the oocyte, and in such a way 
that the resulting biological entity, while being a source of pluripotent stem 
cells, would lack the essential attributes and capacities of a human 
embryo. 
In offering his proposal for ANT, Hurlbut emphasizes that no embryo 
would ever be created or destroyed; since the genetic alteration is carried 
out in the somatic cell nucleus before transfer, the biological artifact is 
"brought into existence with a genetic structure insufficient to generate a 
human embryo." Hurlbut compares the product of ANT to certain ovarian 
teratomas and hydatidiform moles, genetically or epigenetically abnormal 
natural products of failed fertilization that are not living beings but "chaotic, 
disorganized, and nonfunctional masses." If, as Hurlbut suggests, the 
biological artifact is ethically equivalent to a tissue culture, teratoma, or 
mole, there would seem to be nothing ethically problematic about 
harvesting stem cells from it.42 
With these debates in mind, we deployed the teratoma as a real object of 
biotechnological research and, simultaneously, as an ironic and monstrous 
product in the production of BIOTEKNICA. 
42
 The President's Council on Bioethics, "WHITE PAPER: Alternative Sources of 
Pluripotent Stem Cells." Available online: URL: 
http://www.bioethics.gov/reports/white_paper/text.html [date of last access: 
10/10/2007] 
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In order to support the hoax that was our corporate presence in the public 
sphere, we produced a series of written and visual documents. We developed a 
website, a corporate video, and a promotional brochure. In 2004, with the 
assistance of artist/programmers David Bouchard and David Jhave Johnston, we 
developed the first functional interface for the BIOTEKNICA Virtual Laboratory. 
In the virtual laboratory (Fig.2.), users are provided with a laboratory interface 
(mixing zone), consisting of a number of empty vials which can be filled with 
varying amounts of 'bodily' fluids to concoct a unique teratoma. Each vial is 
identified by terminology of our own creation, invented to seem scientific: 
osteogenicphysis, histiopioesis, dermaplasm, megalytrichoma, scaroadipocyte. 
To any specialist, the language is clearly fraudulent and confused but, in the 
public sphere, the non-specialist user interprets the interface as interactive, 
however inaccessible in its scientific content. This body of work was intentionally 
presented in an ambiguous fashion — sometimes in the context of art, and at 
other times as factual representation of a growing biotech firm. The purpose of 
these representations was to illicit a response from the viewer based on their 
perceptions of BIOTEKNICA in a variety of different situations. 
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Shawn Bailey and Jennifer Willet 
BIOTEKNICA Virtual Laboratory 
CDROM and Website 
2004 
As we began to receive and interpret viewer responses, we looked to develop 
new and more visceral corporeal models for our teratoma product line so as to 
shift the project towards a directed bodily engagement between the viewer and 
the teratomatic product line. The clean, cool design and the confident corporate 
voice proved to have a serializing effect on the otherwise grotesque content of 
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the work. The visceral and unruly nature of these technologies, these artistic 
pieces, and the instrumentalization of the biological in biotechnology became 
compartmentalized and diluted by the corporate overtones. Our corporate 
presence — even with the inclusion of monstrous teratoma images — was 
arguably too successful, too convincing, further contributing to the prescribed 
reification of corporate goals as an established value set in evaluating evolving 
biotechnologies. This reaction was counter-productive to our objective of 
encouraging the viewer to develop their own conclusions about the efficacy of the 
technologies, procedures, and protocols presented. 
To remedy this perceived problem of reception, we decided to introduce the 
viewer's body to the biotechnological body in a phenomenological manner. With 
the assistance of artist and designer Kevin Finlayson, we developed a series of 
meat sculpture product lines, utilizing store-bought animal products, synthetic 
wigs, and sewing materials to mimic the appearance of the teratoma. We 
designed the sculptures with numerous parts of various animals that can be 
purchased at the butcher or grocery store. These fist-sized sculptural chimeras 
could contain a chunk of beef tripe, a lamb's kidney, some unshaven pork-belly, 
a bisected chicken, or a heart turned inside-out in order to suggest an actual 
teratoma. The life-sized sculptures were presented frozen in sterile bags, freeze-
dried on a silica bed, or refrigerated in laboratory glassware containing 
suspensions of formalin. Each presentation mobilized a visceral and corporeal 
reaction in the viewer — often somewhere between fascination and disgust. 
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In conjunction with the meat sculptures, we designed a performance called 
BIOTEKNICA Public Autopsy (fig.3.), where we performed public dissections of 
the specimens in the tradition of Rembrandt's The Anatomy Lesson of Dr. Tulp 
(1632) and Dr. Giinter von Hagens' public autopsy in London's Atlantis Gallery 
(2002). This strategy proved quite successful; the performed surgeries were 
convincing in their appearance. However, these performances were also 
destabilized by the very context of their performance (galleries, public venues, 
raves, university art laboratories) as well as by the content conveyed, whether 
verbally, through costume, or media representation. These events provoked 
more questions than answers in their propagation — something that we found to 
be inherently necessary in their production of affect in the viewer. 
In addition to the representational strategies deployed by the meat sculptures, we 
sought a 'real' and actualized participatory relationship with the very technologies 
we were representing and theorizing. In 2003, we met Oron Catts and lonat Zurr 
of Tissue Culture and Art Project (TC&A)43 at The European Media Arts Festival 
(EMAF) in Osnabruck, Germany. They invited us to submit an application for a 
residency at SymbioticA: The Art and Science Collaborative Research Centre44, 
in the School of Anatomy and Human Biology at The University of Western 
43
 Oron Catts, lonat Zurr, The Tissue Culture and Art Project, artist website; 
available online: URL: http://www.tca.uwa.edu.au/ [date of last access: 
01/01/2005] 
44
 SymbioticA: The Art and Science Collaborative Research Laboratory 
institutional website; available online: URL: http://www.symbiotica.uwa.edu.au/ 
[date of last access: 01/01/2005] 
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Australia. Catts and Zurr pioneered the use of tissue culture (TC) and tissue 
engineering (TE) in the production of contemporary art. 
(Fig.3.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA Public Autopsy 
The University of Victoria 
CDROM and Website 
2004 
In 2000, TC&A artists (Oron Catts, lonat Zurr and Guy Ben-Ary) developed a 
seminal work entitled Tissue Culture and Art(ificiai) Womb, also known as The 
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Process of Giving Birth to Semi-Living Worry Dolls, {fig.4.) More widely know as 
The Semi-Living Worry Dolls, the work is comprised of a series of sculptures 
created utilizing tissue engineering technologies, set in a complex mobile (and 
biologically self-contained) laboratory environment. Oron Catts and lonat Zurr 
have since continued with TC&A producing a number of important works 
involving tissue culture protocols, including Pig Wings, Disembodied Cuisine, 
Victimless Leather, and Extra Ear 1/4 Scale in collaboration with Stelarc. In 
addition, Oron Catts is Artistic Director of SymbioticA where, working with Dr. 
Stuart Bunt and Dr. Miranda Grounds, artists are invited to learn new techniques, 
facilitating the production of works that blur the boundaries between art and 
science. Catts and Zurr attribute great significance to training others in 
biotechnological techniques, consequently bringing more non-specialists into the 
fold. Their efforts to share these knowledges with others has culminated in the 
newly established SymbioticA Biotech Art Workshop, co-operated by Oron Catts 
and Gary Cass. A work of art in and of itself, this event provides hands-on, 
personal experience for artists, allowing them to work with techniques of DNA 




Tissue Culture & Art Project 
The Process of Giving Birth to Semi-Living Worry Dolls 
2000 
With our proposed residency at SymbioticA, we wished to learn from their 
expertise and develop TE sculptures of our BIOTEKNICA teratomas, thus 
bringing our theoretical specimens out of their digital environment and into the 
laboratory in a critical, participatory manner. In our initial proposal, we postulated 
a series of three-dimensional tissue prototypes modeled on the teratoma-
containing human tissue extracted from Shawn Bailey's body, though later 
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expanded our plans to include the use of animal cell lines in the production of this 
work. 
In 2004, we commenced work for four months as Research Fellows at 
SymbioticA. Here, we proposed the development of a new work called 
BIOTEKNICA: Organic Tissue Prototypes as a representation of the 
BIOTEKNICA teratoma product line. These pieces consisted of three-
dimensional polymer scaffolds, structurally crafted in order to match the 
irrationality manifested in the teratoma. The structures were completed with the 
application of tissue-engineering protocols in seeding and filling the matrices with 
living tissue.45 During this time, we developed skills and strategies that allowed 
us to grow the prototypes from animal cell cultures with the assistance of TC&A 
(Catts, Zurr), as well as Professor Stuart Bunt, Dr. Stuart Hodgetts, Guy Ben-Ary, 
Cynthia Verspaget, Kira O'Reilly, Gary Cass, and Jane Coakley. (fig.5.) 
45Some of our prototypes were seeded with P19 (a mouse teratoma cell line) and 
the 3T3 mouse fibroblast cell line. In the future we look forward to growing 
others with cells taken directly from the artist's (Bailey's) body through a shave 
skin biopsy procedure. 
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(Fig.S.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA Laboratory Documentation 
SymbioticA, The University of Western Australia 
2006 
We began tissue culture training by growing pre-existing cell lines 3T3 (mouse 
fibroblast) and P19 (mouse teratoma) in the laboratory. Cell lines are isolated 
cells that have been developed for research purposes and are able to divide 
indefinitely when given the appropriate environment in a laboratory. For 
instance, the 3T3 cell line, established by Todaro and Green in 1962, is derived 
from fibroblast cells from a disaggregated Swiss mouse embryo. Fibroblast 
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tissue, also known as scar tissue, is made up of extremely hardy cells and is 
excellent for basic training in tissue culture protocols due to its relative vitality and 
tolerance for a range of conditions (and abuses). Though still subject to 
contamination, other cel l I fhH; as well as primary living or recently deceased 
sources, can prove dishearteningly difficult for practicing amateurs to cultivate. 
Interestingly, the 3T3 line has achieved a sort of immortality: forty years after the 
death of its host donor, scientists and students all over the world continue to 
conduct research using generation after generation of a miniscule portion of the 
body of this long-deceased embryonic life form. At SymbioticA, we learned 
tissue culture cultivation, as well as techniques for observation and 
documentation, and at the end of our residency we began experiments grafting 
cells into three-dimensional structural matrixes. This residency marked our first 
foray into the field of 'wet' or biological art production. 
In January 2006, we returned to SymbioticA to complete the renamed 
Teratological Prototypes, this time in collaboration with Zurr and Catts from 
TC&A. Here, we cultivated the P19 mouse teratoma cell line (fig.6.) in vitro, 
building up a substantial population of healthy cells, both Jive and frozen. 
Simultaneously, we completed a series of 3D scans of teratoma meat sculptures 
and, with 3D digital printing, molding, and casting techniques, produced a series 
of scale teratoma forms to serve as the sculptural scaffolds of the final 
Teratological Prototypes. Each teratoma form was cast in a bioabsorbable 
polymer called P4HB, presented in two half-sections and sewn together with 
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surgical thread. The teratoma scaffolds were placed in a bioreactor chamber, 
along with an abundant population of cells and nutrient solution, and then stored 
in a water-jacketed C02 incubator. As the bioreactor turns, cells are persuaded 
to attach themselves to the' scaffolds rather than the interior walls of the 
chamber. The medium is replaced three to five times weekly with fresh nutrients 
and serums in order to allow substantial cell division to occur, resulting in the 
slow growth of fragile tissue culture sculptures. 
(Fig.6.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA Laboratory Documentation (P19 Cell Line) 
SymbioticA, The University of Western Australia 
2004 
The Teratological Prototypes were exhibited for the first time at ISEA Zero One 
San Jose in August 2006. (Fig. 7, Fig. 8., fig. 9.) On site, we built a functional 
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tissue culture laboratory maintaining the sterile environment necessary to grow a 
series of three Teratological Prototypes live for public view. In 2007, we 
exhibited a related work, called BIOTEKNICA: LiveLifeLab (see attached video), 
another functionaHaboratory installation, at the FOFA Gallery at Concordia 
University. Chapter 4 will present this exhibit in detail. Since then, I have 
continued to conduct hands-on, laboratory-based research at San Jose State 
University (2006), the Concordia University Department of Biological Sciences 
(2007), and The University of Leiden, affiliated with The Art and Genomics 
Centre (2007/2008). 
(Fig-7.) 
Shawn Bailey, Jennifer Willet, Oron Catts and lonat Zurr. 
Teratological Prototypes 




Shawn Bailey, Jennifer Willet, Oron Catts and lonat Zurr. 
Teratological Prototypes 
ISEA (International Society for Electronic Arts) Zero One San Jose 
2006 
With these extraordinary experiences as a non-specialist working in the 
laboratory came two significant shifts in my understanding of biotechnology: (1) it 
became apparent to me that the digital metaphors proliferated in the media, 
public, and even academic discourses are somewhat problematic, and serve to 
obfuscate the very wet, embodied, and bloody nature of harnessing life inherent 
in biotechnology, and (2) the over-specialization of the biosciences promotes a 
perceived exclusivity. In reality, these technologies can be utilized with no threat 
of harm by individuals from all back grounds and demographics. The 
biosciences (the 'life' sciences) are not so difficult or so dangerous as to 
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necessitate over specialize, and sometimes absolute secrecy. Critical Art 
Ensemble would agree. They write: 
The perception that Science is too difficult for anyone other then a 
specialist to understand is socially engrained in those separated from the 
discipline on an everyday life basis. The walls of the division of technical 
labor seam unbreachable. The common English expression "it's not 
rocket science," usually made as a sarcastic remark when someone has 
inordinate trouble with an easy task, is but one example of a manifestation 
of public reverence for the intellectual intensity of science and its 
separation from common daily activities.46 
In other words, the democratization of biotechnology is not only socially and 
politically necessary but also practically feasible in terms of health and safety, 
and the physical and intellectual prowess required to engage directly with this 
skill set. In my experience, working in the lab is a lot like cooking. It is an exact 
science that is, at the same time, always open to personal interpretation - where 
mistakes, accidents, and intentional deviation often prove more successful than 
following the recipe. 
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Shawn Bailey, Jennifer Willet, Oron Catts and lonat Zurr. 
Teratological Prototypes 
ISEA (International Society for Electronic Arts) Zero One San Jose 
2006 
(RE)embodying Biotechnology theorizes, articulates, and demonstrates the 
visual narratives, performative actions, and biological artworks constructed by 
Bailey and myself through the duration of our research / creation project 
BIOTEKNICA. I am working to describe and analyze the embodied knowledges 
and experiences I acquired at the UWA, and in a number of laboratories all over 
the world since. I choose the title (RE)embodying Biotechnology for a number of 
reasons. The "(RE)" implies that biotechnology has always been an embodied, 
life-based process. I see an urgent need to re-engender the language 
surrounding biotechnology with indicators of embodiment. In addition, a 
(RE)embodied Biotechnology also includes the human body and the 
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practitioners' body in a interrelated loop between all subjects, objects, processes, 
and protocols involved in an extended technology of bodies. 
In retrospect, I understand my experiences at SymbioticA as an induction of sorts 
— an induction into biotechnological practices, an induction into the specialist 
class. My colleague and I were invited into the highly guarded site of the 
biological research laboratory, where individuals from the arts and humanities 
(media studies, literary theory, art history, literature, philosophy, and fine art) are 
given a brief glimpse of the inner workings of one of the most significant and 
arguably most powerful arms of the technoscientific industrial complex. I am 
extremely grateful for having been allowed this important opportunity. However, 
it was also incredibly difficult, cathartic and disheartening at times, to experience 
first hand the instrumentalization (and industrialization) of living systems as a key 
aspect of biotechnological research. Simultaneously, it was also strangely 
understandable when evaluating our research goals, the goals of the artists and 
scientists working alongside us in the labs, and the long trajectory of the 
manipulation of living systems in the name of research, health, economy, and 
capital. However, what was made abundantly clear, and is the focus of this text, 
is the enormity of the gap between the representation of biotechnological 
research in the public realm and the actuality of biotech — the people, the 
processes, and the knowledges that are practiced every day in the laboratory. 
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2 | The Artist as Specialist: 
Creative Methodologies for Public Implication in the Biological Sciences. 
With long-established traditions in srlfornedical and biotechnology fields, the 
general public holds very little agency in the decision-making processes that 
dictate research trajectories, evaluation criteria, and the application of 
advancements made in the biosciences. Yet, in my view, the general public is 
encouraged to have a passive relationship with evolving biotechnologies. 
Ironically, we the public tend to receive both the advantages and disadvantages 
of the proliferation of biotechnology, yet we are asked to merely trust the 
specialists to manage its development and proliferation. I am interested in 
pursuing avenues of intervention where the individual layperson — and the public 
as a heterogeneous, social, political entity — possesses an empowered, 
reciprocal relationship with biotechnology. 
A problematic aspect of debates surrounding biotechnology is that the over-
specialization of the sciences tends to preclude any invested participation from 
the individual non-specialist. People don't feel implicated in biotechnology; they 
don't feel as though they have enough knowledge to assert their own opinions. 
We all concede the power to make these complex and difficult decisions to 
scientists, corporations, and the government. I see this lack of implication and 
involvement on the part of the general public as the result of a deeply rooted 
insecurity — an established belief that science is intrinsically too difficult to allow 
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us, as laypeople, to understand evolving biotechnologies, let alone participate in 
their development in any meaningful way. Richard Lewontin proposes a similar 
argument in Biology as Ideology: The Doctrine ofDNA (1991): 
Not only the methods and institutions of science are said to be above 
ordinary human relations but, of course, the product of science is claimed 
to be a kind of universal truth. The secrets of nature are unlocked. Once 
the truth about nature is revealed, one must accept the facts of life. When 
science speaks, let no dog bark. Finally, science speaks in mysterious 
words. No one except an expert can understand what scientists say and 
do, and we require the mediation of special people - science journalists, 
for example, or professors who speak on the radio - to explain the 
mysteries of nature because otherwise there is nothing but indecipherable 
formulas.1 
One strategy to combat a programmed public malaise regarding biotechnology is 
to effectively trump the authority of the specialist class (of scientists and 
engineers, and business people.) This shift can be achieved by placing 
alternative individuals into specialist roles in the public eye. In my opinion, the 
insertion of visible and intellectual difference into traditional roles of scientific 
authority can serve to empower non-specialists, enabling them to participate 
1
 Richard Lewontin. Biology as Ideology: The Doctrine of DNA, (Concord: House 
of Anansi Press, as part of the Canadian Broadcasting Corporation Massey 
Lecture Series, 1991). pp. 8-9. 
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more fully in biotechnological debates. These transgressive biotechnological 
practices have the potential to reveal and illuminate the bodies in biotechnology 
through alternative viewpoints, discourses, and metaphors propagated by non-
specialist participants in the biological sciences. I am proposing a participatory, 
interdisciplinary incursion into the practice and public representation of 
biotechnology. 
If artists, academics, plumbers, accountants and housewives contribute to the 
production of biotechnology, the authority of the specialist — the doctor, the lab 
technician, the scientist — will be diminished. Alternative voices, subjectivities, 
and interpretations of biotechnology will be heard and perpetuated in public 
debate. No longer will the white lab coat and all its connotations — the extensive 
education, the complex language set, the progressive rationality, the assumed 
comprehension of natural truths — prevail as the only valid, authoritative voice 
when determining biotechnological research trajectories and evaluation criteria. I 
am particularly interested in mobilizing the transformative potential of the artist as 
a non-specialist and will continue to emphasize this position with the 
understanding that this interdisciplinary methodology could also be successfully 
mobilized by other non-specialist communities. 
The work of Edward Said informs my proposition, especially his call for 
interdisciplinarity, as a model for the inclusion of non-specialists in the 
biotechnological field. Said describes the possible benefits as well as the 
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unavoidable difficulties in joining the specialist class (particularly as it pertains to 
academia) in "Opponents, Audiences, Constituencies." Said argues that 
universities "...appear to exercise an almost totally unrestrained influence: (in) 
the principle that knowledge ought to exist, be sought after and disseminated in a 
very divided form."2 Within this framework, 
You cannot simply choose to be a sociologist or a psychoanalyst; you 
cannot simply make statements that what you say as a historian (however 
well it may have been researched) enters historical discourse. You have 
to pass through certain rules of accreditation, you must learn the rules, 
you must speak the language, you must master the idioms and you must 
accept the authorities of the field - determined in many of the same ways 
- to which you want to contribute.3 
With this division of knowledge into smaller and smaller groups of specialization 
— and with extensive chains of prescribed rites of passage into each field — 
interdisciplinarity, though touted as the primary goal of most contemporary 
universities and research centers, has little legitimacy in the back rooms (and 
boardrooms) of institutional culture. Individuals working in this manner are often 
perceived of as 'jacks of all trades, but master of none.' Also, researchers with 
interdisciplinary concerns often complain of the pressure to attain expertise in 
2Edward Said. Opponents, Audiences, Constituencies, and Community from The 
Anti-Aesthetic: Essays on Postmodern Culture. Hal Foster edt. (New York: The 




multiple fields in order to be taken seriously in any domain. If an individual or 
research trajectory cannot be discretely categorized in its meaning, historical 
evolution, and rigid standards of evaluation (regarding funding, exhibition, and 
publication), it can prove cumbersome and unruly, sometimes even illegitimate, 
in the institutional setting. 
In the same article, Said argues that we need to collapse the borders between 
areas of specialization in order to impinge upon exclusionary forms of power that 
stem from the discipline-based system of knowledge production and exchange. 
He states, "Instead of noninterference and specialization, there must be 
interference, a crossing of borders and obstacles, and a determined attempt to 
generalize exactly at those points where generalizations seem impossible to 
make."4 At the time this was written, he intended to motivate theorists and critics 
to expand their audiences and participate in journalism as a means of exposing 
more generalized audiences to the evolving theories, whether post-colonial, 
feminist, post-Marxist, or queer, to name a few. However, I am proposing an 
exaggerated form of interference through more disparate forms of 
interdisciplinarity. Instead of academic writers participating in mass print media 
publication, I am arguing for a critical, participatory methodology for 
interdisciplinary incursion in contemporary biotechnologies. My principle interest 
lies at the intersection of art and science, and I propose that this strategy can be 
4
 Edward Said. Opponents, Audiences, Constituencies, and Community from The 
Anti-Aesthetic: Essays on Postmodern Culture. Hal Foster edt. (New York: The 
New Press, 1998), p.11. 
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deployed in any number of fields. In my understanding (as well as that of Said), 
radical interdisciplinarity is inherently political, counteracting established 
hierarchies and divisions of power in the institutional setting, the production of 
knowledge, and the distribution of this knowledge in public discourse. 
Said's proposition allows for non-specialist interference in biotechnology in its 
public representation, but also functions as a strategy for transforming academic 
traditions of specialization. In other words, opening the closed field of 
biotechnology to perceived non-specialists effectively changes established 
research practices in the arts and humanities, where second- and third-order 
texts are often utilized as primary sources in analyzing specializations such as 
biotechnology and the sciences. As a result, researchers and journalists often 
misrepresent or misunderstand the very nature of the practices, the protocols, 
and even the living entities that they are writing about in the biotechnological 
sphere. Academic tradition does not encourage a direct transfer of knowledge — 
and, more significantly, of experience — across specializations. From personal 
experience, I can attest that it is very challenging for a humanities-based 
researcher to fully understand the complexities of genetic modification (for 
example) without ever having set foot in a laboratory or having performed any 
GM protocols. This difficulty also applies to a more general audience: how is an 
individual to think in a complex critical manner about biotechnology if he or she 
has no hands-on experience in the field? Essentially, my argument is two-fold: 
(1) real, hands-on experience with biotechnological protocols allows non-
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specialists such as myself to obtain knowledge and therefore empowerment in 
the critical debates surrounding biotechnology; (2) a shift in the representation of 
the practice of biotechnology to include non-specialists may allow the public to 
perceive their own access and implication in biotechnology and, therefore, will 
greatly increase participation in the field. As a result of this proposed 
involvement with biotechnological protocols, I believe that the bodies in 
biotechnology will become accessible through this first-order experience to the 
non-specialist practitioner and, by extension, to the general public. This 
accessibility may be achieved through shifting representational strategies, 
metaphors, and language sets to describe biotechnological research. 
The Hacker 
In his article "A Biotech Hobbyist Manifesto," Eugene Thacker suggests that we 
look to another specialized technological field that had been profoundly affected 
by non-specialist, amateur, and non-professional contributions to its public 
representation and technological development: computing. "The hobbyist sub 
culture which emerged around personal computing valued certain things: a 
commitment to the innovative potential of the individual, a liberal belief in the 
democratic possibilities of new technologies, an interest in DIY (Do-it-yourself) 
"hands-on" knowledges, and a counter-culture investment in a computer 
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"revolution.""5 This article focuses on early examples for individual participation 
in computing from the 1970s, when individuals were building their own home 
computers from kits — a participation which resulted in the astounding success 
of personal computer corporations like Apple and IBM. Thacker postulates this 
form of hobbyist intervention as a failed example, swayed too strongly and 
eventually subsumed by corporate and market economy values. He argues that 
free choice has not been achieved in this domain. From my perspective, the 
capitalist economy in which digital (and biotechnological) technologies thrive is 
far too entrenched in Western ideology to be overcome in these specific 
instances. However, I would argue (from the standpoint of working 'within the 
system') that traditional hierarchies have been challenged in the digital economy 
by individual amateur ventures into the field. 
I, too, am interested in examples drawn from the analysis of computing and 
digital culture, but I would place more focus on the hacker and the ways in which 
this figure serves as an example for our potential participation in science and 
technology. In order to define the hacker, I look to Wikipedia, an open source 
encyclopedia authored by millions of users — a site where hackers are 
presumably able to define themselves: 
5
 Eugene Thacker. « A Biotech Hobbyist»from Creative Biotechnology: A 
User's Manual; available online: URL: 
http://www.locusplus.org.uk/biotech_hobbyist.html [date of last access: 
09/01/2006] p. 39. 
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A hacker is a person who creates and modifies computer software and 
computer hardware, including computer programming, administration, and 
security-related items. 
In computer programming, a hacker is a programmer who hacks or 
reaches a goal by employing a series of modifications to exploit or extend 
existing code or resources. 
In computer security, a hacker is a person able to exploit a system or gain 
unauthorized access through skill and tactics. This usually refers to a 
black hat hacker. There are also white hats (ethical hackers), and grey 
hats. (See; Hacker (computer security)) 
In other technical fields, hacker is extended to mean a person who makes 
things work beyond perceived limits through their own technical skill, such 
as a hardware hacker, or reality hacker.6 
Hacker involvement in the digital domain has become understood as a central 
factor in the digital revolution and essential to the continued advancement of 
knowledge and technology in the field. Hackers often posses knowledge sets 
and problem solving skills that rival, and possibly exceed, those of the 
professionals in the industry. On the other hand, as in the instance of Steve 
Wozniak and Steve Jobs (co-founders of Apple), many individuals have 
6
 Wikipedia: The Free Encyclopedia. available online: URL: 
http://en.wikipedia.org/wiki/Hacker [date of last access: 05/04/2006] 
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transformed hacker culture into successful corporate enterprises. To use 
another example Linux and Firefox, where hacker culture has produced open 
source products that rival industry models. 
The hacker is presented in popular culture [i.e. in films like Hackers (1995) and 
Antitrust (2001)] as a wayward, chaotic figure, sometimes functioning as an 
instigator towards egalitarian incursions and participation in the digital sphere. In 
actual instances of hacker activities, the 'black hat' hacker posits a mischievous, 
even threatening, counterplayer to established computing corporations through a 
number of highly publicized (and highly prosecuted) illegal hacks; examples 
include individuals such as Kevin Mitnick, Gary McKinnon, and the Cult of the 
Dead Cow. Whether or not these individuals and their actions are interpreted as 
legitimate and/or ethical, the popular media representation of the hacker as a 
fifteen-year-old boy, working in his garage to take down large corporate networks 
and databases, serves an important function in the democratization of computing 
technologies. The dominant image of the specialized computer scientist is 
undermined by the of powerful programming specialists in track pants, drinking 
soda pop, and living with their parents. 
All of these visions of hacker culture (the amateur programmer turned multi-
millionaire business guru, the youthful 'black hat' hacker toppling industry giants 
from their home PC) contribute to a trickle down effect of DIY culture in the digital 
sphere. Today, with the rise of podcasting, file sharing, twitter, wikis, and blogs, 
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in addition to open source models for the production of operating systems, 
networks, hardware, software, and content, millions of 'hackers' all over the world 
are engaging in unpaid work that rivals and challenges the authority of 
professional production in the field. In his lecture "What Business Can Learn 
from Open Source"7 at the 2005 O'Reilly Open Source Convention, Paul Grahm 
argues that the resounding marketplace success of blogging and open source 
models means that businesses need to look to models of amateurism in order to 
survive the rise of hacker culture. He argues that professionalism is overrated; it 
is an established fashion that breeds formality and sterility, leading to reduced 
imaginativity and productivity. He equates professionalism to 'pretend work' and 
open source, individuated participation to 'real work.' With professionalism, work 
and life are separate entities,8 but with amateurism, work and life are intrinsically 
interconnected. This interconnectedness, in turn, breeds deep personal 
investment, dedication, and imaginative potential, leading to far greater gains in 
productivity and accomplishment. 
The successes of hacker culture in the digital domain, public perception of the 
digital sphere promotes an egalitarian ideal for the perpetuation of digital 
7
 Paul Grahm. "What Business Can Learn from Open Source" presented at the 
O'Reilly Open Source Convention (2005) available online: URL: 
http://www.itconversations.com/shows/detail657.html [date of last access: 
05/04/2006] 
8
 Paul Grahm's cutting criticism of professionalization - as an artificial structure 
that segregates work and life could also be applied to notions of scientific 
objectivism from an interdisciplinary critical standpoint. Suggesting that with the 
division of science as distinct from life as counter intuitive and counter 
productive. 
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technologies. Unlike the hard sciences, computer science and its technical 
applications are perceived as publicly and individually accessible. Even 
accounting for Lary Irving's "Digital Divide"9 and the rise of mega-corporations 
like Microsoft in the digital sphere, the perpetuation of hacker models in the 
industry and the larger cultural sphere fosters an important element of individual 
participation and implication in the evolution, value, and trajectories of digital 
technologies. 
In his 1991 text, Hacking Away at the Counter-Culture, Andrew Ross provides an 
early description of this phenomenon that has since resulted in further shifts 
away from specialization in imagining computer skills and technology. 
The elite class profile of the hacker prodigy as that of an under-socialized 
college nerd has become democratized and customized in recent years; it 
is no longer exclusively associated with institutionally acquired college 
expertise, and increasingly it dresses streetwise. In a recent article that 
documents the spread of the computer underground from college wiz-kids 
to a broader youth sub culture termed 'cyberpunks,' after the movement 
among science fiction novelists, the original hacker phone phreak Captain 
Crunch is described as lamenting the fact that cyberculture is no longer an 
9
 The 'digital divide' is a term championed by United States of America politician 
Lary Irving (serving under Bill Clinton) to describe the growing gap between 
those who have access to computer technologies, and those who do not, with an 
emphasis on North / South international politics. 
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'elite' one, and that hacker-valid information is much easier to obtain these 
days.10 
I am arguing that Ross' investigation-can be effectively applied to evolving 
biotechnologies. Computing as he argues is as an excellent example of how a 
specialized technological industry that may be revolutionized through individual, 
hands-on participation. 
However, the hacker model does not address the transformation of the 
technological object, which is of great interest to me in terms of understanding 
biotechnology. Although digital accessibility and authorship have achieved some 
sort of transparency in Western society, our understanding of the fundamental 
principles of computation remains intact. Biotechnology, as well as the continual 
proliferation of digital metaphors used to describe the life sciences, requires an 
even more foundational shift: a shift not only in the perception of accessibility but 




 Andrew Ross. "Hacking Away at the Counter-Culture," in The Cybercultures 
Reader. David Bell and Barbara Kennedy Edts. London and New York: 
Routledge. 2000. p. 259. 
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Although I prefer the term "non-specialist," I am essentially arguing for amateur 
participation in biotechnology — in academia, the public sphere, and 
individualized experience. "Amateur" is an elusive but important term in 
promoting radical interdisciplinarity, utilized by a variety of theorists to describe 
artistic participation in scientific procedures. In colloquial terms, "amateur" refers 
to an individual with little education or skill who participates in a practice for 
personal enjoyment. An amateur is almost never provided with financial 
compensation for their work. Referring to someone as an amateur can often be 
interpreted as a harsh criticism, as it evokes pejorative stereotypes such as the 
Sunday painter or community theatre. However, amateurism does not always 
carry these negative connotations. Historically, the amateur scientist with a 
chemistry laboratory in his or her shed, the amateur astronomer, and the 
amateur radio operator have all been interpreted as connoisseurs, skilled 
admirers, and even valued contributors to fields as they have evolved throughout 
the ages. Even today, the amateur athlete — one who does not receive a salary 
for their sportsmanship — is considered the most elite example of athleticism in 
our society. 
In For the Love of It: Amateuring and Its Rivals, Wayne Booth proposes the 
amateur as one who engages in a practice for the love and pleasure of it with no 
practical use or endgame.11 Booth is a celebrated American professor of literary 
criticism who writes candidly about his musical amateurism as a cellist. I am 
" Wayne Booth. For the Love of It: Amateuring and Its Rivals. Chicago: 
University of Chicago Press. 1999. P.14 
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interested in the participatory nature of his representation of this activity (as 
opposed to an observatory or research-based action) but concerned about his 
implication that there is no practical use or value in amateur engagements. His 
model sees the amateur's role as one of appreciation rather than implicated 
analysis and propagation of a field. 
In her work Academic Instincts, Marjorie Garber provides a more complex 
interpretation of amateurism with a directed focus on amateurism in academia. 
She argues that the term "amateur" is intrinsically linked to the term 
"professional;" amateurism is understood as a labour of love, rather than as a 
professional engagement in a field. Garber divides amateurs into two distinct 
types: the amateur professional, a person trained in one field who writes, thinks, 
and practices in another; and the professional amateur, who she describes as 
more of a public intellectual, most often with no professional affiliations.12 
Though her focus is on academia (whereas the scope of my argument is 
intended to serve a far wider audience), she provides us with some insight into 
the difficulty encountered by humanities-based researchers and, by extension, 
other individuals making amateur inroads into scientific fields. She states, 
"Humanist intellectuals like Lacan, Kristeva, and Luce Irigaray are not regarded 
as provocative readers of science but as imposters, spouters of "fashionable 
nonsense." The split between amateurs and professionals reproduces itself in the 
relative standing of fields: scientists can become humanists more easily than 
12
 Marjorie Garber. Academic instincts. Princeton, N.J.: Princeton University 
Press, 2001. p. 20. 
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humanists can become scientists, in part because the humanities themselves are 
perceived as closer to 'love' than is science."13 Given the perceived imbalance in 
value and measurable benefit to society between the arts and the sciences, it is 
even more important that researchers irr the arts and humanities continue to 
cross the perceived boarders of the hard sciences. 
The Non-Specialist 
I am interested in perpetuating a growing trend towards the revitalization of 
amateur models in the sciences, particularly in the realm of biotechnology. This 
revitalization has the transformative potential to open the field to non-specialist 
participation. However, if this action is to succeed, we must remain acutely 
aware of the powerful authority and impenetrability that has developed around 
the sciences since the rise of modernism. The scientist, unlike the computer 
programmer, is a specialist, rather than a professional. The pursuit of science is 
understood as an objective and systematic means of obtaining knowledge about 
the natural world. Science (and, by extension, medicine) is seen as one of the 
highest orders of knowledge and comprehension in Western society. For the 
conceptions of the amateur and the hacker to be successfully applied to and 
included in scientific fields, the terminology we employ in describing these 
activities must shift away from these sometimes derogatory terms. I believe that 
13
 Ibid. p.32. 
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the term "non-specialist" is the most viable way to describe the interjection of 
unsanctioned participation in what is perceived as an elite set of skills. 
I am proposing this terminology for three reasons. First, it indicates that the 
established paradigm in the hard sciences is one of specialization rather than 
professionalism. This distinction is important because the term "professional" is 
related to the fields of business and commerce, where the final goal is inherently 
economic success. The pursuit of scientific specialization is linked to a different 
goal: the acquisition of knowledge in order to understand the natural world. 
Second, the term "non-specialist" suggests that an individual is participating in a 
field outside their educational knowledge, but it also allows for a wide range of 
interpretation in their skill or knowledge in that scientific field (from layperson to 
almost expert). The term "amateur," on the other hand, encourages the 
interpretation of the non-specialist individual as unskilled, unfocused, and with no 
invested participation in any given knowledge set. Third, the use of "non-
specialist" as opposed to "hacker" circumnavigates the sinister connotations of 
the hacker-terrorist in popular culture — which, at this time in history, can only 
prove damaging for those who participate in scientific fields. These associations 
are only intensified in the field of biotechnology due to international 
preoccupation with (and fear of) bio-terrorism. 
As Thacker points out, there is a substantial disparity in motivation between 
amateur trends in computing and non-specialist participation biotechnology. 
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Like the computer hobbyist, the biotech hobbyist brings the non-specialist 
into specialist zones of activity, involving self-directed learning, hands-on 
experience, community building, and shared knowledges. Unlike the 
computer hobbyist, the biotech hobbyist does not see this development on 
non-specialization as an opportunistic means for establishing a start up 
company.14 
I, too, would like to step away from market economy models as an incentive for 
non-specialist scientific investigation. 
It is already the case that academic and commercial research in the 
biotechnological field is primarily driven by commercial concerns, financial bottom 
lines, and patent rights. It is imperative that alternative intentionalities enter into 
public discourse as a means of considering the ramifications, side effects, and 
drawbacks of current research trajectories outside of economic concerns. From 
my perspective, art is an exceptionally well-fashioned tool for non-commercial 
meditation and participation in this domain.. Birgit Richard argues a similar point 
in her chapter summating the 1999 Ars Electronica Net Symposium. She states 
that "Human needs within biological contexts which are not taken into 
14
 Eugene Thacker. « A Biotech Hobbyist » from Creative Biotechnology: A 
User's Manual; available online: URL: 
http://www.locusplus.org.uk/biotech_hobbyist.html [date of last access: 
09/01/2006] p. 39. 
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consideration by economic interests should be worked out."15 She, along with 
Thacker and myself, sees great potential in non-specialist research from an 
artistic standpoint, as it presents a viable point of entry into biotechnological 
discourse. She argues, -* 
Heightening awareness of the potential and dangers of a new technology 
before it confronts society with a fait accompli is one essential task of art. 
Technical as well as interpretational standards are quickly accepted as 
established facts. With the projection of future genetic worlds, art 
stimulates communication.16 
In my opinion, artists are particularly well-equipped to participate successfully in 
science for two reasons. First, the methodologies of contemporary artistic 
research are inherently fluid and transdisciplinarity; they are able to adjust 
repeatedly to the multiplicity of concerns, knowledges, and tendencies that is 
required for critical engagement with science and its practices. Second, in terms 
of opening up the public representation of non-specialists as participants in the 
hard sciences, artists serve as an ideal model for the democratization of 
biotechnological research. If we see artists — on the television, in the 
newspaper, in a gallery — actively engaging with the tools of science and 
15
 Ibid. p. 33. 
16
 Brigit Richard. "I - Biology and Fake Life Construction: Communication 
Fragments from the LifeSciences Internet Symposium" from LifeScience: Ars 
Electronica 99. Gerfried Stocker and Christine Schopf. Edits. New York: 
Springer-Verlang, 1999. p. 30. 
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technology, it creates a precedent in the public opinion of the sciences, allowing 
them to be seen as open, fluid, and accessible. I am reminded of the worn-out 
(and generally North American) criticism of Modern art: "my kid could do that." 
This model suggests that, given the public presentation of art/science research 
and production in a society plagued by overspecialization, if artists can do 
science, maybe you (and your kid) can too! 
In order to perpetuate a more inclusive, embodied model for biotechnology, we 
need to develop visions of biotechnology that are more open, more participatory, 
and less digitized, less sensationalized. Almost no popular media sources 
contribute to this representational shift, but there is a nascent momentum to be 
found in alternative venues — where artists, theorists, and media activists work 
against the established authoritative, corporate visions of biotechnology. I wish 
to elucidate one artistic field, in which non-specialist participation — generally, in 
science; specifically, in biology and biotechnology — is proliferating on a 
significant scale: bioart. Due to my personal interest and involvement in the field, 
I would like to present bioart as a case study to illustrate the ways in which the 
non-specialist can shift public representation — and, by extension, public 
implication and public understanding — in the field of biotechnology. This is not 
to say that other forms of artistic production are incapable of serving these 
purposes. It is also essential to consider groups and intentionalities outside of 
the arts as important contributors to these types of incursions. However, as it is 
my area of interest and facility, bioart will serve as an excellent example in 
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establishing my argument. 
Bioart 
Bioart is an emerging field of art/science research and production. The term 
"bioart" can refer to many things, and its definition is currently subject to debate 
at conferences, in publications, and in online discussion groups across the world. 
I define bioart as a set of practices that have recently erupted in the growing use 
of biology, or life, in the production of art. This definition can include something 
as fundamental as the mobilization of animals, plants, bacteria, or the human 
body in the production of artwork (including both live and deceased specimens), 
as well as artworks developed for non-human biological audiences. Bioart can 
also involve the mobilization of the biological sciences and biotechnologies in art 
production, utilizing technologies such as genetic engineering, tissue culture, and 
bioinformatics.17 However, bioart is still an evolving field, and as such it is highly 
contested. In order to better understand bioart and its complexities, I wish to 
draw from the writings of artists and theorists working in this domain. 
George Gessert (an established bioartist known for the genetic manipulation of 
irises through breeding processes) defines bioart in his posting to an online 
17
 Some definitions of BioArt also extend through bioinformatics to works that 
deploys a-life and artificial intelligence technologies - though this is not the 
intended focus of this line of inquiry. 
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discussion hosted by Yasmin: Your Art and Science Mediterranean International 
Network. 
Bioart is art that is alive or has living components. Not all bioart involves 
biotechnology, or genetic change. Bioart includes some kinds of ecological 
art and land art, for example Alan Sonfist's recreations of the original biota 
of Manhattan.18 
Here, Gessert asserts a formal or media-based description of the field. His 
definition is useful in understanding the mechanics of what is bioart, but further 
explanation is needed to answer foundational questions. What does bioart do? 
How does it function? What is its place in society? 
Adam Zaretsky, another long-time bioart practitioner, proposes a list of general 
objectives he sees as emergent in bioart practices: 
• Reminding people about the ever-present complexities of vitality, 
mortality and mutation all around us. 
• Giving non-experts the ability to speak intelligently about science without 
having to be a scientist. 
• Providing hands on labs or exhibitions designed to get rid of fears of 
18
 George Gessert. "Exhibiting BioArt" discussion group hosted by Yasmin: Your 
Art and Science Mediterranean International Network, available online: URL: 
http://www.media.uoa.gr/yasmin/viewtopic.php?t=775 [date of last access: 
09/01/2006] 
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complexity while maximizing debates on intelligent applications of 
technology. 
Exhibiting works which rework preconceptions about relationships 
between human culture, other livfng beings and the environment.19 
However, Zaretsky also reminds us that "The artists involved in bioart are not a 
group with a manifesto and a singular programmatic but instead have rifts, 
ethically, philosophically and politically, which keep them from any singular 
consensus."20 
In my purview "bioart" can be seen as a blanket term that refers to a number of 
related methods of art production: genetic art, transgenic art, biotech art, vivo art, 
live art, life art, ecological art, land art, and, by some definitions, performance art 
and body art. Zaretsky is most interested in perpetuating the term "vivoarts" to 
describe "any artistic production that has a living component embedded in it at 
the time of its exhibition."21 Renowned bioartist Eduardo Kac has coined the 
term "transgenic art" to describe his artistic production involving genetic 
engineering technologies. He states, 'Transgenic art, I propose, is a new art 
form based on the use of genetic engineering techniques to transfer synthetic 
genes into an organism or to transfer natural genetic material from one species 
19
 Adam Zaretsky. "The Mutagenic Arts" in ClAC's Electronic Magazine no. 23, 
2005. Available online: URL: 







into another, to create unique living beings. He continues, "The nature of this 
new art is defined not only by the birth and growth of a new plant or animal but 
above all the nature of the relationship between artist, public, and transgenic 
organism."23 Instead of defining "the nature of thisnew art" solely by its media 
(like Gessert), or by the intentionalities of the artist (like Zaretsky), Kac postulates 
an articulated model where the artist, the public, and the biological art/entity (in 
this instance, the transgenic entity) each have trajectories, histories, 
relationships, and intentionalities that intersect at a given point in time. Though I 
am not directly interested in the perpetuation of even more rarified and 
specialized terms like "transgenic art," I am deeply intrigued by the model of 
bioart classification suggested by Kac's definition. In other words, applying 
articulation theory to the analysis of the intersection of two evolving fields — art 
and technology — has the potential to engage a heterogeneous audience. 
"Bioart" is a permeable, interdisciplinary, and unruly term, but this is probably 
why I (as well as many others) am attracted to it. Jens Hauser, arguably the 
foremost curator, critic, and theorist in the field, elucidates the transient and 
transformative nature of bioart in his chapter "Bio Art — Taxonomy of an 
Etymological Monster," drawing our attention to the constant flux of both the 
biotechnological field and bioart. 
22
 Eduardo Kac. "Transgenic Art" in LifeScience: Ars Electronica 99. Stocker, 
Gerfried and Christine Schopf. Edits. New York: Springer-Verlang, 1999. p. 289. 
23
 Ibid. p. 289. (my emphasis) 
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Bio Art isn't just a hybrid; it's also a proliferating mutant term. Biology's 
ascent to the status of "hottest" physical science has been accompanied 
by, on the one hand, the inflationary use of biological metaphors in the 
scholarly disciplines that study culture; on the other, a wide range of 
biotech procedures are simultaneously providing artists with the themes 
for their work as well as the expressive media with which to realize them. 
As this has transpired, the evolution of the term "Bio Art" has somewhat 
resembled the recent hyperbolic career path of the gene-hype launched 
by techno-industrial special interest groups in the 1990s that, in the wake 
of its zenith in conjunction with the media frenzy surrounding the Human 
Genome Project, has been slowly subsiding in the last few years. Bioart 
has not unfolded and developed in accordance with prescribed master 
codes of a determinant post-avant-garde manifesto; instead, it has been 
subject to a process of social drift and divers aesthetic influences from its 
environment.24 
As Hauser argues, the definition of bioart is elusive and hazy at best. With the 
continual flux and change in biotechnology and bioart production, theorization, 
and exhibition comes the reification of practices originally conceived as 
performance art or body art by artists and historians alike. Artists like Stelarc and 
Orlan (understood as performance artists, or even artists engaged in body 
24
 Jens Hauser. "Bio Art - Taxonomy of an Etymological Monster" from Hybrid 
living in paradox: Ars Electronica 2005. Christine Schopf, Gerfried Stocker. Edts. 
Ostfildern-Ruit, New York, Hatje Cantz: D.A.P. Distributed Art Publishers, 2005. 
p.182. 
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modification, who practiced in the 1970s-80s) are today revisited and 
reinterpreted retroactively through the lens of bioart as artists engaged in the 
manipulation of life. These artists, among many others in the fields of 
performance and body art, are looking to bioart practitioners and organizations to 
imagine new artistic entry points into the body. Hauser writes, "Stelarc and 
Orlan, two of the seasoned pioneers of Body Art, have joined the Tissue Culture 
& Art Project in research that is being carried out at the SymbioticA Art & Science 
Collaborative Lab in Perth, in order to utilize tissue cultures to grow an "extra ear" 
and a patchwork-like mantel made up of hybrid skin cultures of diverse donors 
representing a variety of different ethnic origins."25 
There is also a great deal of debate about what bioart is not. Practitioners and 
theorists in the field generally agree that work that does not include a 'life' 
component is not bioart. Gessert states, "Art that represents life (chromosomes, 
DNA, etc.) is not bioart. Computer simulations of genetic processes, evolution, 
plant growth, etc. are simulations of life and not alive, hence not bioart."26 
Hauser contributes a similar argument: "Bio-fictional manifestations such as 
chimera-sculptures, DNA-portraits, chromosome-paintings or mutant-depicting 
digital photo-tricks are no more examples of Bio Art than Claude Monet's 
impressionistic paintings could be classified as "Water Lily Art" or "Cathedral 
25
 Ibid. p. 184. 
26
 George Gessert. "Exhibiting BioArt" discussion group hosted by Yasmin: Your 
Art and Science Mediterranean International Network, available online: URL: 
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Art.""27 However, definitions of bioart are complicated by works that fall into the 
category of genetic art or genomic art. The field of genetics (as well as the larger 
field of bioinformatics) presents a taxonomical quandary, although it is often 
simply misinterpreted or misunderstood and therefore confuses the issue.28 This 
confusion lies primarily in the fact that some genetic and transgenic works of art 
can include living, semi-living, or deceased (and preserved) fragments of life that 
would fall into the propositional category of bioart; however, in other instances, 
genetic art can also be defined as works that involve virtual incarnations or 
artificial life. 
In some A-life circles, the distinction between natural and virtual incarnations of 
the emergent properties of what we refer to as "life" is considered negligent. In 
his text The Garden in the Machine: The Emerging Science of Artificial Life, 
Claus Emmeche explains that, for A-lifers, the "artificial" in "artificial life" refers to 
the artificial nature of the environment in which life is manifest, not the artificiality 
of the life itself. In other words, A-lifers purport that A-life produces very real life 
forms; the only difference is that, in these instances, life exists in entirely artificial 
(computational) environments. In his introduction, he states, "Life is a process, a 
complex, rhythmic pattern of matter and energy. What is important is not what 
kind of matter or what kind of energy we find, but rather the pattern, the process, 
27
 Jens Hauser. "Bio Art - Taxonomy of an Etymological Monster" from Hybrid 
living in paradox: Ars Electronica 2005. Christine Schopf, Gerfried Stocker. Edts. 
Ostfildem-Ruit, New York, Hatje Cantz: D.A.P. Distributed Art Publishers, 2005. 
p. 182. 
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the form. By his definition, artificial life artworks (and possibly other forms of 
digital art production) could be interpreted as part of the canon of bioart. This 
assertion may have been considered true in the past, but as bioart has evolved, 
so has the clarification of its definition. 
In 1993, Peter Weibel curated an exhibition called "Genetic Art" for Ars 
Electronica. Weibel defines genetic art in 1993 as: 
Genetic art as artistic counterpart of genetic engineering is on the one 
hand intended to simulate processes of life with the same modern 
technological tools and methods as the latter. On the other hand, it is to 
use traditional methods and strategies for a critical reflection on the 
potential consequences of such simulations and the synthetic creation of 
life.30 
He argues that genetic art embraces a variety of fields, including evolutionary art, 
biogenetic art, genetic engineering, algorithmic art, robotics, virtual beings, and 
artificial life- In the same year, Gessert postulated a different definition of genetic 
art: "Genetic art is art involving DNA. Domesticated ornamental plants, pets, 
29
 Claus Emmeche. The Garden in the Machine: The Emerging Science of 
Artificial Life. Steven Sampson Trans. Princeton: Princeton University Press, 
1994. p. 4. 
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1993. Available online: URL: 
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sporting animals, and consciousness-altering drug plants constitute a vast, 
unacknowledged genetic folk art."31 In his Leonardo article, he states, "...genetic 
art is not simply a matter of inscribing individual human ideas and fictions into the 
DNA of other beings. Genetic Art involves extremely close and complex 
interactions among species."32 
In his more contemporary analysis "Animals, Art and Technology", which was 
presented at the Break 2.3 New Media Festival (Ljubljana, Slovenia) in 2005, 
Jens Hauser describes a shift in the evolving field of bioart away from Weibel's 
virtual model and towards the one postulated by Gessert: "Bioart is re-
materializing itself. The fascination with the 'code of life' is reseeding and making 
way for a phenomenological confrontation with wetwork."33 He continues to 
describe bioart in more detail as it pertains to laboratory practices: "Bioart has 
become an art of transformation in vitro that manipulates biological materials at 
discrete levels (i.e. individual cells, proteins, genes, nucleotides) and creates 
displays that allow audiences to partake of them emotionally and cognitively."34 
In other words, bioart can be explained as a complex, evolving field that 
describes a heterogeneous, group of art/science practitioners — as well as 
practices, productions, and assertions — at the intersection of technological, 
social, political, and aesthetic considerations of biology, emphasizing the 
31
 Gessert, George. "Notes on Genetic Art," Leonardo Vol 26, No. 3 (1993). p. 
205. 
32
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manipulation and presentation of wet life (as opposed to a-life) in a reciprocal 
relationship between artist, life form, and audience. 
Hauser's theory of bioart as a process of rematerializing bodies is a central to my 
thesis (RE)embodying Biotechnology. However, Hauser criticizes the over-
politicization of bioart practices by artists and theorists, particularly in American 
circles. This is where our models differ. I see an intrinsic relationship between 
bioart practices and the politics of biotechnology. In my understanding, bioartists 
are usually individuals with a background outside of the hard sciences who are, 
either directly or inadvertently, staking a claim in the knowledge production of 
what is arguably the fastest growing field of economic and technological 
exploitation today: biotechnology. Their involvement is a definitively political 
action in relation to our current specialist-driven market economy model of 
biotechnology. Bioart is particularly powerful in that it challenges the firmly 
established belief that biotechnology is an entirely new field of research. It 
reminds us that biotechnology is a very old technology, one that uses biology to 
attain human-determined ends. Animal husbandry, agriculture, and gardening 
can all be understood as biotechnology through varieties of bioart production. In 
addition, bioart postulates new and more expansive models for imagining the 
specialist in cutting-edge biotechnological fields. Although I agree with Hauser's 
assertion that some artists do not deploy the political issues surrounding 
biotechnology as content in their work, I am arguing that the very action of non-
specialist participation in the specialist sphere — as well as the mobilization of 
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the biological and biotechnological in the production of art — is intrinsically 
political. 
A number of bioartists write specifically about the transformative potential of non-
specialist participation in the biosciences. I am particularly interested in the 
writings of Critical Art Ensemble, as well as the writings of Natalie Jeremijenko, 
Heath Bunting and Eugene Thacker in The Biotech Hobbyist, as their social and 
political interpretation of amateurism in art/science production is similar to my 
own. Not all bioartists are interested in the social and political aspects of 
engaging in the biological sciences as artists, but for myself, and a large portion 
of the community, it is central to their research. 
The Biotech Hobbyist Magazine was established in 1998 by bioartists Natalie 
Jeremijenko and Heath Bunting. Its first and only edition can still be accessed 
online.35 In more recent years, Jermijenko and Bunting, along with Eugene 
Thacker and Denna Jones, formed the Biotech Hobbyist Collective, publishing 
new documents and DIY scientific protocols for public edification.36 In her text 
"Amateurity and Biotechnology," Jeremijenko argues that the recent social and 
political changes, in the United States as well as on a global scale have 
militarized biology (in the form of biotechnology) in the public sphere, leaving 
35
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biotechnology largely inaccessible to the general public. Unlike many others in 
the bioart field, she is not postulating that a culture of specialization is what 
prevents individuals from engaging in biotech; rather, it is a culture informed by 
fear, war, and bio-terrorism that dismisses public participation in biotechnological 
practices as dangerous. She argues forcibly in opposition to this shift towards 
militarization: 
The conflation of bioterrorism and biology can only be achieved by 
removing it from everyone's home, purging it from daily experience and 
reintroducing it as a threat (cross-dressed in a biohazard suit), from which 
the citizenry needs to be protected. It can only be achieved because most 
people have never walked into a lab, and never recognized that the pile of 
dirty test tubes, Petri dishes and unwashed equipment on the sink in the 
lab as familiar, these appear alien despite the fact they look rather like the 
pile of dishes beside the sink at home. They have never recognized that 
the laminar flow hoods are not so different from the stove vents in your 
kitchen, have never cultivated the bacteria in their mouth, sterilized (i.e. 
cooked) something or understood that we think with juicy biological 
concepts, organize genetic heritability as much through marriage and 
immigration laws and our performances in bedrooms as we do with sperm 
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banks and gene markers. Life, and politics, and everything in between is 
biological. This is not a territory we can concede to the lobbyists.37 
Jermijenko connects the criminalization of amateur biotechnology with the 
McCarthy-era criminalization of communism and socialism. She argues that 
biology and biological experimentation is not inherently dangerous; it is only 
rendered so when the industrial military complex expends enormous financial 
and human resources in weaponizing biological agents. She concludes that we 
should "take biotech material, experiments and inquiry in to the unsupervised 
autonomy of your home"38 as a form of resistance. This action would reassert 
the autonomy of the individual in this field and also redefine the non-specialist as 
a valuable contributor to society and scientific knowledge. 
In the kits and explorations we have discussed, the one thing that is 
absolutely unequivocally clear is that biotechnology is not something 
confined to well funded academic and corporate labs. The ideas and 
technologies of biotech effect us all. Biotechnology has far reaching 
effects on our health, on our environment and on our politics and many 
effects we cannot yet know or specify. It even effects our own sense of 
political agency in the world: are we predetermined by genetic 
37
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dispositions, or by the environments in which we live. Biotech hobbyist 
emphasizes the later; this is where we can act, change and improve 
things.39 
In "Amateurs and Hobbyists," Heath Bunting makes a similar argument: artists 
need to be active participants in biotechnological research. He illustrates his 
case by outlining a number of his own bioart projects. Bunting, like Eugene 
Thacker, links the biotech hobbyist movement to amateur models in the early 
computing industry — but unlike Thacker and Jeremijenko, Bunting sees an 
imminent future in which biotechnology achieves ubiquity in the home. He 
states, "Similarly I predict that in another ten years time or less the general public 
will be enthusiastic users of domestic biological equipment. As with computer 
systems, biotechnology gadgets will be access points to utility and identity 
products and will be treated with as little thought as mobile telephones are 
presently."40 Although I am not persuaded that this movement is as imminent as 
Bunting predicts, it is interesting to note that biotech gadgets have already made 
their way into the home through avenues of children's science toy sets. Products 
such as the DNA Isolation Lab, the Discovery Kids Ultimate Labs DNA Explorer, 
and the CSI DNA Lab are all available for purchase online or at specialty 
toyshops. On some level, Bunting's prediction is already coming true: a number 
*
9
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of bioartists have purchased these toys for the purposes of research. At a 
substantially lower cost than purchasing new or used lab equipment, non-
specialists who wish to experiment with biotechnology are able to acquire 
durable, functional, and portable equipment. 
Critical Art Ensemble 
Another major proponent of non-specialist participation in biotechnology from a 
politicized perspective is the acclaimed artist collective Critical Art Ensemble. 
Critical Art Ensemble (CAE) is a conglomeration of artists and activists working in 
the United States for the last decade. Its founding members include the artists 
Steve Kurtz, Steve Barnes, Dorian Burr, Hope Kurtz, and Beverly Schlee. The 
group often collaborates with artists such as Paul Vanouse, Faith Wilding, and 
Beatriz da Costa, as well as many others. CAE has published a number of 
books and articles focusing on tactical means for artists and activists to engage 
in hegemonic systems of power and control through capital. They write, "Tactical 
Media is situational ephemeral, and self-terminating. It encourages the use of 
any media that will engage a particular sociopolitical context in order to create 
molecular interventions and semiotic shocks that contribute to the negation of the 
rising intensity of authoritarian culture."41 
41
 Critical Art Ensemble, in The Interventionists: A User's Manual for the Creative 
Disruption of Everyday Life. Thompson, Nato. Edt. 2004, Mass MoCA Press, p. 
115. 
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In my understanding, CAE is engaged in a form of participatory post-Marxist 
criticism, focusing specifically on upsetting capital drives in technological sectors 
through amateur interventions in specialized biotechnologies. In Electronic Civil 
Disobedience: and other unpopular ideas, CAE argues that, in order for civil 
disobedience to be as effective today as it was in the 1960s, activists must 
familiarize themselves with the current channels for the flow of capital so that 
they can impede those flows from the outside. In the past, capital relied on 
physical infrastructure and therefore physical forms of protest were effective (for 
example, a sit-in). But with the digitization of capital must come the digitalization 
of resistance.42 
With (RE)embodying Biotechnology, I am arguing that this strategy can be 
successfully applied in the biotechnological sphere — that with the 
biotechnologization of capital that occurs in technology sectors today, resistance 
must also occur on a biological level if it is to be effective. CAE's more recent 
writings and artworks, which focus on biotechnology (and particularly 
transgenics), are a stunning example of complex biotechnological resistance 
through amateur production. Resistance, as it is mobilized by CAE, is complex 
and can easily be misinterpreted as a blanket critique of all transgenic production 
in the biotechnological sphere. In this instance, resistance implies risk 
assessment — third-party, non-specialist risk assessment of individual instances 
42
 Critical Art Ensemble. Electronic Civil Disobedience: And Other Unpopular 
Ideas. Brooklyn: Autonomedia, 1996. p. 117. 
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of transgenic manipulation towards informed dialogue, critique, and consent. 
CAE explains, 
When we do projects concerning transgenics, one of the most common 
questions participants ask is whether CAE is for or against genetically 
modified Organisms (GMO's). The reply from group members is always 
the same: We have no general position. Each product or process has to 
be taken on a case-by-case basis. Some appear disastrous (primarily to 
the environment), while others seem soundly engineered and useful. 
CAE is a staunch supporter of amateur science in general and, more specifically, 
amateurism as a form of activism and/or intervention in the authoritative capitalist 
drives in the biotechnological sector. They suggest that the amateur possesses 
a vital role in knowledge production in the hard sciences: "They (amateurs) can 
have the ability to spot contradictions and rhetorical cover-ups within the 
dominate paradigms, are freer to recombine elements of paradigms thought dead 
or unrelated, and can apply every day life experience to their deliberations with 
greater ease than can specialists."43 
CAE outlines their reasoning for this deployment of amateur biotechnological 
strategies in their seminal work The Molecular Invasion. In chapter 3, 
43
 Critical Art Ensemble, in The Interventionists: A User's Manual for the Creative 
Disruption of Everyday Life. Thompson, Nato. Edt. 2004, Mass MoCA Press, p. 
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"Transgenic Production and Cultural Resistance: A Seven Point Plan," they 
outline a strategy for cultural resistance, that relies heavily on notions of 
amateurism as an effective form of activism, against industrialized transgenic 
production that. The plan is as follows: 
1 Demystify transgenic production and products 
2 Neutralize public fear 
3 Promote critical thinking 
4 Undermine and attack Edenic and Utopian rhetoric 
5 Open the halls of science 
6 Dissolve cultural boundaries of specialization 
7 Build respect for amateurism44 
CAE has taken a number of steps towards achieving these goals through the 
propagation of amateur scientific protocols and research methodologies in the 
production of art. For example, projects like Free Range Grain, The Cult of the 
New Eve,.Genterra (fig. 10.), and Contestational Biology, amongst others. 
44




Critical Art Ensemble in collaboration with Beatriz da Costa 
Genterra 
St. Norbert Art and Culture Center, Winnipeg 
2001 
CAE serves as arguably the best example of interdisciplinary non-specialist 
incursion into both the biotechnological field and the public representation of 
biotechnology and bioart, not simply because of the quality of their critical 
writings and artwork but because CAE now serves as a legal test case for the 
viability of amateurism in biotechnology. On May 11, 2004, Steve Kurtz, a 
professor, artist and member of Critical Art Ensemble, woke up to find that his 
wife, Hope Kurtz, had suffered a heart attack and died in her sleep. He called 
911. When the paramedics arrived, they observed laboratory equipment, 
samples of bacteria growing in Petri dishes, and books written on biological 
warfare and bio-terrorism in his home. Cranked up on the pervasive media 
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rhetoric of the 'War on Terror,' the police suspected that Kurtz's art supplies 
might be bio-terrorist weapons and contacted the FBI. The FBI sequestered 
Kurtz in a local hotel without pressing charges, sealed off his neighborhood, and, 
with a HAZMAT team dressed in biological hazard suits, confiscated his 
computers, manuscripts, and art supplies — even his wife's body. 
Subsequently, Kurtz and nine of his colleagues were subpoenaed to testify 
before a grand jury. The FBI sought charges of terrorist activity under Section 
175 of the US Biological Weapons Anti-Terrorism Act of 1989 and the expanded 
USA Patriot Act. This law prohibits the possession of "any biological agent, toxin, 
or delivery system" without the justification of "prophylactic, protective, bona fide 
research, or other peaceful purpose."45 This law was applied to Kurtz's 
possession of equipment for DNA analysis and cultures of three common and 
harmless bacterial species (Escherichia coli, Bacillus globigii, and Serratia 
marcescens). Of course, the real danger posed by Kurtz and Critical Art 
Ensemble goes far beyond their possession of simple biological cultures. The 
true threat of Kurtz's practice is not to the health and safety of the American 
people but to the intellectual and ideological stronghold of the corporate and 
government monopoly over biotechnological practices. 
The charges of biological terrorism were eventually dropped, as there was no 
45
 United States Code: Title 18, Part 1, Chapter 10, § 175. Prohibitions with 
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case to support this accusation. However, Kurtz was charged with a civil offence 
of wire and mail fraud to the amount of US$256.46 Scientist Dr Robert Ferrell, 
Chairman of the University of Pittsburgh's Human Genetics Department, was 
also indicted for providing Kurtz with biological materials outside of the material 
transfer agreement he signed with ATCC (the distributor of the bacteria in 
question). If found guilty, Kurtz and Ferrell were looking at the possibility of 
spending 20 years in jail for committing a federal offence. During this time, 
Ferrell became gravely ill, pleaded guilty to a misdemeanor, and was fined 
$500.00 US and given one year unsupervised release for his part in the 
transaction. 
Paradoxically, this unfortunate chain of events suggests that CAE's amateurism 
cannot be interpreted as entirely successful if it lands its artists, researchers, and 
activists in a position where incarceration is a possible outcome. On the other 
hand, this situation can be read as profoundly accurate, in political and tactical 
terms, due to the fact that the highest levels of the American government are 
mobilized in opposition to CAE's amateurism in an attempt to preserve 
specialization .(and therefore government and corporate control) in the biological 
sciences. 
46
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Anna Munster, in her analysis of Kurtz's case, sees the indictment of Kurtz and 
Ferrell as part of a continued societal push towards control of research, 
information, and life through the canon of specialization. 
It is clear that the policing of America means the confinement of people, 
knowledge, resources and cultural production to their proper spheres. 
Artists using materials that are authorized for scientific research cannot 
possibly be conducting research as well. They are clearly defrauding the 
public and this should be regarded suspiciously. As the American scientific 
community has been quick to note, bringing the fraud allegations against a 
scientist also has implications here for the ongoing conduct of scientific 
research (Park, 2004). The routine sharing of resources (materials) 
among laboratory researchers will be subjected to stricter regulation with 
the threat of fraud hanging over collaborative scientific research and 
hence this will see an increasing privatization of both research processes 
and outcomes.47 
Munster's arguments, as well as the events that transpired in the American 
courts, are indicative of the powerful control mechanisms critiqued by CAE in 
their various publications. As of April 21, 2008, the charges have been dropped 
47
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against Steve Kurtz. It was found that there was no instance of fraud in regard to 
the transaction that occurred during the acquisition of the bacteria for CAE 
research. Certainly, damage has been done in terms of directing public opinion 
towards scientific amateurism and bioart as a possible form of bioterrorism — 
there was mass American media coverage of the FBI HASMAT teams rifling 
through Kurtz's home and neighborhood and subsequently much less coverage 
of the downgrading and eventual dismissal of charges against Kurtz. But a 
critical precedent has been set in the US legal system in regard to material 
transfer agreements, and even more significantly in terms of the value and 
validity of non-specialist participatory models for engaging in biotechnology. 
Bioart in the Media 
Outside of this significant but rare instance of the vilification of bioart practices, 
bioart discourse has begun to surface in popular media sources as a valid and 
fruitful incursion into the biotechnological sciences, bioart seems to have 
captured the contemporary media imagination on a number of levels: as a quirky 
and humorous practice, as a tool of social and political activism and criticism, as 
a 'new' evolution in artistic practices, and even as a locus or 'quotable source' in 
the evaluation of contemporary biotechnological research. 
For example, in her article "Bio-artists use science to create art," Jessica M. 
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Pasko writes, 
Adam Zaretsky once spent 48 hours playing Engelbert Humperdincks's 
Greatest Hits to a dish of E.coli bacteria to determine whether vibrations or 
sounds influenced bacterial growth. Watching the bacteria's antibiotic 
production increase, Zaretsky decided that perhaps even cells were 
annoyed by constant subjection to "loud, really awful lounge music."48 
Although some could interpret this humorous portrayal of biological art practices 
as too playful, and possibly dismissive of the social and political ramifications of 
Zaretsky's work, I see the tone of this type of 'human interest' reporting as 
influential in propagating accessibility to the reader. This article is an especially 
good example, as it addresses the 'professional' successes of the artist and 
mixes outrageous and entertaining references to Engelbert Humperdinck with 
reflective philosophical assertions made by the artist himself: "(Bio-art) is a way 
of looking where we interface with ourselves, human culture and the rest of the 
living world," claims Zaretsky.49 The combination of such a witty, almost self-
deprecating tone and sanctioned, even institutionalized criticism of science 
48
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allows for a very accessible set of arguments for the democratization of 
biotechnology. The article concludes in a similar manner: with black humor. 
Part of the problem with bio-art, explained RPI faculty member and Kurtz's 
colleague Rich Pell, is that much of it seems shrouded in secrecy because 
of the laboratory setting. Pell and Reodica are working to combat this 
through the creation of the Center for Bio-Media, a gallery, lab and 
educational facility that will be open to the public. 
"With bio-art, rather than just freaking out about it, you can then go into a 
lab where things are actually happening and then have an 'educated 
freak-out,'" Pell said.50 
It seems that the emphasis on social and political activism and science criticism 
also translates well into more generalized media outlets. Oron Catts and lonat 
Zurr, of Tissue Culture & Art Project, are well versed in speaking to the media in 
a way that emphasizes the critical strategies in their artworks. In the Wired 
Magazine article "Jacket Grows from Living Tissue," they are represented as 
such: 
While there's still lots of research to be done before a fully formed live 
jacket can be created, the artists are quick to point out that they aren't 
interested in creating commercial products or even furthering scientific 
50
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research. Calling themselves conceptual artists who create working 
prototypes, they say their aim is to bring to the forefront the philosophical 
implications of making living organisms tools for our own purposes. 
"It's quite a scary thing, our attitude to life as it is at the moment," said 
Zurr. "And the more we manipulate life for human-centric purposes, I 
wonder now how compassionate we are going to be towards those living 
systems. Our work is more about questioning these things rather than 
saying, This is great, let's go for it."'51 
Even scientific sources that discuss bioart in the media recognize the critical and 
transformative potential of bioart. Here, Dr. Stuart Newman speaks candidly 
about Eduardo Kac's GFP Bunny project as having significant potential in public 
discourse surrounding biotechnology: 
Even one of Kac's most passionate critics applauds him for drawing 
attention to what is now being done in genetics research. 
"It kind of turns the searchlights back on scientists," said Stuart A. 
Newman, a professor of cell biology and anatomy at New York Medical 
College who uses glowing proteins to track how animal limbs develop. 
51
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"There are some pretty awfully deformed animals in transgenic research, 
and scientists have sometimes done these things with no good theory 
behind it."52 
Also, in a most interesting turn, Wired Magazine actually quotes bioartist Oron 
Catts as a critical source for evaluating unrelated scientific claims in the article 
"Careful with that Petri dish," where scientists are working with NASA towards 
growing human replacement organs with tissue engineering technologies in 
gravity-free environments. The article concludes with a quote from Catts: 
"It sounds very interesting and might work for small pieces of tissue rather 
than full organs," said Oron Catts, director of SymbioticA. "The thing about 
microgravity tissue engineering is that it's a great way to make semi-living 
tissue, but the jury is still out in regard to getting the right morphology for 
eventual transplant into the body."53 
I do see very promising inroads into mass media representations of bioart as an 
accessible and transformative social and political practice. However, the quantity 
52
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of mainstream reporting is still relatively low, and quite often the complexity and 
depth of content is disappointing. 
Articles published in artistic or scientific journals are far more likely to delve into 
the complexity of bioart practices. 
"Transgenic animals are often talked about as objects," he says, delighted 
by the attention Alba has received. "I want to talk about transgenics as 
social subjects, and contextualize their existence as for its own sake, to 
shift the discourse away from this cliche of Frankenstein and Dr. Moreau." 
Kac doesn't want to comment on genetics as much as he likes "going in 
the trenches" and using genetic engineering to hold a mirror to itself. "I am 
not interested in reinstating scientific principles," he says. "My work 
doesn't visualize science, it is not meant to duplicate the information that 
circulates from science to media to the public. It is meant to intervene, to 
change, to criticize, point out, reflect and modify." He doesn't really 
consider Alba to be "art" at all. Rather, she is but a small part of a much 
larger, more political project. The GFP Bunny project, says Kac, includes 
not only the process of bringing Alba into the world and integrating her into 
society, but also deliberately provoking the fears, imaginations and hopes 
we have attached to genetics and new life forms. One small hop for Alba; 
one large hop for mankind.54 
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Though the examples that I have provided are telling in regards to public 
perceptions of bioart practices, instances of bioart coverage in the news media 
are still relatively rare. As bioart is still an emerging practice on the international 
art scene, I imagine that media references will continue to grow in numbers as 
the field expands in public discourse. 
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3 | (RE)embodying Digital Metaphors in Biotechnology 
Insert block of new genes into a freshly fertilized egg. The one cell 
becomes two, then four, then eight. Each new version carries the 
extra information. In nine months, a baby is born. Every cell in his 
or her body contains the extra genes. 
Daniel Q. Haney, Life Magazine.1 
In his 2000 article "Designing Baby: Scientists on Verge of Manipulating Human 
DNA," Daniel Q. Haney describes an evolving biotechnological process called 
human germline engineering. He explains how scientists are working to 
genetically alter human blastocysts soon after conception so that genetic 
changes will be passed on to the embryo's future offspring. Haney is exuberant 
in his description of the therapeutic potentialities of this instance of 
biotechnology, but brief and almost curt in describing the actual processes that 
are involved in germline engineering. He relies heavily on digital metaphors to 
describe wet biotechnological practices (involving living organisms) to the 
general public, suggesting that this biotechnological process is much like 
computation. In his article "Were You Born That Way?" (1998), which was 
1
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published in Life Magazine, George Howe Cult compares the future of genetic 
engineering to shopping online. "By the time my daughter's grandchild is ready 
to give birth, prospective parents may design their children at the computer, 
scrolling through genetic menus to pick and choose, from their own DNA pools, 
specific gene clusters for height, weight and eye color, as well as for 
assertiveness, extroversion, happiness and so on."2 Contemporary media 
representations of biotechnology often place great emphasis on notions of 
digitality and programmability as inherent technologies of the human organism, 
suggesting that our 'cumulative' technology — computation — performs the 
ultimate science: enforcing the dominion of human intelligence over nature 
through the application of numeric code to living organisms. 
<copy> <paste> <insert> <delete> <error> 
<code> <program> <download> 
<cross-platform> <software> <hardware> 
These terms, although derived from a variety of linguistic sources, traditions, and 
histories, are all used extensively in describing and interacting with the digital 
domain and have come to evoke strong references to computation in the mind of 
the speaker, writer, listener, or reader. With the exponential proliferation of 
computational technologies on arguably a global scale, we have comfortably 
2
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positioned ourselves, historically and technologically, in the digital era. Digital 
information and communication technologies dominate substantial portions of our 
personal, social and work lives. Email, the Internet, podcasts, chatrooms, 
downtoads, iPods, BlackBerrys, cellphones, and portable hard drives are present 
throughout our daily lives. 
Questions about affect arise when one considers our deeply intimate and 
reciprocal relationships with digital technologies as individuals, as a society, and 
as a civilization. In his introduction to The Cybercultures Reader, David Bell 
writes, 
Are we now so inseparable from our computers that we have effectively 
become them? Are they us? Are they extensions of our identities -
prostheses? Do we blend with them, each incorporating the other, to 
become hybrid cybernetic organisms - cyborgs?3 
The normalization (or even the naturalization) of computational infrastructure in 
our society, ecology, and personal lives has lead to a reciprocal inflection where 
matter and existence is interpreted through a digital technological lens. 
3David Bell, "Cybercultures Reader: A User's Guide" from The Cybercultures 
Reader. David Bell and Barbara M. Kennedy. Edts. New York: Routledge, 2000. 
p.4. 
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In his work The Biotech Century: Harnessing the Gene and Remaking the World, 
Jeremy Rifkin reminds us that, with each technological revolution, society begins 
to interpret itself and the natural world through the metaphors of the dominant 
technological paradigm. He illustrates how the dawn of the printing press, a 
communication technology that was absolutely central to the industrial revolution, 
created new avenues for political and economic activity and new systems of 
organizing knowledge — effectively changing human consciousness and creating 
the new bourgeois man and woman of the modern era.4 With the computer 
revolution, a similar phenomenon occurs. As digital technologies permeate our 
existence, they change the very foundations of our conceptualization to coincide 
with this powerful model. 
Every major economic and social revolution in history has been 
accompanied by a new explanation of the creation of life and the workings 
of nature. The new concept of nature is always the most important strand 
of the matrix that makes up any new social order. In each instance, the 
new cosmology serves to justify the Tightness and inevitability of the new 
way human beings are organizing their world by suggesting that nature 
itself is organized along similar lines. Thus every society can feel 
comfortable that the way it is conducting its activities is compatible with 
4
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the natural order of things, and therefore, a legitimate reflection of nature's 
grand design.5 
f^ifkin both identifies this phenomenon and is subject to it himself. It is 
inescapable for all of us. A few pages earlier in this text, Rifkin states, "The 
computer's mode of organization - especially parallel computing - mirrors the 
processes of living systems where each of the parts is a node in a dynamic 
network of relationships that is continually readjusting and renewing itself at 
every level of its existence as it maintains a living presence."6 As we are 
inherently a product of our own production and reproduction of a computation 
ecology, it is impossible to escape this conceptual loop in which nature and 
information cohabitate and interact with one another. 
However, it is my assertion that, with the ubiquity of digital media in all aspects of 
society, we run the risk of applying this model indiscriminately — to our 
understanding of nature, the body, and biotechnology. I, too, am subject to this 
phenomenon; it is evident in my existence, my self-concept, and my academic 
and artistic research trajectories that possess deep cybernetic underpinnings. I 
am convinced that there are significant parallels between computational models 
and emergent natural behaviors. I am, however, concerned about the resulting 
conceptual collapse of disparity between instances of embodiment and virtually, 
particularly as it pertains to ethical debates surrounding biotechnology. 
5
 Ibid. p. 197. 
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I am not arguing for a distinct border between the body and technology, between 
nature and culture. Cybernetic theory, articulation, pluralism, and, most 
imperatively, dialogical analysis all inform my understanding of the complex, 
evolutionary, and sometimes contradictory intersection of computation and 
biology as it affects our bodies, our society, and our ecology. However, in this 
particular text, I see a strong tendency to describe, imagine, and imbue 
biotechnological protocols with visions and languages that often replace wet and 
sometimes bloody biological manipulations with digital and computational task 
descriptions — a replacement that has the potential to distort the invested, 
embodied, and ecological implications of this type of research. It is my assertion 
that, with this shift in public discourse away from organicism, ethical debates 
addressing biotechnology and its specific protocols (such as tissue culture, 
protein magnification, and mammalian cloning) are often misinformed and 
inhibited by the continual reinvestment in powerful computational metaphors. 
How are we to reconcile the ethical issues presented by the instrumentalization 
of life in biotechnology if we only refer to and imagine the field as a virtual one? 
In other words, there must be variety and divergence in ethical consideration as it 
is applied to information — and as it is applied to the body. 
In this chapter, I want to explore the power of digital metaphors in constructing 
ideological frameworks for the consideration of the ethical implications of 
evolving biotechnologies. My interest here does not reside in the specificity of 
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certain biotechnological ethical debates in and of themselves (as that is outside 
of the scope of this text). Instead, I want to identify the dangers of mobilizing 
digital metaphors in public discourse surrounding biotechnology and investigate 
the possibility of shifting our language and imaginings towards more embodied 
models and paradigms. The goal of this project is to facilitate new grounds of 
consideration for the general public, specialists, lobbyists, corporations, and 
governments in an interdisciplinary and dialogical manner so that we can 
discuss, consider, practice, and plan our relationship — both current and future 
— with ourselves and our ecology in the biotech era. I am only proposing a new 
model for complex discourse; the resulting outcomes and decision-making 
trajectories are left open to the public. 
To support this proposal, I will address a number of points beginning with a brief 
analysis of how metaphors shape our world and our conceptualization. I will 
identify digital metaphors commonly used in describing biotechnology in a variety 
of media, with an emphasis on written and spoken language. I will then locate 
the possible origins of and the practical and theoretical reasons for the continued 
perpetuation of these metaphors. This chapter will close with proposed 
alternative language sets (as primarily generated from the arts and humanities) 
towards the (re)embodiment of biotechnological terminology in public discourse. 
Metaphors 
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To begin with this analysis, we need to address the power of metaphors in 
shaping our concepts of ourselves and the world. George Lakoff and Mark 
Johnson extensively explore the role of metaphors in our construction of meaning 
in Metaphors We Live By. They argue that the use of metaphor is pervasive in 
everyday life — in our language, our thought, our action — and also functions as 
a central component of our conceptual system. They define metaphor as such: 
"The essence of metaphor is understanding and experiencing one thing in terms 
of another."7 Commonly used metaphors establish culturally specific norms for 
understanding a concept, action, or thing. For example, Lakoff and Johnson 
address the Western metaphor of argument as war, elucidating a variety of 
linguistic examples for their readers. 
Your claims are indefensible. 
He attacked every weak point in my argument 
His criticisms were right on target. 
He shot down all of my arguments.8 
The pervasiveness of this adversarial model naturalizes the concept that an 
argument is inherently like a war. However, this is not the case. For example, 
7
 George Lakoff and Mark Johnson, Metaphors We Live By. Chicago: Chicago 
University Press, 1980. p.5. 
s
 Ibid. p.4. 
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Imagine a culture where an argument is viewed as a dance, the 
participants are seen as performers, and the goal is to perform in a 
balanced and aesthetically pleasing way. In such a culture people would 
view arguments differently, carry them out differently, and talk about them 
differently. But we would probably not view them as arguing at all: they 
would simply be doing something different.9 
They argue that metaphors are essential for human conceptualization and 
communication. However, they also address some of the possible drawbacks of 
relying so heavily on metaphorical systems of understanding. For example, they 
argue that strong metaphors only allow us to focus on one aspect of the 
metaphorized concept, keeping "us from focusing on other aspects of the 
concept that are inconsistent with that metaphor."10 This explains my concern 
with digital metaphors for understanding biotechnology. 
Certainly, biotechnology is saturated with computation, both literally and 
figuratively, but it is important to remember that they are not entirely equal; they 
are not inherently the same. The most significant difference between 
biotechnology and computation is the element of organic (and sometimes 
sentient) life, which is pervasive throughout biotechnology and generally absent 
(or existing in satellite relation as the user) in the computational domain. "It is 
9
 George Lakoff and Mark Johnson, Metaphors We Live By. Chicago: Chicago 
University Press, 1980. p.5. 
10
 to/dp. 10. 
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important to see that the metaphorical structuring involved here is partial, not 
total. If it were total, one concept would actually be the other, not merely be 
understood in terms of it."11 If we accept the arguments of Lakoff and Johnson 
and deploy their methodology, we can deduce, from the following statements, 
that individuals and public discourse generally accept and perpetuate digital 
metaphors in describing evolving biotechnologies. 
Recent advances in genetic engineering now allow the design of 
programmable biological artifacts.™ 
Working with lung cancer tissue and laboratory-grown lines of lung cancer 
cells, the investigators used high-resolution machinery to scan the cells' 
chromosomes. They found several areas that had already been identified 
as having copy-number errors, plus five new ones - two where genes had 
been deleted, and three where they had been over-cop/ec/.13 
"/Wtfp.13. 
12
 Dan L. Burk, "Lex genetica: The law and ethics of programming biological 
code" from Ethics and Information Technology 4, Netherlands: Kluwer Academic 
Publishers, 2002. pp. 109-121. Available online: URL: 
http://www.student.cs.uwaterloo.ca/~cs492/papers/biocode.pdf [date of last 
access: 02/01/2009] (My emphasis.) 
13
 "DNA-scanning technology finds possible sites of cancer genes in 
chromosomes of lung cancer cells" from Harvard Science Medicine + Health 
June 30, 2005. Available online: URL: 
http://www.harvardscience.harvard.edu/medicine-health/articles/dna-scanning-
technology-finds-possible-sites-cancer-genes-chromosomes-lung- [date of last 
access: 02/01/2009] (My emphasis.) 
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The bacterium behind one of mankind's deadliest scourges, tuberculosis, 
is helping researchers at the Commerce Department's National Institute of 
Standards and Technology (NIST) and the Department of Energy's 
Brookhaven National Laboratory (BNL) move closer to answering the 
decades-old question of what controls the switching on and off of genes 
that carry out all of life's functions.14 
The actual transfer of a gene is carried out in a complex "cut and paste" 
procedure.15 
As long as DNA specimens are a youthful 60,000 years old or less and 
are in good condition, scientists say they can decode an organism's DNA 
sequence from something as simple as a piece of hair.16 
14
 "Determining How 'Gene Switch' Works: Using Tuberculosis Bacteria To End 
25-Year Quest." from Medical News Today, Feb. 9, 2009. Available online: 
URL: http://www.medicalnewstoday.com/articles/138280.php [date of last 
access: 02/15/2009] (My emphasis.) 
15
 "How Does Biotechnology Work?" from Canadian Food Inspection Agency -
Resource Centre. Available online: URL: 
http://www.inspection.gc.ca/english/sci/biotech/gen/canadae.shtml [date of last 
access: 02/01/2009] (My emphasis.) 
16
 Melissa Suran, "Jurassic Park in Millennium Park? Penn State prof says it 
could happen." from Medill Reports, Chicago: Northwestern University, Feb. 4, 
2009. Available online: URL: 
http://news.medill.northwestern.edu/chicago/news.aspx?id=114307 [date of last 
access: 02/15/2009] (My emphasis.) 
113 
This set of ideas can also be applied more specifically to the scientific domain 
itself. Metaphors possess great power not only in public discourse but in 
specialized discourses as well. 
If we imagine the power of metaphor as it exists in the scientific community, we 
can look to the model of the paradigm as asserted by Thomas Kuhn in his now 
canonical text The Structure of Scientific Revolutions (1967). At the time of 
publication, his arguments were considered quite controversial, as his thesis 
directly challenges the perception of science as a purely objective field of inquiry. 
Instead, he argues that scientific inquiry, although an integral (and possibly 
optimal) mode of seeking knowledge, is a field based in interpretation and 
subject to a multitude of variables rather than an exact reflection of the universe 
around us. He suggests that the majority of scientific work (normal science) is 
driven by paradigms, which he defines as community-driven models for 
understanding the natural world, as well as the driving force for establishing 
parameters and strategies for scientifically investigating that world. He states, 
"Paradigms gain their status because they are more successful than their 
competitors in solving a few problems that the group of practitioners has come to 
recognize as acute."17 This is not to say that a paradigm is necessarily true or 
completely successful, but rather that a community of scientifically established 
individuals has agreed to a set of basic principles by which to guide their 
research. 
17
 Kuhn, Thomas S. The Structure of Scientific Revolutions (second Edition, 
enlarged) Chicago: The University of Chicago Press, 1970. p.23 
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In Crystals, Fabrics, and Fields: Metaphors that Shape Embryos, Donna 
Harraway claims that "An important aspect of a paradigm is metaphor, and it is 
suggestive to investigate the use of metaphor to direct research and its 
interpretation."18 "A metaphor is the vital spirit of a paradigm (or perhaps its 
basic organizing relation)."19 "The crudeness of a paradigm picture both 
stimulates and bounds the imagination, giving direction to the power of abstract 
expression, and linking the contributions of images private to a particular 
scientist, words that aim to communicate insight and theories that formalize 
tested common understanding."20 She argues that metaphors are so powerful in 
the mind of the beholder (specifically the scientist) that they can even effect 
paradigmatic change in the scientific community. Harraway explains her primary 
thesis for her understanding of metaphor to the reader: 
The focus of this study is a period of crisis and reformulation of basic 
concepts in experimental embryology and cell biology. The two major 
concepts sketched above, that of the significance of the metaphor in a 
revolutionary change in paradigm and that of the progressive 
concretization of aesthetic dictates, together form the core of the 
analysis.21 
18
 Donna Haraway. Crystals, fabrics, and Fields: Metaphors that Shape 
Embryos. Berkeley, California: North Atlantic Books, 1976, 2004. p.2. 
19
 Ibid. p.9. 
20
 Ibid. p. 189. 
21
 Ibid. p. 13. 
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This work, originally published in 1976, does not address digital metaphors in the 
biological sciences directly, but it does lay the groundwork for important future 
analysis of the perpetuation of digitality as a metaphor for the biological in the 
hard sciences. 
Although this area of investigation is outside the focus of this text (as I am 
focusing on public discourse), I have selected a few extracts from scientific 
abstracts hosted on the BIOSIS Preview22 journal search service that exemplify 
the use of digital metaphors in describing biotechnological protocols in scientific 
literature for consideration. 
The ability to measure accurately comparative levels of protein expression 
after drug challenge, metabolic stress, developmental programming or 
other perturbation represents one of the most important goals in post-
genomics malaria research.23 
22
 Bios Previews, Available online: URL: 
http://scientific.thomson.com/products/bp/ [date of last access: 06/01/2008] 
23
 Nirmalan, Niroshini; Sims, Paul F. G.; Hyde, John E. "Quantitative proteomics 
of the human malaria parasite Plasmodium falciparum and its application to 
studies of development and inhibition" in Molecular Microbiology 52 (4) : 1187-
1199 May 2004. (My emphasis.) 
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Recombinant DNA technology was used to delete the gene encoding 
lactate dehydrogenase in BCS3-L1 making it entirely deficient in lactic 
acid production.24 
See is, moreover, incorporated into proteins by an expansion of the 
genetic code as the translation of selenoproteins involves the decoding of 
a UGA codon, otherwise being a termination codon.25 
What I am most interested in — and what is closest to the heart of 
(RE)Embodying Biotechnology — is the powerful influence that these metaphors 
have in shaping public opinion and understanding of the science and industry of 
biotechnology. I am most interested in digital metaphors for biotechnology as 
they are presented in television, news (both in print and online), non-
documentary film, and literature, as it is these sources that contribute greatly to 
the public imagining and understanding of biotechnology, rather than scientific 
journals and academic analysis. We have already reviewed a selection of 
quotations from popular news sources that reinforce or exhibit these metaphors 
in terms of 'factual' reporting, but we must also consider fictional incarnations of 
24
 Jeffrey D. Hillman, "Genetically modified Streptococcus mutans for the 
prevention of dental cariesln Antonie van Leeuwenhoek 82 (1-2) : 361-366 
August, 2002. (My emphasis.) 
25
 Linda Johansson, Gafvelin, Guro; Arner, Elias S. J. "Selenocysteine in proteins 
- properties and biotechnological use" in Biochimica et Biophysica Acta 1726 (1): 
1-13 OCT 30 2005. (My emphasis.) 
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biotechnology as they, too, contribute to depicting biotechnology as a 
programmable or virtualized practice. 
Michael Clark writes, "Films with genetic themes represent the point where 
modern biomedical science meets subjective concerns and cultural anxieties 
about individual identity and freedom, and their implicit and explicit messages 
reach and influence millions of people in all walks of life who will probably never 
watch a BBC 'Horizon' documentary or read a popular science book on 
genetics."26 Fictionalized accounts of biotechnology, particularly in the form of 
mainstream commercial films, reach an immeasurably wide, international 
audience. 
These films capture both the attention and the imagination of the public, 
effectively cultivating their perceptions of biotechnology in a manner that is 
arguably more potent than other forms of media. In his book Screening DNA: 
Exploring the Cinema-Genetics Interface, Stephen Nottingham writes: 
The importance of stories in helping us think through scientific issues has 
been increasingly recognized in recent years. In particular, the repeated 
use of metaphors has been shown to shape how we perceive and 
understand issues. The images presented by popular culture appear to 
26
 Michael Clark, "Genetic theames in Fiction films" from The Welcome Trust. 
Available online: URL: http://genome.wellcome.ac.uk/doc_WTD023539.html 
[date of last access: 02/15/2009] 
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have some influence on common belief, and determine what is perceived 
as socially acceptable.27 
Eugene Thacker argues that popular culture is a site where cultural anxieties and 
ambiguities can be played out. He also argues the films, however, rarely focus 
on biotechnology as a primary subject. He states, "Films 'about' genetics and 
biotechnology are usually of two types: those that contain, almost incidentally, 
genetics and biotechnology, but only to motivate the action of the film, or those 
that use genetics and biotechnology to raise larger 'human' issues."28 In an 
online interview with Roy Christopher in 2006, Thacker traces the powerful 
outcomes of genetics as represented in film: 
One thing it means is that these sciences and technologies are normalized 
in a way that the general public going to a film will "accept" their inclusion 
as a matter of course. Certainly there are always SF geeks who dispute 
the technical accuracy of how the genetic mutation actually creates the 
superhero or villain, but on a general level these technosciences have 
become a part of a certain cultural imaginary. 
My concern lies in the representation of the technical actions performed in 
biotechnology. This concern can be seen as easily dismissible — merely a 
27
 Stephen Nottingham, Screening DNA: Exploring the Cinema-Genetics 
Interface. DNA Books, 2000. Available online: URL: 
http://ourworld.compuserve.com/homepages/Stephen_Nottingham/DNA1.htm 
[date of last access: 02/15/2009] 
28
 Eugene Thacker, The Global Genome : Biotechnology, Politics, and Culture. 
Cambridge: The MIT Press, 2005. p.341. 
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geek's desire for technical accuracy — but I am not interested in pure accuracy; 
rather, I am concerned about the ramifications of the visual metaphors that depict 
biotechnological protocols as inherently digital. 
Representations of biotechnology in non-documentary films often emphasize the 
practice of digital technological processes and protocols, in both contemporary 
and future incarnations. An excellent example is Stephen Spielberg's Jurassic 
Park (1993). The film depicts a well-meaning scientist who, using DNA extracted 
from blood stored within fossilized mosquitoes, clones prehistoric dinosaurs. The 
cloning process is described to audiences through a theme park mascot 
character called Mr. DNA. He explains, "thinking machines, super computers, 
and gene sequencers break down the strand in a minute and virtual reality 
displays show our geneticists the gaps in the DNA sequence." He prattles on, 
listing the virtues of cloning, and discusses the connection between genetic and 
digital codes. The laboratory is represented as a sterile computational site 
where, through programming and robotics, life is conceived, in the form of infant 
prehistoric dinosaurs. 
W.J.T. Mitchell writes about Jurassic Park in The Last Dinosaur Book: The Life 
and Times of a Cultural Icon: 
Powerful new computers make it possible to imagine the resurrection of 
the dinosaur as nothing more than a computational problem in biogenetic 
engineering. The same computers make possible digital animation 
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techniques that replace robotics as the cinematic technology of choice. 
The dinosaur is a cyborg, a computer-animated animal, in both the story 
and the medium in which the story is represented.29 
Nottingham notes that Jurassic Park is the third-largest grossing film in cinema 
history, behind Star Wars (1977) and E.T.: The Extra Terrestrial (1982), up until 
the release of Titanic in 1997.30 Produced sixteen years ago, Jurassic Park is 
indicative of a flood of representations within the last three decades that reinforce 
public conceptions of biotechnology as primarily centered around genetic or 
digital manipulations of the body. Since that time, hundreds of films have been 
released that continue to shape public conceptions of biotechnology as driven by 
computation and interface, particularly when it comes to genetics. 
As Thacker argues, filmic representations of biotechnology certainly can and 
should be understood as incredibly complex in the messages and metaphors 
they portray to the general public in regard to ethics, embodiment, and genetic 
technologies. I am not suggesting a blanket one-to-one ratio of representation, 
where all instances of biotechnology in film are solely rooted in portraying 
didactic, digital incarnations of biotech. However, I see a prevalent discourse 
which is based on the notion of interface — with an emphasis on those 
29
 W.J.T Mitchell, The Last Dinosaur Book: The Life and Times of a Cultural Icon. 
Chicago: The University of Chicago Press, 1998. 
30
 Stephen Nottingham, Screening DNA: Exploring the Cinema-Genetics 
Interface. DNA Books, 2000. Available online: URL: 
http://ourworld.compuserve.com/homepages/Stephen_Nottingham/DNA1.htm 
[date of last access: 02/15/2009] 
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biotechnologies rooted in genetics. These representations often present fully 
actualized organisms (bodies) as the output of computational protocols. 
This focus is evident in a variety of films like Minority Report (2002), in which 
fetishized digital interfaces that are connected to three psychics, or "precogs," 
allow police investigators to apprehend criminals before a crime is committed. 
Godsend (2004) also relies on the premise of clean digital/video interfaces, this 
time used in the production of a cloned child in order to replace the diseased son 
of a grieving couple. In these instances, among others, the technical practices of 
biotechnology are misrepresented (or only partially represented) as an extension 
of computation with little or no attention given to the multitude of orders of life 
present in real instances of biotech, let alone the embodied (wet, bloody, unruly, 
and sometimes fatal) and reciprocal practices of manufacturing, maintaining and 
manipulating life in the lab. 
Identifying and investigating digital metaphors for embodied biotechnological 
practices in fictional film representations of the field could (and should) constitute 
a significant body of academic research, although this necessary exploration is 
unachievable within this context. However, I choose to touch on this significant 
area in a tertiary way in order to support my own arguments without overlooking 
this critically important genre of representation in terms of its contribution to 
public discourse surrounding biotechnology. 
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The identification of computational metaphors in public biotechnological 
discourse leads us to an important question: where do digital metaphors for 
describing biotechnological protocols come from? 
Molecular Biology and Bioinformatics 
The short answer is molecular biology. Molecular biology, a term originally 
coined by Warren Weaver of the Rockefeller Foundation in the 1930s, generally 
refers to a branch of biology that studies the chemical and physical properties of 
life at a molecular level. This interdisciplinary field came to prominence in 
scientific circles in the 1940s with the discovery of the structure of DNA and 
subsequent research on protein production and molecular genetics (amongst 
others). Pnina G. Abir-Am highlights the rise of molecular biology, noting two 
shifts in the scientific perception of biology during this era: (1) molecular biology 
essentially displaced evolution as the central problem of the biological sciences, 
and (2) nucleic acids were conceptually transformed into messages of biological 
information.31 
Lily E. Kay, in The Molecular Vision of Life, points to Dr. Erwin Schrodinger and 
his arguments for a genetic 'code script' in What is Life?, as a the forefather of 
informatic models for understanding biology at the molecular level. A Nobel 
31
 Pnina G. Abir-Am, "The Politics of Macromolecules: Molecular Biologists, 
Biochemists, and Rhetoric" in Osiris, 2nd Series, Vol. 7, Science after '40. 1992. 
P.166 
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Prize-winning quantum physicist, Schrodinger applies his knowledge and 
understanding of the physical properties of the external world to the inner 
workings of the organism. What is Life? arguably functions as a locus for the 
metaphorical conjunction of computational and biological functions as early as 
1944. He writes: 
It is these chromosomes, or probably only an axial skeleton fiber of what 
we actually see under the microscope as the chromosome, that contain in 
some kind of code-script the entire pattern of the individual's future 
development and of its functioning in the mature state. Every complete set 
of chromosomes contains the full code; so there are, as a rule, two copies 
of the latter in the fertilized egg cell, which forms the earliest stage of the 
future individual. In calling the structure of the chromosome fibers a code-
script we mean that the all-penetrating mind, once conceived by Laplace, 
to which every causal connection lay immediately open, could tell from 
their structure whether the egg would develop, under suitable conditions, 
into a black cock or into a speckled hen, into a fly or a maize plant, a 
rhododendron, a beetle, a mouse or a woman.32 
James D. Watson confirms the significance and direct influence of this assertion 
in his retelling of the events leading to a successful model for DNA in DNA: The 
Secret of Life. 
32
 Erwin Schrodinger, What is Life? Cambridge: Cambridge University Press, 
1944. Available online: URL: http://faculty.washington.edu/lynnhank/LIFE.doc 
[date of last access: 02/15/2009] 
124 
Schrodinger argued that life could be thought of in terms of storing and 
passing on biological information. Chromosomes were thus simply 
information bearers. Because so much information had to be packed into 
every cell, it must be compressed into what Schrodinger called a 
"hereditary code-script" embedded in the molecular fabric of 
chromosomes. To understand life, then, we would have to identify these 
molecules, and crack their code.33 
In reading What is Life? so many decades after its publication, what strikes me 
most is the relative timing of Schrodinger's analysis. 
Historically, the Second World War marks a significant milestone in the 
development of computational technologies, where researchers and 
governments dedicated substantial resources towards computation-driven 
decryption devices — early computers. Schrodinger's text was conceived and 
published at a time when computation, transcription, and code were central lines 
of research and inquiry on an international scale. His model was undoubtedly 
influenced by this influx of activity. If we re-examine Watson's account of his 
contribution to the growing field of molecular biology, we see that he states, "To 
understand life, then, we would have to identify these molecules, and crack their 
code."34 His choice of words implies that researchers, at that time, conceived of 
33
 James D. Watson and Andrew Berry. DAW The Secret of Life. New York: 




the molecular make-up of life as an encrypted message that needed to be 
deciphered. Watson's language perpetuates a model of cryptography as 
science, analogous to then contemporary war strategies and the birth of modern 
computational devices. Sixty years later, the application of this type of language 
prevails; only now computation and molecular biology are dominant features in 
our civilian technological landscape. The militaristic implications of these 
statements are desaturated but not forgotten. Instead, decrypting (and, 
inversely, encryption) is conceived as a mundane computational function, 
emphasizing digital coding models (or programming), that is central to public 
understanding of biological functions. 
In Watson's time, research in both fields — molecular biology and computation 
— was functioning at only the most elite levels of government, academia, and 
industry. Since the end of the Second World War, computers have proliferated 
exponentially in availability and computing power. These changes have occurred 
in the government, in business, and in public sectors of developed countries. On 
the other hand, molecular biology, as both an object of study and (more recently) 
as a technological tool, has only shown direct application and utilization in non-
specialized spheres in the past few decades. Though both fields stem from a 
similar era, computation is often understood in public discourse as a predecessor 
to biotechnology and, more specifically, to molecular biology. This relationship 
may provide further explanation for the continued application of computational 
metaphors in our description and understanding of the biotechnological domain. 
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If we look to The Language of New Media, Lev Manovich argues that we often 
use our experience, knowledge, and language of pre-existing innovations to 
describe and interpret new technologies. I suggest that this?paradigm, which is 
rooted in communication studies, is a viable strategy for interpreting the language 
surrounding innovation in other fields as well. Contemporary language 
surrounding biotechnology places great emphasis on digital processes as a 
predecessor of the instrumentalization of biological tools — and therefore as a 
viable means of understanding and describing biotechnology. As a result, the 
biotech era becomes inherently understood as a byproduct of the information 
age. 
In How We Became Posthuman, Katherine N. Hayles makes an argument that is 
similar to the position presented by Manovich, and certainly evocative of Rifkin's 
assertions as well. She links the presuppositions of cybernetics with some of the 
foundational assumptions that are mobilized in evolutionary biology. 
The models proposed by evolutionary biologists have encoded within 
them cultural attitudes and assumptions formed by the same history they 
propose to analyze; ... To take only one example, the computer model 
advanced by Jerome H. Barkow, Leda Cosmides, and John Tooby in The 
Adapted Mind: Evolutionary Psychology and the Generation of Culture to 
explain human evolutionary psychology testifies at least as much to the 
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importance of information technologies in shaping contemporary world 
views as it does to human brain function.35 
However, our reliance on digital metaphors is more complicated* than the 
progressive application of technological language in describing new processes. 
Biotechnology, though an old field, has experienced a contemporary renaissance 
due to the intersection of computation and the biological sciences. 
Arthur Kroker investigates this intersection from (an arguably validated) paranoid 
standpoint, utilizing dramatic language and terrifying imagery to elucidate his 
understanding of the convergence of the gap between computation and biology. 
In his introduction to The Will to Technology & The Culture of Nihilism, he 
describes his text as riding "the surface of the body in the form of digital media 
meant to amplify and extend the human sensorium, and, more urgently, 
technology as it invades the surface of the body, colonizing, coding, and 
manipulating the genetic code."36 In a view much different than the one 
presented by Hayles, Kroker sees a truly dystopic endgame at play. He sees an 
intentionality within this convergence, leading us towards a more harnessable 
human — a body directly accessible to programmation by hierarchical power 
structures. He imagines the instrumentalization of humanity as hard/wet ware: 
Katherine N. Hayles. How We Became Post-Human: Virtual Bodies in 
Cybernetics, Literature, and Informatics. Chicago: University of Chicago Press, 
1999, P. 284. 
36Arthur Kroker, The Will to Technology & The Culture of Nihilism: Heidegger, 
Nietzsche, & Marx. Toronto: University of Toronto Press, 2004. p. 3. 
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Are we suiciding ourselves to virtual life? The law of external recurrence 
will not be denied. We do not have a special exemption. The harvesting 
of other species will inevitably have its reverse side: the harvesting of the 
human species at the lip of the Net. Maybe the larger cultural discourse; 
that we are presently caught up in is that digitality and biotech are the 
chosen mechanisms by which human beings will be interfaced to the data 
world, genetically modified for more perfect system transparency.37 
A very real form of convergence thrives in the multi-billion dollar, international 
industry of bioinformatics. Bioinformatics generally refers to the use of 
computational systems to store, manipulate, analyze, model, and even outsource 
biological data. 
The National Institutes of Health, Biomedical Information Science and 
Technology Initiative (BISTI) in the United States of America defines 
bioinformatics as "Research, development, or application of computational tools 
and approaches for expanding the use of biological, medical, behavioral or health 
data, including those to acquire, store, organize, archive, analyze, or visualize 
such data."38 Bioinformatics, or computational biology, has revolutionized 
biotechnology in a way that allows for the modeling of molecular components and 
processes that is exponentially more complex than was possible prior to the 
37
 Ibid. p. 209. 
38
 The National Institutes of Health, Biomedical Information Science and 
Technology Initiative Available online: URL: 
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advent of powerful computer systems. For example, the Human Genome Project 
(HGP) — a thirteen-year research effort coordinated by the US Department of 
Energy and the American National Institutes of Health that focused on 
sequencing the approximately 3 billion chemical base pairs that comprise the 
human genome — would not have been even imaginable before the introduction 
of computation to molecular biology. 
Further complicating my analysis of possible origins and reasons for the 
perpetuation of digital metaphors in biotechnology, bioinformatics, by some 
definitions, can also refer to the practice of computation utilizing molecular 
biological protocols — in other words, the practice of mobilizing DNA as a 
computational device rather than using silicon-based microchips. In his now 
canonical paper "Molecular Computation of Solutions to Combinatorial 
Problems," which appeared in Science (1994), Dr. Leonard Adleman published 
the first experimental results of studies in which DNA molecules were mobilized 
in a computational manner to solve a mathematical problem. In his conclusion, 
he writes, "Nonetheless, for certain intrinsically complex problems, such as the 
directed Hamiltonian path problem where existing electronic computers are very 
inefficient and where massively parallel searches can be organized to take 
advantage of the operations that molecular biology currently provides, it is 
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conceivable that molecular computation might complete with electronic 
computation in the near term."39 
In both specialist and public circles, the perceived success of bioinformatics in 
research projects such as the HGP has created great excitement and optimism in 
the future of molecular biology as a programmable therapeutic tool. This almost 
unfettered enthusiasm can be located in a variety of sources. For example, to 
mark the 2003 announced completion of the HGP — as well as the fiftieth 
anniversary of Watson and Crick's model for the structure of DNA — Nature 
published a special edition containing articles on this theme, including "A Vision 
for the Future of Genomics Research," celebrating recent biotechnological 
achievements: 
The project's new research strategies and experimental technologies have 
generated a steady stream of ever-larger and more complex genomic data 
sets that have poured into public databases and have transformed the 
study of virtually all life processes. The genomic approach of technology 
development and large-scale generation of community resource data sets 
has introduced an important new dimension into biological and biomedical 
research. Interwoven advances in genetics, comparative genomics, high-
throughput biochemistry and bioinformatics are providing biologists with a 
markedly improved repertoire of research tools that will allow the 
39
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functioning of organisms in health and disease to be analyzed and 
comprehended at an unprecedented level of molecular detail.40 
However, in circles aligned more closely with philosophy of science than 
government or industry sources, there is growing criticism for the exclusive 
application of computational biological models for understanding and harnessing 
life. For example, Richard Lewontin, himself a celebrated scientist specializing in 
genetics and evolutionary biology, writes critically about the perpetuation of 
computational models for interpreting all aspects of life in his work The Triple 
Helix: Gene, Organism, and Environment. He states, "The development of an 
individual is explained in standard biology as an unfolding of an sequence of 
events already set by a genetic program, "41 with no accounting for embryological 
development or environmental factors that, he suggests, contribute 
immeasurably to the formation of an organism. He argues that this contemporary 
conception of the origin of life is similar to eighteenth-century models of 
preformationism that depict complex life as the product of a single sperm, which 
was then thought to contain all the components of life — a microscopic infant that 
was waiting for the right conditions for it to grow into healthy adult form. He 
argues that contemporary models, although now relying on computational 
metaphors to explain developmental biology, still stand on the fundamental 
40
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perception that life is somehow predetermined — only now by a programmable 
code called DNA instead of a single sperm. He explains how bioinformatics has 
been deeply impressed upon our concept of life, even in scientific circles. For 
example, "One of the most eminent molecular biologists, Sydney Brenner, 
speaking before a group of colleagues, claimed that if he had the complete 
sequence of DNA of an organism and a large enough computer then he could 
compute the organism."42 To combat this gross overgeneralization, Lewontin 
elucidates the results of experiments involving genetically identical specimens 
that express difference through developmental and environmental change. 
Where Lewontin focuses more on making biological inroads towards critiquing 
the dominance of bioinformatics as an extension of molecular biology, theorists 
like Jeremy Rifkin approach the same problem by analyzing the nature of the 
computational technology as it attempts to describe life. Rifkin illustrates the 
manifestation of computational gene-sequencing protocols on the screen: 
The letters and words are in the form of phosphorescent glows and are 
both ephemeral and frictionless. They do not exist a priori as individual 
solid units but rather come into existence on the screen when the software 
instructions call them forth. They have no past or future but exist only in 
the moment they are flickering on and off the screen.43 
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This description draws attention to the providence implicated in the digital display 
of information that correlates with the molecular composition of a given gene or 
organism. 
I want to look back two decades to earlier models for understanding scientific 
inscription before the mass proliferation of computational models — to the work 
of Bruno Latour and Steven Woolgar in Laboratory Life: The Construction of 
Scientific Facts. What Rifkin and I are both edging towards, though from different 
perspectives, is best explained in terms of what Latour and Woolgar call the 
'phenomenotechnique,'44 where, using the example of experimental biology, 
'natural' phenomena are observed, measured, and simultaneously produced by 
complex scientific techniques that are applied to the object of study. They argue 
that various scientific apparatuses function as inscription devices, producing a 
body of literature — in the form of charts, graphs, and numerical representation 
— to provide the scientific community with information about the object they 
measure. "A first consequence of the relegation of material processes to the 
realm of the merely technical is that inscriptions are seen as direct indicators of 
the substance under study."45 An example of a contemporary biotechnological 
phenomenotechnique is DNA amplification [called Polymerase Chain Reaction 
(PCR)]. In PCR, tiny samples of DNA are multiplied into billions of copies 
through controlled temperature changes, which causes the DNA to first split into 
44
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single strands and then rejoin to form double strands, due to the natural 
attraction between complementary base pairs. The PCR Machine, where DNA is 
inserted and later removed after it has multiplied exponentially, serves as a 
bioassay: a specialized scientific apparatus that provides the researcher with 
experimental results surrounding a given substance or phenomenon that cannot 
be garnered through observational means. "Without a Bioassay, for example, a 
substance could not be said to exist."46 In other words, "It is not simply that 
phenomena depend on certain material instrumentation; rather the phenomena 
are thoroughly constituted by the material setting of the laboratory."47 Ironically, 
Latour and Woolgar are arguing that the scientific community produces a series 
of techniques and tools (bioassays) that are intended to serve as confirmation — 
evidence either for or against — for particular ideas, concepts, or theories48 
about the natural world. However, these bioassays can also be read as culturally 
loaded objects and protocols, producing the results they were designed to 
produce. As Rifkin says, describing computational biotechnological results, 
"They have no past or future but exist only in the moment they are flickering on 
and off the screen."49 
Extrapolating from Latour and Woolgar's arguments, which were originally 
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only in computational form — as a way of modeling results based on 
programmed molecular rules; we can look at them as virtual bioassays, 
producing a 'real' biotechnological substance or phenomenon from computational 
protocols. In other words, contemporary biotechnological research can be 
understood, both metaphorically and now technologically, as producing and 
reproducing a new computational ecology both in the laboratory and the public 
sphere. Contemporary conceptualizations of a virtual laboratory (or 
computational bioassay) producing 'real' or 'natural' life remind me of similar 
arguments proposed by researchers in the artificial life community. Clause 
Emmeche, in The Garden in the Machine, argues that life forms generated 
computationally, though materially different then organic life, are, in process, 
equivalent to natural phenomena. He explains that for A-lifers, the "artificial" in 
"artificial life" refers to the artificial nature of the environment in which life is 
manifest, not the artificiality of the life itself. He argues, "Our unease with 
artificial life is due to an uncertainty about the question of whether it really is 
natures' own games that are depicted in the various simulations, or whether it is 
the autonomous games of an independent mathematical sphere that are given 
life and are achieved without any reference to reality. The naturalism of natural 
science is perceived to be threatened."50 
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Returning to my original assertion that there must be difference in ethical 
consideration as it is applied to information and as it is applied to the body, I want 
to emphasize that the notion of a type of verisimilitude between artificial life and 
organic life, whether metaphorical or literal, is a dangerous over-simplificationv 
In his essay "Data Made Flesh: Biotechnology and the Discourse of the 
Posthuman," Eugene Thacker presents a description of the complex, entangled 
relationship between the computational and the biological in contemporary 
biotechnology: 
Biotech research is unique in that, on the one hand, it employs the 
technologies common to other posthuman fields (principally, 
computer/information technologies), but on the other, its constant "object" 
of study is the domain of the biological (a domain traditionally set apart 
from the technological). Instead of being focused on disembodiment and 
virtuality, biotech research's approach to informatics is towards the 
capacities of information to materialize bodies (bodies amenable to current 
paradigms of medicine and health care).51 
Eugene Thacker. "Data Made Flesh: Biotechnology & the Discourse of the 
Posthuman", Cultural Critique 53 Available online: URL: 
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He continues to elucidate this model in his seminal work Biomedia (2004), in 
which he coins the term 'biomedia' to describe the relationship between digital 
and biological protocols in the biotechnological sciences. He proposes that 
biomedia is a philosophy of technique — an informatic protocol of encoding, 
recoding, and decoding52 to allow for the technical reconditioning of the biological 
sphere.53 He argues that encoding should be understood as the processual 
translation from one medium to another, a shift in material substrates.54 This 
process can be seen in a number of established biotechnological protocols: 
genome sequencing, protein analysis, digital microscopy, and also in biomedical 
applications like MRI and CT scans. 
In other words, with Thacker's definition of encoding, the scope of biology is 
sampled for patterns of relationships, and the acquired information is transferred 
to a new media substrate: the computer. For Thacker, this process is not one of 
dematerialization but rather a shift of essential data from one medium to another. 
With the second step, recoding, in the biomedia protocol, we exit the wet 
biological lab and enter what Thacker calls the "dry lab" or "biology in silico"55 
where biological data can be manipulated, comparatively analyzed, and 
programmed. He further explains his position: 
52
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Bioinformatics tools provide a context in which these patterns of 
relationships are "recoded" as computational integers, algorithms, and 
sets of rules. It is not enough in the case of biomedia generally, to say 
that bioinformatics tools "simulate" the biological body or the cell, for there 
are no ontological claims being made in these practices of recoding. 
Rather, the bioinformatics tools, as recoding practices, assume the 
coexistence of multiple material substrates, and they also assume the 
capacity for inherent data (patterns of relationships) to be mobilized 
across those media. In this sense, "recoding" is equivalent to, but not 
identical with, "wet lab" work with the same patterns of relationships in test 
tubes, petri dishes, or bacterial plasmids.56 
Thacker's understanding of biomedia postulates decoding as the final outcome of 
the biotechnological technique. Decoding is proposed as a form of cryptography, 
in which the body is rematerialized from informational source code towards novel 
reconditioning of biological data. Thacker is critical of this type of conflation, and 
yet at some level he replicates it. 
For Thacker this shift does not necessitate returning to the biological but rather 
newly producing the biological. However, with Thacker's model, the biological is 
interpreted as media. Biological information is seen as transferable across 
media from the biological to the computational domain, ultimately leading us to a 
*lbid. p.21. 
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new biological manifestation. "The practices of encoding, recoding, and 
decoding are geared both to move across platforms and to always "return" to the 
biological domain in a different, technically optimized form. Biomedia returns to 
the biological in a spiral^ in which the biological element is not effaced (the dream 
of immortality), but in which the biological element is optimized, impelled to 
realize, to rematerialize, a biology beyond itself."57 
Although Thacker's definition of biotech is useful for its induction of the wet 
biological body into the bioinformatic fold, he still places overwhelming 
significance on molecular biology and computation in biotechnology — suffering 
from what some call 'genohype' — and consequently side-stepping the significant 
'wet' biological practices that include little or no computational element. He 
mobilizes the field of bioinformatics as the defining feature of biotechnology. I, 
on the other hand, am interested in postulating a more complex model for 
understanding biotechnology, allowing us to view it not merely as a progressive 
development erupting from advances in computer sciences, nor as a field defined 
by its current trend towards bioinformatics, but instead as a living system that 
incorporates social, political, ideological, technological, and biological information 
and processes into a complex, temporally contingent model for understanding 
biotechnology. 
57
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I am particularly concerned by the language deployed by Thacker in his 
description of the shift of information gathered from an organism — a body — to 
a dry lab computational site as a 'cross platform' shift. This language usually 
describes the ability to open frtes or software on two or more distinct operating 
systems that are supported by differing hardware models, shifting between Linux, 
PC Windows, or MAC. Whether this statement is interpreted metaphorically or 
literally, the model presented here is inadequate and threatens to equalize the 
biological and digital spheres. 
Gerfried Stocker, in New Images of Mankind, argues that the utilization of this 
type of language only reinforces larger societal impulses towards the uniform 
application of informational models to our understanding of the body. 
Instead of the transformation of the human spirit into Os and 1s, it is now 
the gigantic operation of the Human Genome Project which it is hoped will 
produce the decoding of the genome as the human operating system. 
And because we have learned so well over the long years of the digital 
information revolution to dress up everything in computer parlance, 
terminology like the "software of life" and reference to the human genome 
as the "human being's operating system" are already solidly established.58 
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I want to elucidate two sets of overlapping and interconnected phenomena: (1) 
computation and digital media (specifically with bioinformatics) is a central aspect 
of contemporary biotechnological research, and (2) digital metaphors (often 
erupting from the success of bioinformatics and computational bioassays) are 
being ubiquitously applied as societal models for understanding biotechnology 
and, by extension, our conceptualization of the bodies, thus obfuscating 
transparent understanding and ethical debate in public discourse on 
biotechnology. Digital metaphors for the biotechnological body are confusing in 
that they allow the general public to conceive of biotechnological protocols as 
equivalent to virtual means of experimentation, rather than as the technological 
manipulation of living embodied entities. What is missing from the application of 
this overpowering metaphor is the acknowledgement of those attributes that fall 
outside of the given paradigm: the live bodies, parts of bodies, bacterial bodies, 
antibodies, all the bodies that are necessary and central to the propagation of 
biotechnological research. 
Alternative Discourses 
From my own experience, the industrialized mobilization of life as a technology 
and resource was the most significant realization I took away from my first 
experiences working in the labs at The University of Western Australia. During 
my second residency in 2006, I maintained extensive lab notes to record my 
experiences there (see appendix 1). In reading these documents years later, I 
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see a vast schism between the language and content of what I experienced and 
the language and content of what is represented in the public sphere in regard to 
biotechnological research. All of the preparatory reading I did in advance of 
working in the laboratories at SymbioticA was insufficient preparation for what to 
expect during my residencies. 
I am particularly struck by the entries written on the day we received PAWS 
Animal Ethics Training59 at the Large Animal Research Facility on UWA campus, 
as they indicate the embodied nature of biotechnological research — the 'life' in 
the lab. 
We begin with the rats. The rat handler is a nice young attractive 
man, who immediately tells us he prefers to work with rats as they 
don't bite as much. He immediately begins telling us all about the 
breed of rats, bread right on UWA campus. He lifts one out of a 
cage by its tail. It squirms. He says to hold onto it a third away 
from the rump, firmly but carefully, as sometimes the tail can be 
ripped off. He states that this can be a very upsetting experience 
for both the rat, and the handler. The rat is placed on his hand, 
with tail still in grasp. It immediately urinates all over his sleeve. 
Yellow spilling into white cotton. He allows the rat to hide its head 
59
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in the crook of his arm. 
We are taught how to sex the animals. The male's genitals are 
farther from the anus then the females. Two rats arespFesented to 
us ass up. Then we are introduced to the mother with newborn 
pups. We are each given a small pup to hold. They are 
translucent, purple and pink skin, with organs, and stomach full of 
milk visible through the skin. The small rat pup splays still in my 
gloved hands, breathing, and heart visibly pumping. Vibrating. 
Trying to stay still with still closed eyes. I am holding life in my 
hands. Instrumentalized life in the biosciences takes on a new 
more concrete understanding in this moment. I am silent; I can't 
hear anything in the room for a few pregnant moments. I deliver 
the rat back to it's mother quickly, so as not to be bitten - and we 
are told never to handle pups without gloves on as the mother will 
immediately kill the pup if she smells our sent on the animal.60 
It was this schism — between the public face of biotechnology and the actual, 
hands-on experience of the processes, procedures, and protocols that were (in 
my perception) so hot, loaded, and teaming with life — that necessitated 
(RE)embodying Biotechnology and led to what I can only describe as a cathartic 
60
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and disillusioning induction into the specialist class. As a result, the urgency of 
this argument, and the thrust towards perpetuating alternative voices in the 
description and recounting of the biological sciences, has profound social and 
political ramifications — as well as great personal significance. ~fe 
Within the Bioart Community, we can find a chorus of voices attesting to this 
schism, proliferating alternative language sets that describe biotechnology in the 
public sphere. For example, in Kathy High's artist website Embracing Animal,6' 
she describes the protocols utilized for germline genetic engineering of 
transgenic rats in the laboratory: 
First, the scientist or breeder chooses a gene. This gene is isolated and 
many copies of it are made using the techniques of molecular biology 
(PCR, etc.) Then hormone injections are given to the egg-supplying 
(donor) rat [mom(1)] for hyper-ovulation. She releases many, many eggs 
from her ovaries. She spends her last night with a frisky male 
inseminator. Then she is killed and her fallopian tubes are cut open and 
the fertile rat eggs are suctioned out. These eggs are viewed closely 
under a microscope and a very small needle is used to inject them with 
the gene of choice. Then, hormone injections are given to one or more 
surrogate 'uterus' donors [moms(2)] to simulate a pseudo pregnant state. 
The embryos that tested positive for having taken up the new gene are 
61
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implanted into the surrogate uterus of the [moms(2)] rats. The embryos 
that don't test positive are destroyed. Any rats that are born not 
expressing the gene of choice are killed after birth. Any rats that do have 
the transgene in their genomes are bred with each other and then bred 
with their sons and daughters to secure the continued transmission of the 
gene.62 
As an artist engaging directly with genetically engineered rats, she deploys this 
description with full knowledge of the implications of her participation in this 
embodied technological exchange. She offers her readers access to the 
complexity of such practices without deploying a didactic or moralizing tone in 
her discussion of this complex phenomenon. However, there is an element of 
anthropromorphization; she labels the rats "mom 1" and "mom 2." Within the 
website, she presents this procedure and these life forms in a pluralistic fashion. 
Her text is not devoid of a positioning, but neither does it reject the use of 
scientific research strategies; instead, her writing investigates the complex 
relationship that we have with the resulting transgenic organisms. 
Her website focuses on the lives of three transgenic lab rats: Matilda Barbie, 
Tara Barbie, and Star Barbie. Each were born in a laboratory environment where 
they served as breeding rats and, after donating approximately a year of their 
lives and two litters each to the propagation of scientific research, were 
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subsequently adopted by High to live out their days. For High, the rats become 
a locus for a matrix of generosities, demands, readings, and understandings. 
They are cute, but strangely grotesque. They demystify our fears of transgenic 
animals? but they also instill a greater fear in a science — and a humanity — that 
would engineer and manipulate such feeble animals for human gains. They are 
not pets, but they have human toys: a Fisher Price farm set, for example. We 
cannot help being touched by High's gesture of rescuing these animals from the 
fate of research specimens — and yet she writes of her own research with the 
rats, most notably administering homeopathic treatments and charting the 
effects. To what end? Is High only again instrumentalizing these organisms to 
serve human desires? It seems that the rats need her, but High also seems to 
need them. It is at this contradictory juncture that Embracing Animal is most 
successful: it explores the truly complex relationship between humankind and 
transgenic laboratory animals. 
High's text describes the very same process that I present at the beginning of 
this chapter by Daniel Q. Haney in his Life Magazine article. 
Insert block of new genes into a freshly fertilized egg. The one cell 
becomes two, then four, then eight. Each new version carries the extra 
information. In nine months, a baby is born. Every cell in his or her body 
contains the extra genes.63 
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The disparate discourses and the level of detailed complex consideration 
revealed in comparing these two descriptions of virtually identical protocols is 
astonishifigF Not only are digital metaphors the dominant model for 
understanding genetic engineering in this mass media representation, but all 
complexity inherent in the protocol is lost, failing to provide even a basic 
understanding of this process to the non-specialist reader — let alone any 
window into understanding the process in an embodied, reciprocal, or lived 
sense. 
Another good example of artist-generated language sets that describe 
biotechnological protocols resides in a documentation of cultivating artificial skin 
grafts by Polona Tratnik, taken from her piece 37°C: 
"Medical laboratories cultivate skin cells to provide skin substitutes 
(artificial skin) for transplants. The perception of this living tissue in the 
laboratory, however, dose not fit the everyday perception of skin. The skin 
comes from a living human body. It is cut out and sent to the laboratory, 
where it is cut into smaller parts - all the pigment cells are removed, as is 
fat. What is kept is only the cells, which are placed on a mainly 
transparent scaffold. Although this skin comes to the laboratory from the 
external world, it seems completely distant from that world; it is not at all 
similar to what we know as skin. When entering a laboratory we must put 
http://www.genetics-and-society.org/resources/items/20000305_ap_haney.html 
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on overalls and paper slippers and may not touch things without gloves. 
There is a certain contradiction between the warmth and intimacy of the 
body and life on the one hand, and the coldness, glass, metal, blue-green 
colors, sharp lights, and rationality of the laboratory on the other.64 
Tratnik provides a description of the medical applications for the tissue culture 
technology she utilizes in her artwork. In 37°C, she creates a gallery-sized 
incubator (a womb) and in it maintains a constant temperature of 37°C in order to 
successfully house several wax sculptures of body parts in vitrines that are 
layered with artificial human skin. However, in creating an ideal environment for 
the tissue culture sculptures, she is in turn creating an inhospitable environment 
for the gallery visitors. "A temperature of 37°C in the external environment is too 
high for us to feel comfortable, since our body is producing energy to warm itself 
exactly because we live in an environment that is colder than 37°C." 
This same process (creating artificial skin) is described to the general public in a 
BBC article called "Artificial Skin 'Cuts Scarring"' by Pallab Ghosh: 
The skin is created from a matrix made up of fibrin, a protein found in 
healing wounds. 
M
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To this is added human fibroblasts - cells used by the body to synthesise 
new tissue. 
In a process that effectively replicates the way the body makes new skin, 
the cells produce and release another protein, collagen, which makes the 
matrix more stable. 
It is in this form that the "skin" is implanted into a wound.65 
Ghosh's description of artificial skin relies heavily on retelling the laboratory 
protocol from an 'objective' standpoint. In his description, there is no allusion to 
the viscosity of the life involved in the procedure or to the larger social, political, 
embodied ramifications of this technologization of skin cells. Some would argue 
that the 'objectivity' of this news report, or the scientific language of this article, is 
desirable and works so as to not lead the reader in their interpretation of the 
procedure described. However, I would argue that the chosen language set also 
serves to disassociate the reader from a subjective, emotive, or embodied 
response to the procedure. Additionally, with the authority we ascribe to 
scientific language, Gosh's recounting of the production of artificial skin becomes 
intellectually impenetrable from the layperson's perspective. 
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I am not suggesting that scientific discourse surrounding biotechnology should 
not be perpetuated in public discourse. What I am suggesting is that we could 
benefit from a>chorus of voices in describing these techniques and procedures. 
A pluralistic and dialogic public discourse filled with many language sets, 
including the voices of the hard sciences, non-specialists, literary voices, even 
those from the radical opposition of animal research like PETA,66 would allow for 
the general public to have a deeper understanding of the biotechnological 
research that is conducted in highly specialized, closed sites. This chorus of 
representation would allow for complex public debate about scientific research 
today, as well as regarding our biotechnological future, in a meaningful and 
impactful way. 
What will result from this measure? We can look to the discourse and 
representation surrounding human illness and disease in the last fifty years as an 
excellent example of the insertion of alternative voices into public discourse of 
science. In 1978, Susan Sontag published her now famous article "Illness as 
Metaphor." She writes aptly of her personal experience as a cancer patient in 
the 1970s and discusses the powerful impact that the war-based metaphors 
(often used to describe the diseased patient's body) had on her own personal 
suffering. "Military metaphors contribute to the stigmatizing of certain illnesses 
and, by extension, of those who are ill. It was the discovery of the stigmatization 
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of people who have cancer that lead me to write Illness as Metaphor. This 
text, and others like it, assert feminist, personal, experiential voices in discourse 
on medicine and are arguably responsible for significant shifts in both public 
debate and patiertfeare since the 1950s. With this shift, thousands of alternative 
voices have entered into the narratives surrounding human illness to varying 
degrees of effect and influence on patient experience and medical practices and 
procedures. Jackie Stacey writes in 1997 of an almost overabundance of such 
voices in the polyphonic representation of cancer in contemporary society: 
The market for books about cancer is enormous. Amongst the expanding 
health and fitness/self-development/New Age and spirituality sections of 
highstreet bookstores and the increasing number of publications for sale in 
health food shops, books about cancer are not hard to find; in fact, they 
are hard to avoid.68 
She continues: 
For many people with cancer these books are the starting point of coming 
to terms with the diagnosis. They are read in hope of finding a story that 
fits, of finding a story that offers hope, of even finding a story that ends 
happily. They are also read for information about the disease or about the 
treatment; some offer the chance to learn the language of oncology, to 
understand the principles of chemotherapy or radiotherapy; others 
67
 Susan Sontag, "Aids and It's Metaphors" from Illness as Metaphor and Aids 
and It's Metaphors. New York: Doubleday, 1990. p.99. 
68
 Jackie Stacey, Teratologies: A Cultural Study of Cancer. New York: 
Routledge, 1997. p. 2. 
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educate their readers on the workings of the immune system, the anti-
cancer diet or the negative effects of stress on the body. Read all of them 
and you can become an expert in your field, and expert on your particular 
disease%nd an expert on yourself.69 
Although Stacey is critical of the wellspring of self-help books available to cancer 
patients and their families today, I would argue (and I am sure that she would 
agree) that the presence of these voices in the construction and representation of 
disease has lead to staggering changes in the medical system, patient 
empowerment, and general health knowledge since. 
In making this argument, I need only to refer to the Principles of Gynaecology 
textbook published in 1962 by T.N.A. Jeffcoate. This text openly advocates lying 
to patients about their medical conditions (or lack thereof) with the understanding 
that clinical knowledge is best left restricted to the doctor or specialist in order to 
maintain the health and sanity of the patient. For example, in the treatment of 
dyspareunia (painful coitus), he instructs the physician: 
If it is clear that the patient is unlikely to co-operate, it is best to desist at 
once, to allay her fears and to explain that the entrance to the vagina is so 
narrow that it requires dilation under anesthesia. This operation is carried 
out to such an extent that the vagina will admit three fingers. As soon as 
local tenderness has subsided, usually at the end of 48 hours, graduated 
Ibid. 
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glass or plastic vaginal dilators are passed by an experienced nurse or by 
the medical attendant. On the first occasion only the smallest size is used 
and the approach must be cautious. The real purpose of these 
instruments issnot to dilate the vagina further but to convince the patient 
that her trouble is corrected and to give her confidence.70 
Since that time, the proliferation of alternative voices in academia and in general 
public discourse, these hierarchical and restrictive practices are no longer 
accepted (or, at the very least, drastically reduced) in the medical establishment. 
In addition, the medical establishment itself has become a source of alternative 
language sets used to describe the human body, patient experience, and human 
illness. 
Media personalities like Dr. Oz from Oprah77 and Dr. Brian Goldman from the 
Canadian Broadcasting Corporation (CBC) radio program White Coat, Black Art72 
are medical practitioners who, through the media, are disseminating information 
and critical analysis of their own profession in the public sphere. For example, 
Goldman writes about patient pain management in his introduction to one of his 
radio broadcasts: 
70
 T.N.A. Jeffcoate. Principles of Gynaecology. London: Butterworths, 1962. 
p.643 
71
 Oprah.com Available online: URL: 
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For the vast majority of patients, the best method of doling out pain meds 
- by far - is to have you - not health professionals like me - in charge. 
You receive a supply of pills and take then when you feel you need to. Or, 
they hook you up to a pain pump and you push a button whenever you 
need a top up - with a lockout feature that keeps you from getting too 
many doses. Not only do patients like having control, but studies show 
that when they're given control, they use fewer meds than they do when 
people like me are in charge. The only downside to pain pumps is that 
they add to the cost of health care. 
But in my opinion, the extra cost is worth it.73 
It is my argument that the successes we have seen in regard to growing patient 
empowerment and reflexive modification of the medical system in response to 
patient needs result from a number of important factors, including the insertion of 
alternative voices — patient voices — into public discourse surrounding the 
medical profession. I also believe that this model for the disruption of hegemonic 
power structures could be aptly applied to the biological sciences and the biotech 
industry. However, unlike in medicine, the alternative language sets are unlikely 
to spring forth from the 'object' of study — the life forms within the labs — and 
instead will have to come from alternative and amateur practitioners and/or 




environment, the processes, and intentionalities of the researchers differently 
then those with years of training and indoctrination into the biotechnological 
specialist class. 
One early example of this type of transgression into the lab from an almost 
anthropological perspective is documented in Bruno Latour and Steve Woolgar's 
book Laboratory Life: The Construction of Scientific Facts. Latour spent 21 
months in the 1970s as a resident in Roger Guillemin's lab at The Stalk Institute. 
Through a distinctly different language set and observational lens, Latour and 
Woolgar explain their interpretation of the site, the flow of information therein, 
and the roles of the various workers in the lab. Dr. Jonas Salk writes about his 
distinct use of language in his introduction to Laboratory Life: 
The approach chosen by Bruno Latour was to become part of a 
laboratory, to follow closely the daily and intimate processes of scientific 
work, while at the same time remain an "inside" outside observer, a kind of 
anthropological probe to study a scientific "culture" -to follow in every 
detail what the scientists do and how and what they think. He has cast 
what he observed into his own concepts and terms, which are essentially 
foreign to scientists. He has translated the bits of information into his own 
program and into the code of this profession. He has tried to observe 
scientists with the same cold and unblinking eye with which cells, or 
hormones, or chemical reactions are studied - a process which may 
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evoke an uneasy feeling on the part of scientists who are unaccustomed 
to having themselves analyzed from such a vantage point.74 
This type of work can be used to contextualize and locate the origins of the very 
language shift I am arguing for in Bioart practices as it relates to evolving 
biotechnological practices. It is possible that Adam Zaretsky and Julia Reodica 
state it best: 
Our pride and willingness to discuss important issues surrounding 
nature/culture issues and human/other relations implies a public invitation 
to intelligent debate. Conceptual novelties are expressed in the living arts, 
with or without the meddling of artists, scientists or ethicists. Life is alive 
and mutating, officially and unofficially. It is only within the situational 
ethics of pluralist integrities that an effective debate has a chance of 
flourishing. Life is not composed of pat answers and shallow 
assumptions.75 
74 Dr. Jonas Salk, "Introduction" from Latour, Bruno and Steve Woolgar, 
Laboratory Life: the construction of scientific facts, (second edition, enlarged) 
Princeton: Princeton University Press, 1986. p. 12. 
Zaretsky, Adam and Julia Redioca. "The Workhorse Zoo Art and Bioethics 
Quiz." From Emutagen, artist website; available online: URL: 
http://www.emutagen.com/wrkhzoo.html [date of last access: 08/01/2008] 
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4 | BIOTEKNICA: LiveLifeLab: Practical Considerations in Exhibiting Bioart. 
Up until this point, the emphasis of (RE)embodying Biotechnology has been 
relatively theoretical, historical, and political in arguing for the transformative 
potential of biological art practices, inspired by my experiences as an artist 
entering and working in the laboratory. In the introduction, I elucidated the 
overwhelming subjective transformation of art that I experienced as an artist 
entering the laboratory for the first time, learning to reimagine the body and 
gaining a new perspective on reciprocal ecologies. In Chapter 2, I argued for 
contemporary bioart practices as a strategy for undermining overspecialization in 
the hard sciences and democratizing biotechnology. In Chapter 3, I addressed 
the dangers of proliferating digital metaphors in public discourse surrounding 
biotechnology and looked to alternative language sets produced by the bioart 
community to describe bioart practices and the science supporting such work. 
I now wish to focus on a more practical and experiential retelling of the pragmatic 
actions, the embodied and emotional responses, and the technical successes 
and failures resulting from a dedicated attempt at an artistic engagement with the 
tools of biotechnology in the public presentation of bioart. I wish to reveal the 
work involved in this type of research and creation: the relentless efforts 
necessary to create small moments of transformative, hands-on interaction — 
both reciprocal and embodied — between human non-specialists and the 
multifarious orders of life in the lab. In addition, of course, I want to address and 
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discuss the inclusion of these moments in public discourse through the site of the 
gallery and subsequent media representation. 
A great deal of bioart production takes place within the labyrinths of scientific 
institutions. Artists seek access to these specialized sites in order to produce 
works that require rarified facilities, bioassays, restricted biological agents, and 
specialized training. Often the works produced in these sites are condemned to 
never leave the lab. Often documentation serves as the only exhibitable product 
of works made and/or actions conducted. Often bioart, in its embodied 
incarnation, serves a tiny audience of one (the artist), with the possible exception 
of a few more (the scientists sharing bench space in the lab). However, for 
myself and for a number of bioart practitioners, it is integral to extend these 
experiences to the general public. The exhibition of bioart practices has the 
potential to allow audiences to catch a glimpse of real biotechnological entities, to 
allow them the opportunity to experience hands-on, 'wet work' for themselves, 
and to allow them to come to their own experiential conclusions about the life 
forms and protocols with which the artist chose to engage. 
The public presentation of 'live' bioart creates a number of concerns and issues 
pertaining to the mechanics of building a portable laboratory: local rules and 
regulations, gallery restrictions, and audience reception. To investigate this 
component of bioart production, as well as the performative, political, and artful 
nature of navigating the practicalities of its public presentation, I wish to present 
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an instance of BIOTEKNICA research, conducted in collaboration with Shawn 
Bailey: our second presentation of live biological work at a gallery site — 
BIOTEKNICA: LiveLifeLab. I will relate the artistic intentions of the exhibition, the 
techniques involved, and the institutional and technical hurdles we overcame in 
presenting this work in a gallery. Through the analysis of this event, I wish to 
elucidate the transformative and politicized actions towards the democratization 
of biotechnology that have been outlined in earlier chapters: (1) a shift in the 
language used to describe biotech in public discourse, (2) a shift in the 
representation of the biotech specialist towards a more inclusionary, 
interdisciplinary model, and (3) an instance of hands-on experience for non-
specialists that demystifies and re-embodies biotechnological protocols. 
The following excerpt from the LiveLifeLab gallery text provides an excellent 
introduction to the intent and content of this particular installation within the larger 
context of ongoing BIOTEKNICA research: 
BIOTEKNICA began as a media studies and interventionist art project, 
which projected its' viewers into a future where designer organisms are 
generated on demand. The organisms produced by BIOTEKNICA are 
modeled on the Teratoma, an unusual cancerous growth containing 
multiple tissues like hair, skin, and nervous systems. Monstrous as this 
may seem, scientists today see the Teratoma as an instance of 
spontaneous cloning, and are conducting research on the Teratoma with 
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the goal of developing future technologies. BIOTEKNICA both embraces 
and critiques biotechnology, considering the contradictions and deep 
underlying complexities that these technologies offer the future of 
humanity. -^ 
Since 2004 BIOTEKNICA has adopted a critical participatory methodology 
bringing our theoretical specimens out of their virtual environment and into 
biological science laboratories. Serving as Research Fellows at 
SymbioticA: the Art and Science Collaborative Research Laboratory at 
The University of Western Australia, Willet and Bailey began growing 
living prototypes that serve as new representations of the BIOTEKNICA 
product line. Here they commenced research with tissue culture protocols 
in the production of artwork as pioneered by Oron Catts and lonat Zurr, of 
the internationally recognized Tissue Culture & Art Project, and 
SymbioticA founders. In 2006, they returned to SymbioticA - and worked 
in collaboration with Catts and Zurr on a new project entitled Teratological 
Prototypes. The four artists successfully constructed and exhibited a 
complex functional laboratory installation for ISEA: Zero One San Jose in 
the summer of 2006.1 
The exhibition BIOTEKNICA: LiveLifeLab (Feb 27 - March 23, 2007) was hosted 
1
 Jennifer Willet and Shawn Bailey, BIOTEKNICA: LiveLifeLab, exhibition 
statement, 2007. 
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at Concordia University's FOFA Gallery in the Integrated Engineering, Computer 
Science and Visual Arts Complex (EV) under the leadership of gallery 
coordinator Lynn Beavis. This exhibition marked BIOTEKNICA's first 'live' 
exhibition of tissue culture in Canada, as well as our first solo attempt at building 
a lab in a public site.2 
LiveLifeLab was conceived of as an extended performance, where two artists 
within an institutional context would try to build a tissue culture laboratory, 
conduct research, and sustain life in a gallery environment. The project was 
described as such: 
BIOTEKNICA: LiveLifeLab is a new installation and durational 
performance that reflects BIOTEKNICA research and production to date. 
Here the traditional gallery setting serves multiple functions: exhibiting 
prototyped objects; video and digital print documentation; a live art 
performance site; and a tissue-engineering laboratory. In the context of 
LiveLifeLab, Bailey and Willet will conduct an 'experiment' of sorts (an art 
action) in which the two artists will construct a functional tissue culture lab 
in the gallery, and continue their ongoing research into creating new living 
art forms for the duration of the installation. 
2
 In 2006, we built a portable lab in collaboration with Oron Catts and lonat Zurr 
at ISEA Zero One San Jose. 
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This work results from ongoing questions arising for artists working with 
specialized scientific protocols and confronts the problems of access -
accountability - and specialization - that typically inhibit non-specialist 
engagement and understanding of the sciences. 
LiveLifeLab is a propositional performance and installation that may result 
in transformative experimentation for the artists and viewers alike; or might 
simply fail, in infrastructure - material transfer agreements - sterility 
and/or aesthetics.3 
The installation consisted of three distinct parts — the public street window, 
gallery installation, and functional laboratory — all linked ideologically and 
technically by a looped descriptive video. 
Housed on St Catherine's street in Montreal, The FOFA Gallery has access to 
the largest shopping and entertainment street in the city. As one of our primary 
goals was the democratization of biotech (and, by extension, bioart and 
contemporary art in general), we sought an effective strategy to extend our reach 
outside of the university community and into the general public. We decided to 
activate the window with a 24-hour digital slideshow of photographic 
documentation of laboratory work conducted by BIOTEKNICA over the previous 
three years (fig.ll). The softly pulsating images of tissue culture and tissue 
3
 Jennifer Willet and Shawn Bailey, BIOTEKNICA: LiveLifeLab, exhibition 
statement, 2007. 
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engineering protocols luminesced in the window, attracting a range of interested 
(and sometimes confused) street traffic. Hands, cells, and flasks became actants 
in a reflective stainless steel theatre. 
(Ffc.11.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA: LiveLifeLab 
FOFA Gallery, Concordia University 
2007 
The main gallery space is accessible from the street and through internal 
corridors in the new Concordia Engineering, Computer Science and Visual Arts 
Integrated Complex (EV building). At this site, we presented a 'dry' gallery 
installation that was sparse, sterile, and grand in scale. We wished to integrate 
the cool, corporate sensibility of the EV building and the corporate criticism 
mantra of earlier BIOTEKNICA investigations in order to draw a connection 
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between our research, the site of the institution, and the 1997 Andrew Niccol film 
Gattica. We imagined this segment of the installation as a waiting room where 
visitors could view documentation and sculptural remnants of our work, also 
allowing them a place to sit, contemplate, and discuss the exhibition (fig.12). We 
presented sixteen large-scale, macro photographs of ongoing laboratory work 
conducted at SymbioticA and San Jose State University. Each image consisted 
of hands manipulating biological samples — instances of life — ranging from 
microscopic cell lines growing in flasks (not visible to the naked eye), cells 
seeded in scaffolds in bioreactor environments, and larger, more visceral animal 
parts (a bone and tongue) from which samples are harvested for growing primary 
cell cultures. 
The tones of the images were sombre, cadaverous, and generally bleached of 
colour, with the occasional vivid tone of a bright pink plastic flask stopper or a 
deep purple nutrient solution. One wall featured fifteen of these oversized prints, 
creating a weighted wall of imagery — sterile, cool, and grotesque — so large as 
to attract viewers off of the street and impose a sense of authority upon them. 
The prints towered over the site — and over the viewer. Another wall featured a 
single image, most clearly representative of the outcome of our work on the 
Teratological Prototypes: a close-up of female gloved hands, cupping a 
bioreactor vessel (an artificial uterus,4 of sorts) which contained three plump 
Marie-Pier Boucher, Metaformation: prolegomenes a I'exo-sphere, in progress, 
2007. 
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prototypes engorged with living cells taken at ISEA (International Society for 
Electronic Arts) San Jose in 2006. 
(Ffc.12.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA: LiveLifeLab 
FOFA Gallery, Concordia University 
2007 
Across the gallery, in stark contrast to the abundance and colours of the prints, 
stood two small, internally lit glass shelves featuring preserved Teratological 
Prototypes (completed in 2006 in collaboration with TC&A), scaffolds, casting 
molds, and new prototype sculptures developed in Hexagram and I'Universite de 
Montreal 3D rapid prototyping facilities with the assistance of Edgar Perez. The 
miniaturism, yellow light, and almost banality of these small works functioned in 
contrast to the industrial scale of biotechnological representation and 
reproduction, allowing for close scrutiny of each object. 
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Last, a video played on a large-scale, flat panel screen that was hung above a 
seating area consisting of two black leather benches and a round glass table with 
a large biohazard symbol *ej§feed into it. Titled Teratological Prototypes, the 
video served as documentation, as a source of technical information for the 
viewer, and reflexively as an artistic intervention, playing on tropes from 
corporate biotech videos and science documentaries. A soothing female voice 
explained the terms and processes presented on the screen, resonating 
throughout the entire gallery space. Sterile but sexual undertones permeated the 
video; penetration after penetration was shown, highlighting the ways in which 
scientific protocol reproduces life in the laboratory. 
The last segment of LiveLifeLab was an approximate BSL1 tissue culture 
laboratory in a small room usually reserved for video projections (f/g.13) . This 
project was approved by the university and built by artists. BSL1 stands for 
Biological Safety Level One, meaning that the lab "is suitable for work involving 
well-characterized agents not known to consistently cause disease in healthy 
adult humans, and of minimal potential hazard to laboratory personnel and the 
environment."5 To meet BSL1 standards, a variety of precautions were taken, 
such as providing researchers with a hand wash station, sharps disposal, and 
Available online: URL: http://www.d.umn.edu/ehso/biosafety/bsl1.html [date of 
last access: 04/10/2007], Reproduced from "Biosafety in Microbiological and 
Biomedical Laboratories, BMBL 4th Edition" with permission from the Center for 
Disease Control (CDC). 
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enforcing a rule that banned eating on the site. These measures ensured that 
the site was clean, functional, and possessed no health risk to users or viewers. 
(Ffer.13.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA: LiveLifeLab 
FOFA Gallery. Concordia University 
2007 
In contrast to the stark nature of the rest of the installation, the lab was visually 
hot and theoretically loaded, overflowing with equipment and resulting 
associations. In addition, it was a colourful romper room, where artists engaged 
with live biological entities through scientific protocols. The predominant decor 
was established by the black walls and ceiling, large red shelves installed at the 
back of the site, an internally lit sterile hood borrowed from the Department of 
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Biology, and stainless steel workbenches. The polished metallic surfaces 
reflected light and colour throughout the room. Lab coats were baby blue, media 
lids were orange, and vial racks came in multiple colours. The site was cordoned 
off from the general publicfwith transparent vinyl flaps, normally used in industrial 
loading bays and waste management facilities. Sometimes empty, and 
sometimes bustling with artists and curious visitors on tour, the lab was the heart 
of the installation. The liminal boundary between the lab and the gallery was 
signified by two small biohazard signs in order to meet BSL1 regulations, but 
these signs also alluded to the true biohazard in the installation: the human body. 
We are more likely to cause harm to the cell cultures then they are to us due to 
the possibility of contaminating the specimens with the billions of microorganisms 
hosted by the human body. Its contents were both functional and aesthetic, both 
sterile and multicoloured, and the room was literally packed to the ceiling with 
equipment and supplies. All this support and infrastructure was to maintain the 
microscopic cells at the heart of the installation; as a result, the room was 
teeming with life. 
The laboratory was planned as a site where we could continue our ongoing 
research, but also as a theatrical set — a performance space. The performance 
aspect of LiveLifeLab was multifold. First, there was the overarching 
performance of our attempt to build a functional laboratory by the end of the 
exhibition. As we were invited to participate in this exhibition on extremely short 
notice (only three months in advance), we had resigned ourselves to the 
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likelihood that the lab would not be fully up and running on the day the doors 
opened. However, we had scheduled a vernissage mid-way through the 
exhibition, at which the public would be invited to join us in the gallery to view the 
work, celebrate, and experiencefifst-hand the acquisition of cells from a primary 
source (bovine bone marrow — f/g.14) in a functional laboratory environment. 
(F/g.14.) 
Shawn Bailey and Jennifer Willet 
BIOTEKNICA: LiveLifeLab 
FOFA Gallery, Concordia University 
2007 
The second order of performance included enacting tissue culture protocols and 
sterile techniques on a more regular basis during the exhibition, both alone and 
with small invited audiences. Throughout the duration of LiveLifeLab, we 
conducted two primary cell acquisition protocols from commercial meat products, 
we performed a defrosting protocol of the 3T3 cell line in the Department of 
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Biology, we conducted serum distributions and 'feeding' of the cells with the 
replacement of nutrient solution several times, and we eventually terminated our 
cell cultures with the addition of bleach to all cell flasks. Twice weekly, and also 
at random times in between, we suited up and invited viewers to suit up with us 
and engage in a participatory art/lab ecology called LiveLifeLab. 
Ironically, the life we cultivated in LiveLifeLab was only with us for a short time. 
In a matter of days, the cells had become contaminated with long, narrow, figure-
eight chains of bacteria. I was heartbroken to peer into the eyepiece of the 
microscope when, only the day before, I had seen fledgling cell cultures, 
multiplying and growing stronger. The flask was now hosting a second order of 
visitors — bacteria — which were fatal to the delicate cells. Certainly, there are 
microfiltration procedures that can, in some cases, cull the unwanted bacteria, 
but if our suspicions were right about the source of contamination, this procedure 
would have served little use. 
We came to believe that the sterile hood was not, in fact, sterile. Despite the fact 
that it was originally designed for portable teaching purposes in plant culture and 
mycology, we were hoping that this hood would suffice for our purposes. 
Although it was presented to us as a BSL2 workspace, certified earlier this year, 
its design showed that the hood was actually a BSL1 unit (designed to protect 
the specimen from contamination, but not the researcher). In addition, the 
adhesive proof of inspection dated the unit's last certification in 2004. Last, the 
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access point to the 'sterile' work environment provided no Plexiglas protection 
against contaminants (which can often come from the user's breath) from 
entering the workspace. Immediately upon its delivery, we had predicted that the 
hood would pose significant problems in maintaining sterility. In addition to 
contaminating our immediate cell samples, we were concerned that the primary 
storage bottles for the expensive serums, antibiotics, and trypsin may also have 
been compromised, which would have resulted in the probable disposal of our 
entire stock of biological supplies. In this instance, working with life required total 
environmental control over processes that are inherently unruly and susceptible 
to contamination. 
However, contamination aside, LiveLifeLab was a resounding success for a 
number of reasons. Not only was it a great opportunity for us, but it also set new 
standards in Canada for extending the boundaries of artistic research into the 
infrastructure and protocols of the hard sciences. We were able to test the 
boundaries of biological specimen acquisition for non-specialists through two 
strategies: (1) the use of commercially purchased food products as a primary cell 
source in tissue culture, and (2) the delivery of an established 3T3 cell line 
ordered by the Department of Biology, and transferred to our satellite lab. Last, 
we experimented with (and subsequently failed at) establishing a sterile 
environment in a high traffic gallery setting. 
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The title "LiveLifeLab" best describes this endeavour in a concrete way. We 
were interested in the live presentation of life in the laboratory to a non-specialist 
audience. In conceiving of the title, we choose to deploy the term "life" in a dual 
manner, referring to both the life in the incubator or under the microscope and 
also to the primate life — the human life — that shares the laboratory ecology 
with our microscopic collaborators. This work served to reveal the bodies in 
biotechnology in a communal and demystified manner — as a sliding scale of the 
living. It also worked to challenge established perimeters of specialization in the 
university context, collapsing discrete disciplinary divisions and politely insisting 
that science belongs to all of us. LiveLifeLab challenged entrenched notions of 
legitimacy and power in the construction of scientific authority over the 
manipulation of life. We conceived of LiveLifeLab as an open-ended installation, 
allowing the audience to have first-order experience of tissue culture and a BSL1 
laboratory without a scripted outcome. The audience was provided with a set of 
information and experiences and allowed to come to their own conclusions about 
the efficacy and ethics of non-specialist participation in biotech. 
However, what is most significant in a project like LiveLifeLab is not necessarily 
the final manifestation of the gallery installation, but rather what is behind the 
scenes: the actions, negotiations, successes, and failures of building such a 
project. With BIOTEKNICA, we were almost more interested in the 
conversations, persuasions, and manipulations of the status quo that were 
necessary for us to engage in this type of production than in the production itself. 
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As a result, an interdisciplinary methodology was necessary to convey all of 
these complexities to our audiences. Texts like this one work in chorus with the 
installations, the website and media productions to present all aspects of the 
project — to reveal "what is behind the scenes, so often guarded in 
biotechnological research and industries. With this in mind, in all of its politicized 
intentionalities, I will direct the remainder of this text towards breaking down the 
different hurdles, offices, regulations, and setbacks that were necessarily 
managed in the production of LiveLifeLab. I will divide this analysis into five 
discrete sections: on-site gallery negotiations, specialized scientific purchasing, 
establishing a host laboratory, health and safety, and our participation in a Vision 
TV documentary film shoot about BIOTEKNICA. I feel that it is imperative to 
undermine the veneer of authority that comes with any public presentation of 
biotechnological protocols with the free sharing of information, as well as with a 
transparent representation of BIOTEKNICA in all its successes and failures. 
LiveLifeLab: On Site Gallery Negotiations 
In the field of bioart, there is much discussion and debate as to how to prepare 
and facilitate art galleries, museums, festivals, and institutions towards the 
successful exhibition of living artworks. There seems to be great interest in 
exhibiting works from this field in international art circles, but there is also great 
hesitation, as bioart requires infrastructure as well as both technical and 
personnel support not typical to most art exhibitions. A few institutions (Exit Art, 
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Museo Extremeno e Iberoamericano de Arte Contemporaneo), festivals (Ars 
Electronica, The Biennial Electronic Arts Perth) and curators (Jens Hauser, 
Antonio C. Pinto) have made ongoing commitments to exhibiting bioart. 
However, often curators afrd galleries interested in bioart prefer to host a 'dry' or 
documentary exhibition. Some artists would argue that bioart only exists when 
'wet' life is exhibited in the gallery,6 and others are prepared to make this 
concession. Last, there are some institutions that are pleased to make inroads in 
exhibiting bioart, even though they have little experience working with biology. In 
this instance, the artist becomes primarily responsible for his or her own technical 
support, facilitating linkages with the local scientific community and maintaining 
the installation on site for the duration of the exhibition. 
In regards to LiveLifeLab and the FOFA Gallery, our experience was the latter; 
we encountered a gallery director and staff that enthusiastically welcomed the 
project into their space, but were able to provide little to no support to accompany 
an exhibition of this scale and complexity. In addition, the FOFA Gallery was a 
new exhibition site, allowing only a very short production time-line from the date 
of invitation to the opening of the exhibition. These circumstances put Shawn 
Bailey and myself into an unusual position where we were left to negotiate a 
number of complex, internal university measures with a variety of offices 
(Purchasing, Health and Safety, the Department of Biological Sciences) on our 
6
 Adam Zaretsky, "The Mutagenis Arts" in ClAC's Electronic Magazine, no. 23, 
2005. Available online: URL: 
http://www.ciac.ca/magazine/archives/no_23/en/dossier.htm [date of last access: 
04/10/2007] 
175 
own — and in a very short period of time. Ideally, if one were doing an exhibition 
of this magnitude on a university campus, the gallery would serve as a liaison, 
managing the daily negotiations. However, since we were both employees at 
Concordia University at the, time, we were in the unique position of working 
directly with our home institution. In addition, this dialogue would normally take 
at least a year to transpire, in order to ensure that all parties come to a common 
understanding and agreement. With compressed time constraints and a lot at 
stake, this exhibit was by far the most difficult endeavour undertaken by 
BIOTEKNICA in its seven years of production. 
LiveLifeLab: Specialized Scientific Purchasing 
Purchasing the specialized scientific equipment, disposables, serums, solutions, 
and live ceil samples is also a complex and invested process. There are two 
reasons for this: industry regulations and university regulations. Industry 
regulations stipulate that biological specimens (in this case, established cell 
lines) can only be ordered by certified and registered laboratories even if the 
specimen is categorized BSL1, indicating that there is no known harm. There 
was no possibility of us achieving this type of certification in three months for a 
transient gallery laboratory, so we had to look to other laboratories on campus to 
gain access to the 3T3 mouse fibroblast cell line with which we wished to work. 
In terms of university regulations, we were subjected to a series of purchasing 
policies that we had never encountered before, such as blanket agreements, 
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purchase orders (<1000.00 CDN), purchase requisitions (<5000.00 CDN), and 
putting orders to tender, soliciting competitive bids for items over 5000.00. 
The academic/scientific purchasing system is not intended to encourage 
extracurricular interdisciplinary participation. We spent many hours on the phone 
explaining that we were artists. We had all sorts of questions that I'm sure were 
unusual. It was difficult to explain that yes, colour was important to us, and that 
we wished for our purchases to be delivered to a gallery rather than to a lab. 
Purchasing, in and of itself, is a specialized profession. In industry 
circumstances, the purchase of any product requires far more negotiation than 
our typical daily consumer purchases. Price, delivery, invoicing, and payments 
are all up for negotiation. As we were working on a very tight schedule, we 
pressed hard for guaranteed delivery, often making sacrifices in terms of price 
and payment. Labs are rarely built in a period of three months, and it was 
difficult to ensure delivery in time — and in the instance of some of the larger 
equipment, it was outright impossible. 
We made several attempts at purchasing the required items at a variety of 
venues before arriving at successful solutions. In the beginning, we contacted 
local and international companies directly, with little success. We then changed 
our course of action and approached Purchasing Services at our university for 
assistance. Unfortunately, the dedicated scientific purchasing agent had 
resigned earlier that week, and although she was gracious enough to provide us 
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with industry contacts and a brief description of the purchasing process, we were 
essentially left to our own devices. 
We found that the university hassalready negotiated a variety of blanket 
agreements (with reduced pricing) with local distributors, and we learned that, if 
we followed the protocols correctly, spoke to the appropriate salesperson, 
carefully filled out the paperwork, and received prompt administrative signatures, 
we could purchase all of our disposables in a somewhat efficient manner. We 
met with company representatives from Sarsted and Fisher Scientific and made 
a series of orders, after ensuring that the items were in stock and could be 
delivered in time for the opening of the exhibition. This was our first opportunity 
to stock a lab of our own, and we took full advantage ordering a years supply of 
{consumables}: disposable lab coats, latex gloves, 5, 10, and 25 mil pipettes, 
assorted tissue culture flasks, 50 mil vials, racks, beakers, kin wipes, specimen 
containers, petri dishes, sterilization envelopes, tape, tweezers, scalpels, 
scissors, and biohazardous waste bags. 
Where we encountered real difficulties was in purchasing major equipment, 
serums, and solutions. In order to keep cells alive outside of the body, you need 
a lot of the body — the technoscientific body7 and the actual body — to create a 
thriving environment. To this end, we chose to purchase some large equipment, 
7
 Oron Catts and lonat Zurr, "The Extended Body" in Artnodes: Intersections 
between Arts Sciences and Technologies, 2006. Available online: URL: 
http://www.uoc.edU/artnodes/6/dt/eng/catts_zurr.pdf [date of last access: 
04/10/2007] 
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a C02 incubator, a laminar flow hood, an inverted microscope, and a bioreactor 
to serve as the technological matrix in the exhibition. Each item incurred a series 
of size restrictions, price ranges, and functionality (basic models versus 
specialized additions). Although we had worked with all of this equipment before, 
we were overwhelmed by the multitude of choices and specifications that we had 
never encountered before. We found ourselves asking a multitude of questions: 
what is the difference between an l/R (infrared) and T/C (temperature coefficient) 
sensor? And what are the benefits of a water-jacketed unit over direct heat? 
Can you explain that to me again? Ultimately, the results were mixed. 
For example, the C02 incubator was a pricey purchase, but a necessary one. 
Cells living in vitro require an approximately 5-10% C02 environment, which 
controls the osmolality (a measurement of the osmotic particles in a solution) and 
pH (the measure of the acidity or alkalinity of a solution) levels of the delicate cell 
cultures. In the past, we had used a hybridization oven stocked with carbon 
dioxide packs with some success, but we wished to professionalize our 
equipment for future research and production. We approached Fisher Scientific 
for a basic model and, after days and weeks of negotiation, we agreed on a 
model, price, and delivery — only to find our order severely delayed by 
purchasing services. We were unaware of the tender process, and had to 
negotiate in order to have the purchase order put through without competitive 
bids. Once that was completed, the unit we had selected was out of stock, so we 
quickly substituted it for another model. Though the incubator would not arrive in 
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time for the opening of the exhibition, we were able to get it in days before the 
vernissage and live performance event. However, delays with the C02 regulator 
and gas supply made for an expensive sculptural object displayed in the corner 
of the gallery with no functionality^. 
Other items were accomplished with various levels of success. The laminar flow 
hood necessary for creating a sterile environment to complete the tissue culture 
protocols also presented difficulties. Hoods are often manufactured on demand, 
and delivery was not possible in time for our event. In addition, only one model 
was narrow enough to fit through the corridor opening to the laboratory. In the 
short term, it would have sufficed, but we were looking to purchase a more 
substantial unit to support our ongoing research. Instead, we decided to borrow 
a portable teaching hood graciously offered by the Department of Biology. 
The inverted microscope also posed problems, as the models carried by 
suppliers with established relationships with our university were research-grade, 
large, heavy, and inordinately expensive — far outside of our budget. An 
inverted microscope is a specialized piece of equipment even within the 
biological sciences. All of the optics are housed under the stage, allowing for 
flasks containing live cultures to fit on top of the apparatus. This structure 
enables light to penetrate upwards through the cell membranes, allowing direct 
focus on the bottom of the tray. We solicited a variety of local labs to borrow one 
with no success. Eventually, we ordered a simplified model via the Internet from 
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a supplier in the USA, only to have it caught up in customs. Fortunately, we were 
able to retrieve it, though a mere one day before the vernissage. This piece of 
equipment was absolutely necessary, as cellular life is only really visible through 
a microscope, and all the impact of oufsproject would be lost if our viewers were 
unable to see the cells for themselves. Otherwise, LiveLifeLab could have been 
interpreted as only a complex story, a sleight of hand relying on the construction 
of scientific authority — believe what we tell you, there are living cells in that 
flask... 
The last piece of large equipment that we required was a bioreactor. A 
bioreactor serves as a sterile micro-gravity environment best used to grow 3D 
tissue-engineered sculptures. The adherent cells we worked with are subject to 
gravity and cling to the bottom of stationary tissue culture flasks. In order to coax 
the cells to adhere to a 3D scaffold, the bioreactor continuously rotates, providing 
no stable surface (other then the scaffold) for the cells to attach. Though we had 
worked with a Synthecon model (originally developed by NASA to carry cells into 
space) in Australia and received promise of the loan of a stand-alone soft 
bioreactor from Wave Bioreactor as part of our ongoing Teratological Prototypes 
project, we were unaware of the highly specialized nature of this equipment. We 
quickly learned that Synthecon and Wave Bioreactor are the only two suppliers of 
this type of equipment. Since the bioreactor establishes the central aesthetic of 
the display of tissue engineered sculptures, we sought a device that was different 
from those previously used in conjunction with Oron Catts and lonat Zurr of 
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Tissue Culture & Art Project. We settled on the Synthecon perfusion rotary 
system for its changed appearance and advanced functionality, which allows for 
the continuous flow of fresh media into the bioreactor chamber. This feature 
allows for the bioreactor to be leffrfeplonger durations, as it does not require daily 
replacement of media by hand. In addition, the risk of contamination with this 
unit is substantially lower, as the vessel is not repeatedly opened and exposed. 
However, this unit is much more expensive then those we had priced in the past. 
Fortunately, we were able to negotiate an excellent discount (and a small 
simplification of the electronic components) through the company representative 
due to the non-profit nature of our research and the promise of frequent display 
of the unit in international art exhibitions. 
Outside of the large equipment, we were also confronted with great difficulties in 
procuring the variety of serums and solutions needed to support a functional 
tissue culture lab. DMEM (Dulbecco's Modified Eagle's Medium) is a vitamin-rich 
solution which houses and feeds the cells in vitro; FBS (Fetal Bovine Serum) is a 
product made from the blood of cow fetuses added to the medium to provide the 
cells with nutrients normally received from the host organism; PenStrep 
(Penicillin-Streptomycin) is an antibiotic medication added to prevent bacterial 
contamination as the cell cultures have no immune system of their own; Gluta 
Max is an essential amino acid; Trypsin is an enzyme extracted from the 
stomachs of cows, used to break the bonds between cells for redistribution of cell 
cultures; PBS (phosphate buffered saline solution) is used to wash cells without 
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damaging their membranes; double distilled water was needed to rinse scaffolds; 
and Bleach and 70% ethanol were needed for cleaning and sterilization. Suffice 
it to say that most of these items cannot be purchased at local commercial 
outlets. After many failed attempts to frrid*a distributor that was interested in 
dealing with us (and our temporary laboratory location), we directly contacted an 
international supplier, Invitrogen. Invitrogen ships laboratory-grade serums and 
solutions on twenty-four hour notice, allowing for us to receive most items in 
short order. 
We were pleasantly surprised to find that they would accept orders and credit 
card payments over the phone, and that they also seemed to have little 
restrictions on where they could deliver the supplies. This proved useful for our 
purposes, although it was also a bit disconcerting. Invitrogen, in their terms and 
conditions clause, protects themselves from any liability, arguing that the receiver 
is responsible for providing adequate housing, safety, and personnel (TQI, or 
Technically Qualified Individual). A TQI is defined by the USA Toxic Substance 
Control Act as: 
a person or persons (1) who, because of education, training, or 
experience, or a combination of these factors, is capable of understanding 
the health and environmental risks associated with the chemical 
substance which is used under his or her supervision, (2) who is 
responsible for enforcing appropriate methods of conducting scientific 
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experimentation, analysis, or chemical research to minimize such risks, 
and (3) who is responsible for the safety assessments and clearances 
related to the procurement, storage, use, and disposal of the chemical 
substance as may be appropriatefeor required within the scope of 
conducting a research and development activity. (CAA Q&A Database, 
May 1997) II.B.68 
At this juncture, it is important to note the irony of our direct dealings with the 
biotech industry in support of a project intended to encourage critical scrutiny of 
that industry. Over the years, I have found that it is impossible to engage 
critically with biotechnology without also becoming a part of its community and 
infrastructure :— and therefore a participating member of that hierarchy. By 
joining the community, working alongside scientists who were conducting a 
variety of research, and, with LiveLifeLab, economically and conceptually 
investing in the corporate reproduction of ongoing biotechnological research, we 
were even further entrenched in the very system we wish to critically analyze. 
This position furthered our 'gone native' status — as Oron Catts has often said of 
his own work with lonat Zurr, "we are embedded reporters," with all the 
unraveling connotations implied by that position. 
8
 USA Toxic Substance Control Act, Available online: URL: 
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LiveLifeLab: Establishing a host laboratory. 
In order to build a temporary laboratory in a non-specialized environment, we 
required the support of a host laboratory to gain access to the infrastructure and 
the acquisition of restricted cell cultures. Unlike the processes discussed thus 
far, establishing a host laboratory was far more personable, creating an ongoing 
dialogue with colleagues in the Concordia University scientific community about 
the nature and intentionalities of BIOTEKNICA. We contacted the Department of 
Biology, requesting technical assistance with LiveLifeLab. We were very pleased 
to receive a response from Dr. James Grant, Chair of the Department of Biology, 
directing us to their Technical Officer Sonia Ruiz. We met with Ruiz, explained 
our ongoing research with TC and TE, and provided her with a slideshow of our 
exhibit in San Jose. We spoke of the democratization of science, biotechnology, 
and TC and TE; we discussed the ethical and aesthetic implications of bioart, as 
well as our deep respect for and fascination with the biological sciences. 
Although she expressed great interest in BIOTEKNICA, she informed us that 
Concordia University houses no ongoing research in mammalian tissue culture. 
Though their lack of specialization in our protocols proved to be a small setback 
in terms of accessibility and equipment, they were fitted with enough 
infrastructure and expertise in related fields to assist us. Ruiz agreed to provide 
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technical support in three ways: (1) in the loan of a BSL1 portable sterile hood, 
(2) the acquisition of the 3T3 cell line directly from ATCC9 or from a local 
researcher, and (3) to provide access to the department's autoclaving facilities for 
sterilization of tools, equipment, and double distilled water. In exchange, we 
agreed to confirm health and safety approval of the satellite laboratory site before 
accepting any biological materials from the department and to provide public 
recognition of support provided by the Department of Biology in the propagation 
of LiveLifeLab. 
Although Ruiz was ultimately unable to secure any cell lines from local 
researchers, she did place an order for the 3T3s to be delivered directly to her 
laboratory. Unfortunately, the cells did not arrive until the day of our vernissage, 
preventing us from including them in the installation on such short notice. 
However, we had planned in advance for this contingency by performing two 
primary cell acquisitions from commercially purchased cow femurs, both before 
the vernissage and then in front of a live audience during the opening event. 
This small setback aside, we were pleased to receive the cells in good condition. 
A day later, we worked in the department's teaching laminar flow hood to defrost 
the cells and suspend them in nutrient solution for delivery to the gallery site. 
Defrosting cell samples is a delicate process. They are frozen and suspended in 
an antifreeze solution, which prevents ice crystals from breaking the cellular 
9
 ATCC: The Global Bioresource Centre, Available online: URL: www.atcc.org 
[date of last access: 04/10/2007] 
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membranes. Though the antifreeze is necessary (and harmless) at -80 degrees 
Celsius, once the sample is brought up to room temperature, it requires 
immediate dilution in TC media (DMEM + 10% FBS) to prevent cell loss. The 
tiny vial was delivered to the site in a box of dry ice. The vial was then removed 
and its contents were defrosted in a warm water bath. The sample was pipetted 
up and down to break up the pellet of cells in the bottom of the vial, then 
transferred to a larger vial containing warm medium. This vial was centrifuged, 
drawing the cells into a pellet once again, allowing Bailey to draw off the 
antifreeze and medium, only to be replaced with fresh medium again and 
transferred into a new tissue culture flask. By this point, the cells had suffered a 
rather traumatic morning and required a 'rest' in ideal living conditions — at 37 
degrees Celsius, surrounded with fresh media, and 5% C02. The Department of 
Biology did not have a C02 incubator, so we immediately transported the cells, 
double wrapped in biohazard Ziploc bags, to the campus gallery across town. To 
keep the cells warm, I held them in my sweater next to my stomach, keeping 
them at body temperature as we road the bus into the city. I couldn't help but to 
think of the final scene in Mike Nichols' The Graduate (1967), where Benjamin 
and Elaine escape her wedding in the back of a public bus; she is dressed in 
white, and they are smiling a secret smile to each other. In this instance, 
however, I am exhaling into the collar of my sweater every few minutes to keep 
my stomach warm and moist, hoping to mimic ideal tissue culture conditions with 
self-produced C02. 
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In general, our interactions with the scientific community in this capacity were 
mutually respectful — even delightful and rewarding. From my experience, 
individual researchers in the hard sciences work in small communities or even 
isolation (much in the same way&that artists work), and are thrilled when 
individuals outside of their area express interest (or even amateur expertise) in 
their specialized field. Arguably, the larger institutional culture of 
overspecialization serves not only to exclude more general audiences from a 
particular practice or discourse, but also to ostracize the specialist class from 
external interaction with language barriers and perceived hierarchies. In this 
instance, the reception of our proposed collaboration at Concordia University was 
overwhelmingly positive from administrative units, faculty, and particularly from 
technical staff. 
However, it is important to note that some ideological clashes (although they are 
rarely terminal) result from this type of interdisciplinary cohabitation of the arts 
and sciences. I can think of many instances of argument and debate that I have 
encountered over the years between researchers in the two fields. In the 
instance of LiveLifeLab, we did encounter some healthy resistance to our 
research from the scientific community. While giving the Technical Officer Ruiz a 
tour of our exhibition after the vernissage, she related to us some concerns she 
had received about her participation in our project. Apparently, when our 
exhibition invitation was forwarded to faculty members in the hard sciences, there 
was some concern regarding our website and the anti-corporatization arguments 
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made in the writing, imagery, and dissemination of BIOTEKNICA. Ruiz was 
contacted by one professor in particular who had started a biotech company of 
his own, based on government-funded research he had conducted at the 
university (a very common practice amongsfcprofessors in the sciences). He felt 
it was unreasonable for the department to support art/science research that 
worked in opposition to commercialization strategies in the sciences, and held 
Ruiz accountable for her work with BIOTEKNICA based on the content of our 
website. Of course, my heart sank, as we had never provided Ruiz with a link to 
the site directly, and had inadvertently put her in a difficult position. However, 
she concluded that, as Technical Officer, it was her responsibility to support 
faculty research in the sciences regardless of its content (and outside of her 
personal opinions), and felt justified in her decision to work with us by providing 
technical support. In hindsight, I am unsure about what motivated us to avoid 
directing Ruiz to our website during our first meeting. Did we edit it from our 
presentation intentionally? 
LiveLifeLab: Health and Safety 
Possibly the most difficult aspect of successfully launching LiveLifeLab was our 
dealings with the Concordia Health and Safety Office. Conceptually, Bailey and I 
had always chosen to work within the established channels towards effecting 
social and political change. We were interested in working towards changing 
policies at the institutional and governmental levels that prevent open discussion 
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and dialogue in the field of biotechnology. Because of this methodology, we 
always worked directly with institutions and, as a result, within their community 
standards and protocols in activating those behaviors and actions that exist at 
the periphery of established standards for engagement. To this end, we 
suggested that the gallery contact the health and safety office (H&S) as soon as 
we agreed to attempt to build a lab in the exhibition. What we received in 
response was a curt notification that we were not to complete the exhibit as 
planned until we had contacted H&S directly and met with an officer to discuss 
our plans. 
We made arrangements to meet with H&S officers immediately and prepared a 
presentation slideshow that featured our last laboratory installation at ISEA in 
San Jose. We also prepared a list of questions, as well as a list of probable 
materials and protocols that would be used in LiveLifeLab. At our meeting, we 
were offered a variety of H&S suggestions, proper disposal containers, and 
requested to provide an official list of hazardous materials and protocols. We 
agreed to keep the appropriate MSDS (Material Safety Data Sheets) available on 
site, mark all hazardous materials, and provide gallery staff with transparent 
information of the possible harm (or lack of harm) that the exhibit posed to 
viewers. We also agreed to a full laboratory H&S inspection before the cell line 
was transferred to our site, and to store hazardous material in appropriate 
conditions. 
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However, the conversation took an unusual turn. We were presented with 
concerns about the 'perception of harm' on behalf of our viewers, and the 
possible legal ramifications of these fears for the university. We argued that the 
perceptions of our work were outside of the scope ofeH&S regulation and, in fact, 
were solely the domain of artistic freedom. It was explained to us that, although 
the perception of LiveLifeLab was an artistic concern, it was also the role of H&S 
officers to field questions when employees and visitors to Concordia University 
perceive themselves at risk. With this understanding, we offered to minimize the 
perception of risk, with the understanding that H&S officers would fulfill their 
prescribed job description by making themselves available to any individuals who 
have questions about the safety of the exhibit. 
Our discussions focused a great deal on the presence of household bleach in the 
laboratory. Bleach was the most harmful substance we proposed to bring into 
the lab. Bleach is a necessity in TC and TE protocols, as it is powerful enough to 
kill all biological waste, thus allowing researchers to pour used serums and 
solutions down the drain as a safe means of disposal. H&S was concerned, as 
bleach has been banned from campus as a cleaning agent due to its corrosive 
potential, poison risk, and chlorine odor. The hazards are described as thus: 
Potential Health Effects Eye: May cause irreversible eye injury. Contact 
with liquid is corrosive to the eyes and causes severe burns. Skin: 
Causes skin burns. Ingestion: May cause methemoglobinemia, cyanosis 
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(bluish discoloration of skin due to deficient oxygenation of the blood), 
convulsions, and death. Causes severe digestive tract burns with 
abdominal pain, vomiting, and possible death. Methemoglobinemia is 
characterized by dizziness, drowsiness, headache; shortness of breath, 
cyanosis (bluish discoloration of skin due to deficient oxygenation of the 
blood), rapid heart rate and chocolate-brown colored blood. Inhalation: 
Harmful if inhaled. Causes severe irritation of upper respiratory tract with 
coughing, burns, breathing difficulty, and possible coma. May cause 
pulmonary edema and severe respiratory disturbances. Chronic: Chronic 
inhalation and ingestion may cause effects similar to those of acute 
inhalation and ingestion.10 
We were told that the gallery did not have suitable ventilation to accommodate 
such a substance, and that people might complain of perceived risk if bleach 
fumes were able to escape their container (or the lab), possibly alarming the 
university community. We agreed to provide proper containers (with diligent lid 
coverage) for bleach solutions and to store the bleach at a better ventilated 
location in the art department when it was not being used on site. In addition, we 
agreed to dispose of used bleach solutions in a private manner, and not in public 
washrooms, to again dissuade any possible fears in the general public. We 
offered the same precautions in the use of 70% ethanol as a cleaning agent, and 
even went so far as to purchase 95% alcohol from the liquor store as a 
10
 MSDS sheet available online: URL: 
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consumable replacement for industrial ethanol. Later, the suggestion that we 
transport the bleach and alcohol to a better ventilated storage facility was 
withdrawn. 
The last concern brought to our attention was another surprise. We were 
informed that a number of university staff unions were on 'work to rule' action 
against the administration, including the technicians. Certainly, we were aware 
of this action (and in support of their cause). However, we could not see how this 
affected LiveLifeLab. H&S was concerned that, if they allowed us to open a 
satellite lab on campus without a paid technician as specified in their collective 
agreement, there might be a grievance action taken out against us during this 
time. We were very concerned that poor labour relations on campus might affect 
the outcome of our exhibit. We made it clear to H&S that an art installation with a 
laboratory component was distinctly different, and was separate from university 
policy in managing permanent campus laboratories. 
Overall, we were left with the perception that the successful launch of our lab 
was contingent on approval by H&S officers, with the implication that we may not 
receive this approval. We went so far as to mention the ramifications of 
perceived academic and artistic censorship in the event that a common ground 
could not be reached in this matter. I specifically asked that, if we followed all of 
the protocols and standards outlined in the discussion and posed no known risk 
of harm to ourselves and our viewers, would our project approval be given. The 
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response was a "yes," but it was marked by great hesitation. We left the 
meeting feeling very discouraged. 
In a follow-up email, we outlined the agreements and discussions that had 
transpired during the meeting to H&S as well as a number of Concordia 
University administrators. In a written response which we later received, it was 
made clear to us that H&S was in no position to block the exhibition — but, as we 
already agreed with the Technical Officer of the Department of Biology, without 
their approval there was to be no transfer of the purchased 3T3 cell line to our 
satellite location. The successful completion of the exhibition was, in fact, 
subject to H&S approval. 
After much correspondence, and as the vernissage drew nearer, we booked a 
walkthrough meeting with the Director of H&S for the final inspection of our lab. 
The meeting was an unusual one. Unfortunately, I was unable to attend; 
however, I was informed that suggestions were made about the variety of 
possibilities that could result in the failure of LiveLifeLab. For example, it was 
proposed that if the gallery electrical grid failed, our specimens would be lost; if 
an individual were to make a complaint to the appropriate government office, 
LiveLifeLab could suffer a literal lockdown, and the gallery doors would be 
chained until a full investigation was completed. Bailey assured H&S officials 
that we were prepared to take all of the appropriate steps to prevent these 
outcomes with the assistance of their office. He spoke confidently and 
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competently about the precautions, techniques, and substances present in the 
lab, dissolving any perceived tension. In the end, a balance was reached, and 
we made a few minor changes: ensuring our biohazard signs were posted in both 
French and English, adding some labels to unmarked bottles, and replacing our 
latex gloves for vinyl ones provided by the H&S office. The end result was H&S 
approval of our lab in time for the vernissage and the eventual delivery of the 3T3 
cell line. 
LiveLifeLab: Vision TV Documentary 
The last constraint we experienced was self-imposed, and provided us with an 
excellent opportunity. We had been contacted a couple of months in advance by 
an associate producer at Vision TV (a Canadian, faith-based television network) 
who was interested in doing a television documentary on bioart in general and 
wanted to specifically focus on BIOTEKNICA. 360° Vision was a current affairs 
program that "spotlights spirituality in contemporary Canada."11 They tackled 
issues directly concerning organized religion (like gay and lesbian clergy 
members), as well as current affairs issues form a spiritual perspective (for 
example, rising gang violence in Canada). Though we did not contextualize 
BIOTEKNICA or evolving biotechnological debates in this regard, we felt strongly 
that, if we were arguing for the democratization of biotechnology, all perspectives 
1
' Vision 360 from Vision TV, Available online: URL: 
http://www.visiontv.ca/Programs/current_affairs_360.html [date of last access: 
04/10/2007] 
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should be taken into consideration. With this in mind, as well as the quality of 
previous documentaries produced by the 360° Vision team, we agreed to 
participate. We invited the producer, Janet Aronoff, and her crew to join us for 
the three days surrounding our LiveLifeLab vernissage. This timing would 
ensure that cellular life would be in the lab during filming, and also best convey 
the electric tension of presenting live biological specimens and protocols at a 
public event. However, this also meant exposing ourselves at a very busy time 
to a very public recording of our ongoing artistic practice. 
The day of our vernissage, we spent the morning conducting interviews in our 
private residence. Then, the crew followed us to the butcher, slowing every step 
of the process, as we explained the practical and ethical aspects of our work in 
minute detail. The crew also became privy to all of the last minute meetings we 
conducted that week — attending our final Health and Safety inspection, 
defrosting of cells at the host laboratory, and the vernissage itself. They also 
arranged meetings with academics and theologians in the gallery for external 
interpretations of our installation. 
During our initial discussions with Vision TV, we were asked if we knew of any 
detractors of our work. I mentioned Carol Gigliotti, a professor at Emily Carr 
College of Art and Design who had published texts in opposition to contemporary 
bioart practices. Unbeknownst to us, Vision TV flew Gigliotti into Montreal and 
interviewed her onsite about our exhibition the day before our public performance 
196 
event. The scrutiny was provocative, well-intentioned, but somewhat 
uncomfortable and invasive during this stressful time. 
The documentary has not yet aired as of April 2007, so I cammi attest to the final 
narrative that will be presented to 360° Vision audiences. However, I was 
pleasantly surprised by the recorded reactions from gallery visitors and 
academics. Though the crew seemed genuinely interested in and supportive of 
our practice as we presented it to them, they were also searching for 
controversy. We allowed the producer to interview attendees at the gallery 
event. They were asked for their reaction to the exhibition, particularly as it 
pertains to ethics, morality, and spirituality. The producer seemed surprised, and 
a little disappointed, that those who attended the vernissage were resoundingly 
in support of our interdisciplinary art/science mandate and production. One 
individual's response was so positive that he was recorded jumping up and down 
hollering the merits of our performance. 
It is my understanding that Gigliotti did not provide the directly oppositional 
quotations that they were hoping for. In addition, the theologian that they brought 
in suggested that our work would only enter the realm of religiously objectionable 
if we were conducting research on human subjects (as according to the Christian 
hierarchy of life, which suggests that man's body is divine, whereas the animal 
body is a resource for human consumption, manipulation, and control). Of 
course, upon hearing this, we committed our earlier work with the Hackett 
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(human epidermal) cell line to record, and also recorded our future plans to take 
skin samples from Shawn Bailey to create our own open source artist cell line. 
We did not see a categorical distinction between human and animal cell sources 
— rather, we wished to undermine perceived hierarchies:between the human 
and animal kingdoms and embrace the continuum of bodies mobilized in 
biotechnology. 
Once the filming was over, we were left exhausted, confused, and feeling as 
though we had been taken advantage of — like minor circus freaks, closely 
examined by the lens and the masses for horror and entertainment value. We 
were also discouraged by the producer's continual quest for objections and 
dissent, particularly as she often attempted to mobilize us to assist her in 
unearthing controversy. Though our working methodology encourages our 
viewers to come to their own conclusions about our practice, TC and TE, and 
biotech, we felt newly responsible to produce a negative feedback loop on 
demand for the camera. Last, we parted with a new understanding of the level of 
scripting involved in documentary productions. The subject of documentation 
often required artificial lighting, repetition, rescheduling, and even reenacting to 
better serve the lens. This aside, we are glad to have committed to this project, 
as it serves as an excellent record of an exciting point in our artistic lives and as 
an extended public interface for BIOTEKNICA: LiveLifeLab to perpetuate itself. 
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In detailing the various administrative, industrial and economic hurdles that we 
overcame in building LiveLifeLab, I am trying to convey an imposing message 
that we received from various individuals and offices through their actions (and 
sometimes inaction): research involving scientific protocols is carefully guarded, 
and outsiders are not welcome. We learned that, without almost superhuman 
resolve, significant funding, and a persuasive language set, non-specialist 
participation in codified scientific channels is almost impossible. With the 
successful completion of this exhibition, we gained new understanding and 
respect for earlier generations of bioartists working within institutional contexts, 
such as Joe Davis (MIT), Tissue Culture & Art Project (UWA), Beatriz da Costa 
(UofCI), Kathy High (RPI), and Natalie Jeremijenko (UCSD). We were very 
pleased that LiveLifeLab established many important precedents at Concordia 
University and within the greater Canadian community, though we were 
exhausted, and a little disheartened, by the process. 
In a previous paper, "BIOTEKNICA: A Case Study in Bioethics and Human 
Tissue Culture in Art," we developed a language set to describe the dual 
intentionalities we experienced that working in the labs as 'double agency.' 
We have entered into a critical/participatory relationship with biotech in 
general and tissue culture in particular. In this capacity we understand our 
position to be like that of double agents. Not in the Cold War sense of the 
term, but rather as a participant with dual intentionalities. Here, we are 
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welcomed into a highly specialized environment inaccessible to the 
general public. We are simultaneously engaging collaboratively, 
respectfully and excitedly with the individuals, protocols and institutional 
structures of the site - while at the same time, from a different standpoint, 
gaining outsider insight and observations (and criticisms) that are 
published in other communities. Often these roles are at odds -
sometimes easily synchronized, but always co-present.12 
With LiveLifeLab, I feel that this sense of double agency extended even further 
into our practice, in terms of the necessary administrative give and take, and 
compromise that was required of us. In the past, our investment in laboratory 
certification and functionality was almost non-existent, given our status as visitors 
in already functional labs. In this instance, the stakes were higher: we were 
working at our own university, where negotiations were constantly forging new 
territory and establishing precedents that, as all parties were aware, would have 
long-term repercussions for BIOTEKNICA and Concordia University. 
The push and pull we felt in working as individuals in the SymbioticA labs (what 
to reveal and not reveal of our established critical framework, the slow 
colonization of the non-specialist perspective) was less systemic and always 
temporary, lasting only as long as our Australian residency visas. With 
12
 Jennifer Willet and Shawn Bailey, "BIOTEKNICA: A Case Study in Bioethics 
and Human Tissue Culture in Art" in press, 2007. 
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LiveLifeLab, these forces were at play on a larger scale — compromises were 
more permanent, deeply effecting the administration of the BIOTEKNICA from a 
structural and managerial perspective. 
It is imperative to note that each individual that we encountered during this 
process was aptly fulfilling their job description (producer, purchasing agent, 
health and safety officer, technician). The criticism launched here is not aimed at 
individuals or personalities, but rather at the larger institutional framework — a 
culture of bureaucratic control — with the goal of supporting North American 
standards of full disclosure, safety, and responsible spending of tax-payer 
dollars. Reasonable aims — necessary checks and balances — amassed into a 
juggernaut machine of administrative and specialized impenetrability. In Hannah 
Arendt's canonical analysis of the Adolf Eichmann trial for crimes against 
humanity, she writes of the 'banality of evil'13 in the individuals that enacted the 
atrocities of the Second World War, but also of the bureaucratic functionality of 
these atrocities. I am by no means putting the systematic dehumanization and 
culling of a people through holocaust measures on equal footing with liberty 
infringements resulting from the overspecialization of the biological sciences, but 
I am alluding to the powerful systems of control that a bureaucratic state wields 
over discourse and actions of individuals and communities in pursuing 
knowledge outside of normalized (and sanctioned) courses of action. Extreme 
interdisciplinary, especially that which infringes on science (which we tend to 
13
 Hannah Arendt. Eichmann in Jerusalem: A Report on the Banality of Evil 
(1963). Rev. ed. New York: Viking, 1968. 
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perceive as the highest order of knowledge, with the greatest potential for harm 
and profitability), is inherently obstructed by the same bureaucratic institutions 
that we rely on for its regulated management. 
With LiveLifeLab, so much of our time and resolve was expended in negotiations, 
correspondences, and sheer physical and emotional will that the subtle play and 
reflexive empathic relationship I usually experience with laboratory ecologies 
played an inferior role in this particular art action. The unwavering forward thrust 
required on our behalf disallowed our more usual reflexive working strategies. 
Barbarism might better explain it — replacing cell lines with fresh kill bones, and 
a rotary power saw wielded to access the interior of the institutional and animal 
body. We exhausted ourselves in the creation and production of this exhibition, 
only for our work to be contaminated due to faulty equipment. Bacteria (and 
unhappy artists) became the only life in LiveLifeLab. 
In hindsight, I might categorize LiveLifeLab as a failed ecology of sorts, where a 
harmonious balance between life forms (artists, cells, bacteria, and health and 
safety officers) was attempted but never ever quite achieved. I am reminded of 
another 'failed' ecology that existed years ago, when I attempted to start my first 
garden from store bought seeds. I carefully planted, watered, and watched 
dozens of fragile life forms in my living room window. A couple of months in, as 
the plants were becoming hearty, and the weather was warm enough to think of 
moving them outside, we (the plants and I) suffered a massacre, enacted by my 
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disabled but playful house cat, Bouts. I imagine that he had watched me dote so 
much attention on the seedling trays that he took it upon himself to pull them all 
down, crumpled on top of one another on the living room floor. Some of the 
plants recovered, but most did not. Heartbroken, I wrote to George Gessert for 
sympathy, a bioartist known for his work with selectively breeding irises. In his 
response, he reminded me that life is a violent process. "Your cat understands 
the spirit of gardening, which is messy, and involves random destruction and 
death. I hope you don't get discouraged. Life thrives in spite of it all."14 This 
personal experience helped me to contextualize and understand LiveLifeLab. 
Life is hard — all that is alive dies — and even unwanted contamination equals 
the successful propagation of another entity with which we share our ecology. 
I wish to conclude this case study by addressing arguments presented in earlier 
chapters to elucidate how these concepts play out in regard to this instance of 
bioart. LiveLifeLab contributes in multiple ways towards my arguments for a shift 
in the language used in describing biotech in public discourse, a shift in the 
representation of the biotech specialist towards a more inclusionary 
interdisciplinary model, and an instance of hands-on education for non-
specialists in demystifying and (re)embodying biotechnological protocols. 
If we look back throughout this chapter, we can see a specific language set that 
is deployed in constructing the public representation of LiveLifeLab. Phrases like 
14
 From personal correspondence with George Gessert, 2005. 
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'feeding the cells' and giving them a 'rest' permeate BIOTEKNICA discourse. I 
am particularly interested in proposing this installation as a 'laboratory ecology' 
filled with cells, bacteria, and human bodies, imagining the lab not as an artificial 
and controlled environment, but rather as another ecological point of interaction 
amongst multiple species. This point is aptly made in another work of bioart 
Workhorse Zoo (2002) by Julia Reiodica and Adam Zaretsky, in which the artists 
cohabitated for a week in a laboratory installation with an assortment of 
organisms including bacteria, yeast, plants, worms, flies, fish, frogs, mice, and 
humans. The concept of a laboratory ecology, in terms of written and visual 
language, draws reciprocal attention to the embodied interconnectedness and 
mutual reliance between researchers and the organisms (and parts of 
organisms) that cohabitate in biotechnological research labs. Here, specialists 
are also artists, H&S officers are also bodies, cells are also collaborators, and 
witnesses/students are introduced to all contributing bodies. 
In closing, I wish to relate one specific meeting with a group of student non-
specialists in the lab. As I arrived to feed the cells on a Tuesday afternoon, I 
found a small group of art education students waiting for me in the gallery. They 
had arranged to meet with their professor and witness the bi-weekly feeding 
performance. We began with a group discussion in the installation waiting room, 
but quickly moved to the lab. They seemed surprised when I asked them all to 
wash their hands, suit up in plastic lab coats, and join me in feeding the cells. A 
couple of individuals chose to stay outside, only to change their minds and join 
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us minutes into the performance. We began with a short health and safety 
introduction, and then moved into hands-on demonstration of cellular microscopy 
— with ample question and answer. I then proceeded to feed the cells, asking 
for student assistance and carefully describing each step of? the process. The 
event concluded with group discussion of the ethical complexities of evolving 
biotechnologies, the processes at hand, and LiveLifeLab as a work of bioart. 
Once we were finished, the instructor asked the students to analyze the 
performance strategies deployed by myself in our interaction. One student 
proposed a pedagogical model — a form of art/science education; another 
identified my use of colloquial language and self-deprecation as a means of 
reducing specialist authority; and another student suggested that they needed to 
question altogether what my motivations and intentionalities were, proposing that 
they should not allow the white lab coat to prevent themselves from critically 
engaging with my presentation. At the centre of this small discussion, I felt a 
warm blush moving across my body as I recognized the resounding success of 
LiveLifeLab in allowing others to enter into a critical participatory relationship with 
biotechnology, if only in this small instance. 
BIOTEKNICA: LiveLifeLab was the last major exhibition of the BIOTEKNICA 
collective. Months later, we wrote about this incarnation of the project in 
"BIOTEKNICA: Teratogenic Strategies For Critical Bioart Production" as suffering 
from a consumptive end. The attributes that made BIOTEKNICA successful — 
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particularly our ability to relentlessly push through the necessary chain of 
command institutional/scientific circles — eventually inhibited the original 
transformative political spirit of the project, through a process of bureaucratic 
reification. In hindsight, I can only see it as a slow death by paperwork: Where 
bureaucracy overcame the desire to make the work. 
These cumulative experiences marked a significant shift in our 
collaborative practice - away from the mere representation of mutation -
and towards a teratomatic interventionist methodology. BIOTEKNICA 
itself, has been transformed into a teratogenic agent - where instead of 
analyzing biotechnology from an external position, it begins to infect and 
produce irrational affect in both scientific and artists communities. 
BIOTEKNICA has become an un-nameable entity - organism - skirting the 
boundaries of art and science. As James G. Wilson describes in his six 
principles of teratogensis; "Teratogenic agents act in specific ways on 
developing cells and tissues to initiate sequences of abnormal 
developmental events."15 BIOTEKNICA also serves to initiate sequences 
of abnormal developmental events, at cellular, social, political, artistic and 
scientific levels. Ironically, and reciprocally, BIOTEKNICA's transmutative 
effects have also contaminated itself, and the artists/actants who set the 
process in motion, hypocritically instrumentalizing (devouring and 
mutating) life forms to propagate it's own robustness - subsuming itself, 
15
 James G. Wilson. Environment and Birth Defects (Environmental Science 
Series). London: Academic Pr. 1959. 
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and it's host organism. BIOTEKNICA, like the cancerous teratoma, is 
subject to it's own self prescribed vicissitude, and consumptive end.16 
16
 Jennifer Willet, Shawn Bailey. "BIOTEKNICA: Teratogenic Strategies For 
Critical Bioart Production" in Mutamorphosis Conference Proceedings, CIANT, 
2007. 
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5 | (RE)embodying Biotechnology: Conclusion. 
If we are going to work with the P19's we need a different mix of serums in 
the nutrient fluid. We ordered a bottle of Donor Calf Bovine Serum. It is 
the colour of a good beef stock. I spent hours alone in the lab today. 
Defrosting the serum and dividing it into 7.5 ml dosages. Enough to make 
100 ml of prepared nutrient solution (along with 5 mil of the usual fetal 
bovine serum). Serum is an interesting thing. It is the blood of the calf or 
fetus with all the cells and platelets removed. Horrific actually. And also 
interesting, we are postulating the ability to grow cells outside of the body -
but how much of the body to we need to bring into the lab to create a 
hospitable 'artificial' environment for the cells to proliferate? 
... if I cut of my hand, you say me and my hand. 
If I cut off my leg, you say me and my leg. 
If I take out my kidney, liver and intestines, you say me and my 
intestines...intestines. 
But if I cut off my head, do you say me and my head or me and my 
body?... 
loosely remembered from Roman Polanski's The Tenant1 
1
 Jennifer Willet. BIOTEKNICA \ ORGANIC TISSUE PROTOTYPES \ 
LABORATORY NOTES, unpublished manuscript, 2004. 
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(RE)embodying Biotechnology is an articulation of my own experiences working 
as an artist and a non-specialist in the biological sciences. This document charts 
the activities and results of the 'work,'2 in the sense proposed by Noam Chomsky, 
that I have engaged in over the last several years. Although they seem to be 
separate, each chapter contributes to the development of a very simple 
argument: biotechnology is not separate from life. This statement is true in three 
senses. First, the processes and protocols that occur in laboratory environments 
are part of a continuum of human engagement in the manipulation of life. 
Second, biotechnology is not only defined by its processes and protocols, its 
metaphors and specimens, but also by its tangled and interconnected relations 
with society, individuals, communities, and ecologies. Third, biotechnology is a 
reciprocal technology of the body that engages with multifold instances of life — 
bacteria, proteins, cells, animals, scientists — as specimens, tools, procedures, 
and purveyors; when we manipulate life in this manner, we are ultimately 
manipulating ourselves. 
1 have proposed a variety of concepts and strategies in each chapter that allow 
for engagement with these notions, and I now wish to articulate their direct 
connection with the conception of biotechnology as indivisible from life, as a 
technology of the body, as ecology. This conclusion, which includes references 
to phenomenology, cybernetics, and discourse analysis, serves to theorize and 
2
 Mark Achbar and Peter Wintonick, Manufacturing Consent: Noam Chomsky and 
the Media, 1992. 2:39:15 
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interpret the 'work' outlined in earlier chapters, but also marks the beginning of 
my next cycle of research. In chapter 2, I argued for non-specialist participation 
in the biological sciences with the application of alternative methodologies, 
community standards, and dissemination of results towards the democratization 
and transformation of the biological sciences in public discourse. I recounted 
some of the successes and failures of this proposition, emphasizing the dangers 
of 'going native'3 and proposing a critical participatory relationship with biotech. 
However, my intention is not to suggest that these alternative practices work in 
didactic opposition to the hard sciences, but rather that they function in a 
reflexive manner, both critiquing and embracing biotechnology. 
Bailey and I explain this threshold position in our paper "BIOTEKNICA: A Case 
Study in Bioethics and Human Tissue Culture in Art." 
In this capacity we understand our position to be like that of double 
agents. Not in the Cold War sense of the term, but rather as a participant 
with dual intentionalities. Here, we are welcomed into a highly specialized 
environment inaccessible to the general public. We are simultaneously 
engaging collaboratively, respectfully and excitedly with the individuals, 
protocols and institutional structures of the site - while at the same time, 
from a different standpoint, gaining outsider insight and observations (and 
3
 Bruno Latour and Steve Woolgar, Laboratory Life: the construction of scientific 
facts, (second edition, enlarged) Princeton: Princeton University Press, 1986. 
P.44. 
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criticisms) that are published in other communities. Often these roles are 
at odds - sometimes easily synchronized, but always co-present.4 
Alternative, non-specialist practicessin the biological sciences contribute to this 
notion of biotechnology as a life science by functioning on a number of levels, 
primarily through propagating alternative models in public discourse and in the 
lab to allow for a wider representation of specialists (or non-specialists). A 
heterogeneous body of practitioners suggests that biotechnology is not 
necessarily understood from the perspective of rationality and scientific method 
or from models established through business and industrialization. 
Biotechnology can also be perceived as an art form — as poetry, as family, as 
cultivating, as rearing, as sexuality, as care of the self and the other. If we make 
ourselves available to alternative, non-specialist practitioners of biotechnology, 
then biotechnology will no longer only be understood as an applied science, but a 
life practice as well. 
This line of argument was resumed in chapter 3 with the investigation of digital 
metaphors used to describe biotechnology in public discourse, which I argue 
serves to virtualize the field in its ethics and representation. I propose that we 
look to the metaphors in the visual and written language put forth by the bioart 
4
 J.Willet & S.Bailey. "BIOTEKNICA: A Case Study in Bioethics and Human Tissue 
Culture in Art." From Louise Poissant and Ernestine Daubner, eds. Critical Issues: 
Art of the Living (Submitted to Washington University Press.) 2006. 
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community to create a more embodied language set or, ideally, a plurality of 
language sets in describing biotechnology. 
In Chapter 4, I present an account of the intricacies — the successes and failures 
— of presenting biological artworks in public forums within the context of my own 
collaborative work BIOTEKNICA with the goal of inviting other non-specialists 
into a temporary art/laboratory environment. It may have been a wiser choice to 
present a chapter recounting a different threshold — my own passage into 
biotechnological specialization. However, because the rest of (RE)embodying 
Biotechnology is already so invested in this narrative, I chose to elucidate the 
deeply entrenched rules, regulations, guidelines, and languages that work 
against interdisciplinary art/science practices. Cornerstone ideologies are 
arguably slow to change, and disciplinary notions of specialization in the hard 
sciences is no exception. Conversely, however difficult it is to accomplish in a 
practical sense, we are working in a time where it is possible to effect this sort of 
change; the canon of disciplinary boundaries is waning, and a return to 'pre 
science'5 models for production and reproduction of biotechnology — of life — is 
becoming possible once again. My intention in this chapter is to provide a 
detailed account of the hurdles and negotiations that are achieved behind the 
scenes of a bioart exhibit, and illustrate the ways in which they are central to and 
necessary for creating the conditions in which the individual non-specialist viewer 
5
 Thomas S. Kuhn, The Structure of Scientific Revolutions (second Edition, 
enlarged) Chicago: The University of Chicago Press, 1970. 
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can interact directly with the orders of life in the biotechnological laboratory. In 
this instance, biotechnology is presented not only as a life science, but as a 
function of cultural life, procedural life, administrative life. It is presented as a 
pragmatic retelling of the bureaucratic 'work' componerrt-of manipulating and 
presenting life in a context outside of the hard sciences — as transformative, 
embodied, political art. 
Through these chapters, I want to argue for a critical participatory approach 
towards understanding biotechnology that is indivisible from life — as a 
technology of the body, a technology of your body. Ironically, I can't help but to 
notice the connections between this reciprocal model of biotechnological 
embodiment and earlier feedback models proposed under the term cybernetics 
— linked to electronics, mathematics, and computation — in defining our 
relationship to biotechnology. 
Norbert Wiener and related thinkers developed the field of cybernetics6 in the 
1940s. It was originally posited as a science associated with electrical 
engineering in the analysis and development of non-linear electronic circuits 
called statistical mechanics. Statistical mechanics is a system that describes and 
predicts the function of an electronic circuit as a self-regulating entity, one that 
performs operations of analysis, synthesis, and automatic self-adjustment. 
6
 Norbert Wiener, Cybernetics: or Control and Communication in the Animal and 
the Machine. Cambridge: The MIT Press, 1965. 
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Essentially, statistical mechanics was established to imagine machines that, on a 
primary level, could self-learn new functions. The key element, developed by 
Wiener, was the insertion of the functional feedback into the electrical circuit. 
With this function, non-linear circuits could not only direct electronic pulses (or 
code, or information) across a string of nodes, but each node possessed the 
ability to produce new impulses or modify original impulses based on the 
particular attributes, functions, and external variables of the individual node. With 
this model, each node is able to monitor the impulses it receives for 
inconsistencies, static, or degradation of the original signal, and self-modulate or 
notify the larger system if systematic equilibrium is disrupted, thus creating a 
contingent and self-regulating circuit. 
This notion of a contingent, self-regulating circuit has been applied to the 
scientific process itself, as charted by Katherine Hayles in her analysis of the 
Macy Conferences,7 with the inclusion of the 'observer' (or the scientist) in a 
cybernetic loop with what is observed. With this ideal for interpreting scientific 
study, the observers are included in the system rather than looking at it from the 
outside.8 In other words, the very presence of the scientist, as well the process 
of observation, changes both the observer and what is observed. This 
observation is useful for articulating reciprocal, embodied notions of 
biotechnology in that it directly implicates all of us in its continued propagation. 
7
 Katherine Hayles. How We Became Post-Human: Virtual Bodies in 
Cybernetics, Literature, and Informatics. Chicago: University of Chicago Press, 
1999. p.99. 
8
 Ibid, p.74 
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However, in order to circumnavigate the problematically sterile, computational, 
and mathematic underpinnings of Wiener's cybernetics, we need to merge the 
language of embodiment with cybernetic models to avoid the dangers of 
virtualizing metaphors in describing this process. 
Katherine Hayles would agree, as she addresses this issue herself: 
The problem with this (Wiener's cybernetic) approach lies not so much in 
the analogical relations that Wiener constructed between living and 
mechanical systems as in his tendency to erase from view the very real 
differences in embodied materiality, differences that analogies did not 
express. Confronted with two situations, he was much more inclined to 
move easily and quickly to an abstract level, where similarities in patterns 
became evident, than to remain attentive to the particularities that made 
each situation unique. No doubt his own lack of involvement in the nitty-
gritty work of the lab was a contributing factoring his elision of embodied 
materiality.9 
The desire to integrate notions of embodiment into the cybernetic model of the 
observer leads me to consider phenomenology in describing our relationship to 
biotechnology, particularly Maurice Merleau-Ponty's writings on vision in The 
Visible and the Invisible. Here, he argues for the viscosity of the human body as 
it permeates itself with the world — and the world with itself — creating a concept 
9
 Ibid. p.99 
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of the flesh of the world. He writes, 'The thickness of the body, far from rivaling 
that of the world, is on the contrary the sole means I have to go unto the heart of 
the things, by making myself a world and by making them flesh."10 He proposes 
that the embodied, tactile thickness of the human body — your body — is the 
inescapable measurant of all the perceived dimensions of the world.11 
Returning to the scientific/cybernetic notion of the observer, Merleau-Ponty 
incorporates embodiment in the observational process as he describes vision as 
a palpitation of the flesh world. He writes, "If we now turn to the seer, we will find 
that this is no analogy or vague comparison and must be taken literally. The 
look, we said, envelops, palpates, espouses the visible things."12 Like the 
cybernetic observer, the embodied, palpitating observer proposed here is 
reciprocally seen (and arguably changed) by what he or she observes: 
Thus since the seer is caught up in what he sees, it is still himself he sees: 
there is a fundamental narcissism of all vision. And thus, for the same 
reason, the vision he exercises, he also undergoes from the things, such 
that, as many painters have said, I feel myself looked at by the things, my 
activity is equally passivity - which is the second and more profound 
sense of the narcissism: not to see in the outside, as the others see it, the 
contour of a body one inhabits, but especially to be seen by the outside, to 
exist within it, to emigrate into it, to be seduced, captivated, alienated by 
10
 M. Merleau-Ponty. The visible and the invisible . Evanston, IL: Northwestern 
University Press, 1968. p. 135. 
" Ibid, p.249 
n
 Ibid. p. 133. 
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the phantom, so that the seer and the visible reciprocate one another and 
we no longer know which sees and which is seen.13 
And yet, there is a distinct difference between the models proposed by Werner 
and Merleau-Ponty and the proposed model of bioart as I have described it to 
you. With (RE)embodying Biotechnology, I am not only asking for the recognition 
of the presence of one's body as inextricable in the observation of other bodies, 
particularly in a complex laboratory ecology, but also to manipulate those bodies 
and reciprocally and effectively manipulate your own body. I am proposing a 
proactive model in order to connect oneself to the processes of life — eating, 
sleeping, reproducing, killing, dying — through the hands-on manipulation of life 
in the lab. The models set forth by Wiener (1965) and Merleau-Ponty (1968) 
predate contemporary incarnations of biotechnology and the post-1980s super-
stellar rise of molecular biology as the most celebrated branch of 
biotechnological research. 
Evelyn Fox Keller charts this shift in the biological sciences in its earliest 
incarnations (from observational models to practice-based models) in her book A 
Feeling for the Organism: The Life and Work of Barbara McClintock: 
Up until the end of the nineteenth century, biology had been primarily an 
observational science; biologists had sought to capture the mysteries of 
13
 Ibid. p. 139. (my emphasis) 
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nature by documentation and description, rather then by a priori 
explanation. The early twentieth century saw the transformation of biology 
into an experimental science. But for many researchers, commitment to 
the integrity ^ of the organism, and a reverence for the opulent variety of 
nature, remained. Not until the advent of Molecular Biology did the final 
break with earlier tradition occur. The long-standing tension between the 
organism as a whole and its constituent physico-chemical parts appeared 
at last to be relieved. Biology could now be seen as a science of 
molecular mechanics, rather than of living organisms, or even of "living 
machines."14 
I am proposing a conceptual and practical integration of observational, holistic, 
and naturalist models with biomechanical experimental models. This integration 
would result in a perspective in which the organism and its constituent parts are 
regarded simultaneously, moving away from reductionist models and towards 
more inclusive, ecological ones. This allows for the application of biological 
models to understand and interpret the human perpetuation of biotechnology. 
The interpretation and practice of biotechnology from this perspective allows for 
two significant shifts in our perception of the biosciences: (1) a renewed regard 
for all the life forms present in the biotechnological ecology is made possible, and 
14
 Evelyn, Fox-Keller. A Feeling for the Organism: The Life and Work of Barbara 
McClintock. New York: Henry Holt and Company, 1983. p. 181. 
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(2) human biotechnologies can be seen as indivisible from life in the natural 
world - and also from our own lives. As Lewontin writes: 
So, we must put away the notion that out there is a constant and fixed 
world that human beings are alone disturbing and destroying. We are 
certainly changing it, as all organisms do, and we certainly have a power 
that other organisms do not have, both to change the world extremely 
rapidly and, by willful activity, to change the world in various ways we may 
think beneficial. Nevertheless, we cannot live without changing the 
environment.15 
From an ecological perspective, we can see biotechnology as bodies 
manipulating bodies, species manipulating other species as well as themselves 
and their environment, in a reciprocal, reflexive, and reactive (though not always 
conscious) manner. Another way to imagine an ecological model for 
biotechnology is through the application of proprioceptive models to the biological 
sciences and, more specifically, in describing our relation to the bodies in 
biotechnology, as well as the extended body16 in the technoscientific sphere. 
Historically, the biological sciences have placed great emphasis on the 
exeroceptive senses (particularly sight) as observation, as if the subject of 
15
 Richard Lewontin. Biology as Ideology: The Doctrine of DNA. Canadian 
Broadcasting Corporation, Massey Lecture Series, 1991. p. 89. 
16
 Oron Catts and lonat Zurr, "The Extended Body" in Artnodes: Intersections 
between Arts Sciences and Technologies, 2006. Available online: URL: 
http://www.uoc.edU/artnodes/6/dt/eng/catts_zurr.pdf [date of last access: 
04/10/2007] 
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biotechnological research is inherently separate and therefore observable to the 
scientist (and, by extension, humanity). However, with the ecological 
understanding of biotechnology that I am proposing, proprioception may serve as 
a more accurate and articulated model for understanding the production of 
knowledge and life in this field. Proprioception is the sensory perception of the 
relative positioning of the body in its environment, comprising of directly linked 
sensorimotor functions that allow the body to move through space. 
The term was coined by C.S. Sherrington in 1906 in his article "On the proprio-
ceptive system, especially in its reflex aspect." He describes a reciprocal and 
reflexive relationship between the internal organism and its external environment: 
"But the organism itself, like the external world surrounding it, is a field of 
ceaseless change where internal energy is continually being liberated, whence 
chemical, thermal, mechanical, and electrical effects appear. It is a microcosm in 
which forces which can act as stimuli are at work, as in the macrocosm 
around."17 Proprioception relies on a deep field of neurological receptors that are 
subject to both internal and external stimuli. 
Therefore, a character of the stimulations occurring in this deep field is 
that the stimuli are traceable to actions of the organism itself, and are so in 
much greater measure than are the stimulations of the surface field of the 
organism. Since in the deep field the stimuli to the receptors are delivered 
by the organism itself, the deep receptors may be termed proprio-ceptors, 
17
 C.S. Sherrington, "On the proprio-ceptive system, especially in its reflex 
aspect." Brain, 1906, 29: p.471. 
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and the deep field a field of proprioception. 
A proprioceptive model, as opposed to an exeroceptive model, allows us to 
conceive of biotechnology as a science ofc^the body and the ecology 
simultaneously — a science of our bodies in interaction with other bodies. In the 
proprioceptive model for imagining biotechnology, I am most drawn to 
Sherrington's view that the internal organism, like the external world, is teeming 
with life and energy, moving towards always shifting equilibriums. This model 
opens up our understanding of our position in the biotechnological era. 
Moving away from a hierarchical understanding of the scientist — the specialist 
— allows us to manipulate life in a way that enables life forms to engage with one 
another in a multitude of ways. In addition, the proprioceptive model allows for 
the concept of prosthesis to enter into the equation. The proprioceptive system 
is able to accommodate the addition of external objects, tools, and instances of 
life into the proprioceptive system of an organism. Not only do the tools of 
biotechnology (the sterile environments, pipettes, beakers) become incorporated 
into the notion of a body moving through time and space, but the billions of 
bacteria housed within that body — and, by extension, the billions of life forms in 
the laboratory — become incorporated as well. 
Ibid, p.472. 
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As I have argued throughout (RE)embodying Biotechnology, the best strategy for 
mobilizing proprioceptive and ecological models in the practice of 
biotechnological protocols is through a critical, participatory methodology, where 
individual non-specialists participate directly in the practice of biotechnology, 
whether by breeding plants, activating yeast, making yogurt, or cultivating 
mammalian cells under sterile conditions. These small incursions are significant 
in both transforming the field and in actualizing a proprioceptive relationship with 
the bodies in biotechnology in a personal and embodied manner. Here, I am 
asking other non-specialists to join me in performing bioethics; I am inviting you 
to manipulate life, embrace life's violent processes, and gain new understanding 
and gratefulness for the small sacrifices, tragedies, and miracles that occur in the 
laboratory every day. 
In regard to this notion of a practice-based bioethics, I can provide an example 
from the bioart community. In April 2007, I was witness to and photographer of 
an avian embryology lab at The Art and Genomics Centre at The University of 
Leiden lead by bioartist Adam Zaretsky.19 As a component of his Vivo Arts 
course, the students, as well as several visiting artists and scholars, were given 
fertile pheasant eggs and instructed to manipulate the embryos for aesthetic 
purposes through a variety of measures. 
19
 see Jeanette Groenendaal and Zoot Derks. 'Dangerous Liaisons" 2007. Video; 
available online: URL: 
http://video.google.com/videoplay?docid=4579567496694967354&q=&hl=en 
[date of last access: 07/01/2008] 
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The lab gives students the tools and skills they need to interact through 
the humanities with their four day incubated and windowed eggs. The 
students are offered microsurgical, teratological and naked plasmid 
injection as developmental embryology tinkering tools. In this lab the 
students are given a chance to make their first transgenic vertebrate, an 
embryonic pheasant.20 
Part scientific lab and part Viennese actionist happening, participants were each 
provided with a fertile and incubated egg (between 4 and 7 days old) and were 
taught how to open up the egg in such a manner so as not to kill the developing 
embryo, allowing them to view its beating heart and articulated limbs. Next, the 
participants were asked to transform the embryonic body through physical 
manipulation with tools, the injection of a contaminate or mutagen, or though 
genetic manipulation. Some refused to participate at all and stood in the hallway 
for the duration of the procedure; others excitedly asked for more eggs so that 
they could attempt a number of manipulations. The range of responses varied 
widely. Once the procedures were completed, the eggs were returned to the 
incubator to allow for continued growth, with the understanding that they would 
have to be put to death before hatching in order to meet the standards of local 
animal research ethics. 
20
 Adam Zaretsky. "Birdland: Avian Developmental Embryology Arts Project", 
abstract for artist talk, The University of Exeter, May 14 2007. available online: 
URL: 
http://www.exeter.ac.uk/research/networks/information/Bioartdescription.shtml 
[date of last access: 07/01/2008] 
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However, the full ramifications of this lab in practical animal ethics would not be 
revealed until one week later, when Zaretsky asked each participant to determine 
the manner in which their embryo was to be killed. Some were killed with an 
excess of Valium, some were pulverized, one was cooked in the autoclave; all 
were considered to be ethical actions by the animal research ethics committee at 
the university. 
The participants grew uneasy with their actions — group mentality and the 
festivities of the day encouraged young artists to commit actions and deaths that 
some later deemed unethical — and remorsefully critiqued and mourned their 
own actions. Robert Zwijnenberg (Director of The Art and Genomics Centre) 
later described the event as truly a hands-on lesson in ethics: holding a life in 
one's hands and determining its fate.21 
In the name of transgenic art, fledgling artists are utilizing lab technique as 
a new medium to produce living and often mutant living art forms. As 
these 'sculptures' live and die, often at the whims of the artistic 
investigator, the personal, non-repeatable moments take on a ritual air. 
What kinds of rituals do interdisciplinary Art and Biology practices entail? 
How do they reveal the implicit rituals of science? What new performative 
rites come out of mixing ethics and esthetics in the laboratory? Scientists 
also have their methodologies of creative flourish and humane sacrifice. 
: |
 Robert Zwijenberg in personal conversation with Jennifer Willet April, 2008. 
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But, scientific and artistic play is often based on different paradigmatic 
reading of what the act of experimentation is. As artists learn laboratory 
technique, the rituals of science and new rituals of sci-art unfold, decouple 
i ? and reconfirm magical thinking in both arenas. How does animal research 
relate to the history of animal sacrifice? What is the role of subjectivity in 
developmental embryology? Is transgenic protocol also a ritual for the 
cultural production of liminal monsters. And how does mutagenesis 
impede or coerce the imaginary in the lifeworld? Through an analysis of 
artists confronted with the responsibility of ending the life of transgenic 
pheasant embryos, (which they had altered with plasmids in the name of 
art,) I hope to show living rituals for new biotechnological processes as 
they are invented.22 
What is to be learned from a critical participatory model for engaging with 
biotechnology? What have I learned as an individual entering the specialized 
site of the laboratory? I have learned that science is not the purely objective, 
truth-seeking methodology that is it is held to be in public discourse. Although it 
is a very good methodology, science is not exponentially more successful in 
describing and manipulating the natural world over all other methodologies in 
regard to the acquisition knowledge in our society. Regardless, the fundamental 
22
 Adam Zaretsky. "Birdland: Avian Developmental Embryology Arts Project", 
abstract for artist talk, The University of Exeter, May 14 2007. available online: 
URL: 
http://www.exeter.ac.uk/research/networks/information/Bioartdescription.shtml 
[date of last access: 07/01/2008] 
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divide between nature and culture that underwrites the modernist scientific 
project is a fiction. 
Bruno Latour writes of this same notion in his canonical text, We have Never 
Been Modern. He argues that the modernist project for imagining nature and 
culture as distinctly separate — the idea that one is capable of separating oneself 
from that which is observed — is not possible, and has never been successfully 
achieved. He writes, "How could we be capable of disenchanting the world, 
when every day our laboratories and our factories populate the world with 
hundreds of hybrids stranger then those the day before?"23 "How could we be 
chilled by the cold breath of the sciences, when the sciences are hot and fragile, 
human and controversial, full of thinking reeds and of subjects who are 
themselves inhabited by things?"24 From my experience, he is correct. The lab 
is a site teeming with multiple orders of life; the scientists are fallible, confused, 
poetic, and inspiring individuals who are just as driven by subjectivity, instinct, 
training, and specialized methodology as the rest of us. And how can I separate 
myself, a radical, political artist working in the laboratory, a non-specialist 
participating with scientists in the reciprocal manipulation of life, from what is 
observed? Arguably, it is through this process of a critical, participatory 
engagement with biotechnology that I have become enchanted with the practices 
of science — in addition to the bodies in biotechnology — as hot and fragile. 
23
 Bruno Latour, We Have Never Been Modern. Catherine Porter Trans, 




Whether it is Oron Catts' model of the 'embedded reporter or more typical 
accusations of the anthropologist 'gone native,' the outcome of several years of 
working in laboratory environments (and all that this experience entails, 
methodologically and practically, in the instrumentalization of life) has given me 
the ability to view biotechnology, in a complex and reciprocal sense, as a life 
practice. This perspective has offered me great insight, great harm, as well as 
potential for new understanding, for fraternity, and for total annihilation. 
Before this time of experience, embodied knowledge, horror, and disillusionment, 
it was easier to critically refute science and, more specifically, biotechnology for 
their barbaric, unethical, and unnatural manipulations of life from the perspective 
of theoretical textual analysis. But this strategy offers no resolution, according to 
Latour: 
Demonizing may be more satisfying for us because we will remain 
exceptional even in evil; we remain cut off from all others and from our 
own past, modern at least for the worst after thinking we were modern for 
the best. But totalization participates, in devious ways, in what it claims to 
abolish. It renders its practitioners powerless in the face of the enemy, 
25
 Oron Catts. "Hands on Emersion" from Visual Culture and Bioscience virtual 
symposium hosted by The National Academy of the Sciences, J.D. Talasek and 
Suzanne Anker edts. available online: URL: 
http://visualcultureandbioscience.blogspot.com/2007/03/catts-hands-on-
immersion-for-oron-catts.html [date of last access: 07/01/2008] 
227 
whom it endows with fantastic properties. ... A past from which we are 
forever separated by radical epistemological breaks cannot be sorted out 
again by anyone at all.26 
I want to illustrate the ways in which my perspective as an artist, an academic, 
and a practitioner of biotechnology allows me to provide answers in regard to an 
ethical evaluation of evolving biotechnologies. As I stated in the introduction to 
(RE)embodying Biotechnology, my goal is not to simplify and provide measurable 
responses to the problems we face in the biotechnological age, but rather to 
complicate the discourse surrounding this field, and allow individuals to come to 
their own conclusions — to do their own 'work.' I am unabashedly maintaining a 
position against the continued corporatization and industrialization of the life 
sciences. My research / creation practice is aimed towards a more 
democratized, embodied, reciprocal, and grateful model for perpetuating 
biotechnology. However, I am aware of the ways in which this position might be 
viewed as untenable or unachievable, in light of the deeply entrenched nature of 
economy as a cornerstone of our society and the undeniable benefits of the 
current market economy model with the successful development of therapeutic 
biotechnologies. 
26
 Bruno Latour, We Have Never Been Modern. Catherine Porter Trans, 
Cambridge, Mass: Harvard University Press, 1993. p. 125. 
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However, this text, as well as my artistic practice, illustrate the possibility (on a 
very small scale) of alternative incursions and practices in the biological 
sciences. It is possible that my assertions may be read as naive or dangerously 
utopic in our current social, political, and economic climate. Although I would 
agree that, in all likelihood, both the direct effect of this thesis and my continued 
bioart production will not result in any immediate or revolutionary change in the 
state of affairs, I do believe in the 'trickle down effect.' The history of art, 
particularly the long-term repercussions of avant-garde art, provides many 
instances in which radical or objectionable forms of artistic production have 
permeated mainstream society and the production of meaning. In the instance of 
bioart, I look to the writings of George Gessert for justification and understanding 
of bioart and my own transgressions in the lab: 
Do artists cross the line when they breed plants or animals, or use the 
tools of biotechnology? Scientists routinely cross the line. So do farmers, 
business people, military men, and doctors. Only artists and certain 
religious people hesitate. Of course one of the great human dilemmas is 
that we do not know the extent of our powers. We invent outrageously 
and casually as we breath, but we have no idea where our inventions will 
take us. Extinction? Slavery? 1000 years in Disneyland? Even if the 
Holocaust had never happened, we would have good reason to worry 
about where knowledge of genetics and DNA will take us. We will need all 
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the awareness we can muster to engage evolution. To the extent that art 
favors awareness, the more artists who cross the line the better.27 
I am not offering any immediate, concrete sototions. Applied resolutions to 
specific and universal ethical problems that are prevalent in the biotech era are 
not the function of art. From my perspective, art is about asking questions — 
aesthetic questions, ethical questions, political questions, questions of meaning. 
How do we choose to value life, whether it is our own lives, the life of a sick child, 
an embryo, a lab rat, a cell line, or bacteria? Where do we draw the line? Art 
occupies a unique position, in which it can perform these questions (and propose 
new critical methodologies) outside of traditional, rational intentionalities and 
produce meaning in a multitude of ways. 
As a result, this text, like my artwork, functions in the realm of dialogical criticism, 
conflating a symphony of polyphonic voices of signs and meanings both in the 
moment of authorship and in their interaction with the observer. Dialogism, as 
argued by Mikhail Bakhtin, provides three methodological components in its 
analysis of a text or utterance, which proves useful for my purposes: (1) in 
locating the object of analysis in its historical and critical context, (2) in observing 
a wide range of traditions in the analysis of a given text and maintaining 
27
 George Gessert, "Notes sur I'art de la selection vegetale" in L'art biotech'., 
Jens Hauser, ed. (Nantes, France : Le Lieu Unique, 2003), p. 47 Catalogue from 
the exhibition L'art biotech' (authors' translation). 
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interdisciplinarity, and (3) in deploying and seeking polyphonic heterogeneity in 
the analysis and content of texts and objects. 
Bakhtin describes the dialogical phenomenon as it applies to characters in a 
polyphonic novel in Problems of Dostoevsky's Poetics: "Dostoevsky, like 
Goethe's Prometheus, creates not voiceless slaves (as does Zeus), but free 
people, capable of standing alongside their creator, capable of not agreeing with 
him and even rebelling against him."28 He continues, "What unfolds in his works 
is not a multitude of characters and fates in a single objective world, illuminated 
by a single authorial consciousness; rather a plurality of consciousnesses, with 
equal rights and each with its own world, combine but are not merged in the unity 
of the event."29 Through dialogue and characterization, the polyphonic novel 
manifests a multi-voiced examination of an idea, arriving at several 
complementary and contradictory conclusions. This description of the extended 
possibilities of performing literature — literature as a site of multiple 
intentionalities interacting with one another — is a helpful tool for reading 
(RE)embodying Biotechnology, for reading BIOTEKNICA, and for interpreting 
bioart as a performed experiment, an experimental methodology where 
outcomes are never assured. 
28
 Mikhail Bakhtin, Problems of Dostoevsky's Poetics. Trans. Caryl Emerson. 
Minneapolis: U of Minneapolis P, 1984. p.6. 
29
 Ibid p.6. 
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Instead of concrete solutions, I want to offer the analysis I have provided in 
proposing bioart as a productive form of interference and, reciprocally, an 
analysis of the interference I experienced as an artist in the laboratory 
manipulating life towards artistic ends. I suggest that we look to Michael 
Foucault's The Order of things. There is a passage in the preface in which he 
describes his reaction to reading Jorge Luis Borges' The Analytical Language of 
John Wilkens, including an unusual taxonomy of animals. He writes: 
This book first arose out of a passage in Borges, out of the laughter that 
shattered, as I read the passage, all the familiar landmarks of my thought 
- our thought, the thought that bears the stamp of our age and our 
geography - breaking up all the ordered surfaces and all the planes with 
witch we are accustomed to tame the wild profusion of existing things, and 
continuing long afterwards to disturb and threaten with collapse our age 
old distinction between the Same and the Other. This passage quotes a 
'certain Chinese encyclopedia' in which it is written that 'animals are 
divided into: (a) belonging to the Emperor, (b) embalmed, (c) tame, (d) 
sucking pigs, (e) sirens, (f) fabulous, (g) stray dogs, (h) included in the 
present classification, (i) frenzied, (j) innumerable, (k) drawn with a very 
fine camelhair brush, (I) et cetera, (m) having just broke the water picture, 
(n) that from a long way off look like flies'. In the wonderment of this 
taxonomy, the thing we apprehend in one great leap, the thing that, by 
means of the fable, is demonstrated as the exotic charm of another 
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system of thought, is the limitation of our own, the stark impossibility of 
thinking that.30 
I remember laughing the first time I read this passage. However, years later, 
after having traversed the threshold of the biological sciences as an artist and 
non-specialist, my reaction is much different. 
I am not sure if I admire Foucault's ability to laugh with the realization of the 
complete social constructedness of established orders and the collapse of our 
age old distinction between the Same and the Other — or if I believe that 
laughter is a possible response to a complete denaturing of the philosophical and 
ideological precepts around which one chooses to construct their existence. 
From my experience, it is entirely crushing, particularly when this knowledge 
comes about through an embodied and participatory involvement with a radically 
different order of things. Barbara Herrnstein Smith aptly describes this 
uncoupling, when our perceived relations with other species is disrupted: 
The impulses in question are deeply corporeal and, accordingly, when 
disturbed by sudden or dramatic domain crossings ... likely to elicit that 
complex - jointly psychic and bodily - set of responses we call cognitive 
dissonance: that is, the sense of serious disorder or wrongness - and, 
with it, sensations of alarm, vertigo, or revulsion - that we experience 
30Foucault, Michel. The Order of Things: An archaeology of the Human 
Sciences. Trans. Unknown. New York: Vintage Books, 1994. p. xvi 
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when deeply ingrained cognitive norms are unexpectedly violated. 
I was reminded of Foucault's prologue again recently as I was reading a scientific 
paperf "Magnetic Resonance Microscopy of the Adult Zebrafish."32 The first 
sentence of the article reads: "Magnetic resonance microscopy (MRM) is an 
imaging modality that allows for noninvasive acquisition of high-resolution images 
in intact opaque animals."33 "Intact opaque animals" is a category of animal that I 
had never conceived of before — a category so far outside of my experience 
(before setting foot in a laboratory and working with such animals) that it still 
upsets my attention today. This term serves as an indicator, a reminder of the 
horror34 of attaining real, embodied knowledge and participation in another, 
radical universe where the instrumentalization of life is so normalized that one 
forgets that life is a violent process. This term is also a reminder of the horror 
that I myself have experienced over the years through ever further induction into 
the biotechnological field. 
This unnerving collapse of taxonomy, knowledge, and experience is also 
described in the writings of Kira O'Reilly, a performance artist from the United 
Kingdom, who also was initiated into laboratory practices at SymbioticA in 2004. 
31
 Barbara Hermstein Smith, "Animal Relatives, Difficult Relations," in 
Differences: A Journal of Feminist Cultural Studies Vol.15, No1, 2004. pp 2-3. 
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She wrote a performative lecture entitled "Marsyas - running out of skin," that 
was presented at the Biennial Electronic Arts Perth (2004). "Marsyas" is a 
provocative work of art and academic research. Through cruel language, inner 
voices, and cold analytical turns, she elucidates the turmoil she experienced 
working with living systems in the name of art. In this text, O'Reilly argues for 
ambiguity in understanding and performing embodied art practices. She publicly 
presents the power and importance, as well as the harm and humility, in 
instrumentalizing living systems. While practicing the harvest of primary cells, 
O'Reilly witnesses the institutional sacrifice of a pig for another experiment at the 
university. After the scientists have harvested from the pig, she begins her 
exploration of the animal's body. She writes, "When my clumsy blade 
accidentally tears her gut I see pigs breakfast spill. In my minds eye I see my 
breakfast spill. Following the pig biopsy I feel deeply ashamed. You stupid, 
stupid cow."35 This work becomes about the disillusionment of the non-specialist 
— about induction. The artist is horrified with herself. The audience is horrified 
with the frank retelling of animal sacrifice procedures enacted in scientific 
laboratories every day. O'Reilly serves as a stand-in, as our stunt double, 
allowing us to witness those aspects of scientific research that are often closed to 
the public gaze. I am drawn to this body of writing, as it eloquently and 
accurately expresses the sensations that I experienced as a non-specialist 
practicing a variety of laboratory procedures involving the manipulation of life; her 
work is a description of both standing witness and participating in a fascinating 
35
 O'Reilly, Kira. "Marsyas - running out of skin" presented at the Bio Difference 
conference, *Biennial of Electronic Arts Perth*, Sept. 11, 2004, p.7. 
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an horrific set of practices that we call the life sciences. 
The denaturing process that Foucault describes in recognizing other taxonomies 
of the world is helpful in explaining my experience of gaining a new 
understanding of the sliding scale of life in the laboratory (and, by extension, in 
external ecologies). Foucault's description is also useful in terms of 
understanding the direct affront that bioart poses to contemporary definitions of 
art. The "slow, crushing dance"36 that O'Reilly describes (and performs) in 
relation to the pig can also be applied in relation to the shift in art practices, 
intentionalities, and outcomes that is necessary when an artist chooses to 
manipulate life in the parallel universe of the lab. With induction comes the 
transformation of, or interference37 with, all the fundamental rules, precepts, and 
understandings of art production. 
This transformation occurs on a number of levels. The accepted norms, 
methodologies, benefits of specialization, strategies of display, and deep 
investment in representation are all turned on their side. This shift is a 
catastrophic taxonomical event for someone who has invested a decade of their 
life in firmly securing these notions of art at their conceptual centre. When an 
artist moves from the studio in to the lab, the fundamental rules of practice 
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such as histories of performance, nudity, and self-experimentation, become 
impeded, if not prohibited, for reasons of health and safety, and respectful 
practices (such as respect for the dead and respect for other scientific research 
trajectories occurring in the sameiafr). Methodologically, the artist must adjust to 
a concrete, experimental, practical mode of production that has less room for 
play, accidents, spilling, and seepage. In terms of specialization, the artist is also 
forced to relinquish their specialized skill set in an environment where their skills 
have little currency, again learning the most basic of concepts and procedures. 
Normal strategies of display and presentation of artwork are also useless when 
most of the research that is undertaken in the lab cannot be removed from the 
specialized, sterile, and regulated environment. In instances where removal is 
possible, bioart often also necessitates the transfer of the laboratory 
infrastructure, the technoscientific body,38 and the fragile artwork into the gallery 
setting. What I have found to be the most overwhelming experience, however, is 
the total annihilation of notions of representation when practicing in a field where 
practices and outcomes reside firmly in the realm of the real — in life. 
In response to the denaturing of our conceptions of life, bodies, the relationships 
between bodies, biotechnology, and art, and in the spirit of enabling a critical 
participatory methodology for performing bioethics in the biotech era, I wish to 
end with a quote from a short essay by Barbara Herrnstein Smith: 
38
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Such questions cannot be answered simply or finally and, in a sense, 
cannot be answered at all. Rather, they restate the fundamental 
difficulties involved in any attempt to determine in a formally principled or 
univocal way - whether scientific or philosophical, naturalistic or 
humanistic - our relations to other creatures. This is not in my view, a 
despairing observation. On the contrary, what it indicates in the 
necessary openness of these questions to ongoing address. When all the 
arithmetic is a priori and the conclusions all forgone, there is no intellectual 
or ethical activity at all, just the animation (so to speak) of a set of 
mechanical (so to speak) procedures. In operating without fixed or formal 
principles, one is confronted, of course, with the need for continuous 
attention and responsiveness: for investigating and registering, 
remembering and imagining, comparing and assessing, and deciding 
under conditions of essential uncertainty and, in a sense incoherence. 
These requirements, however, could seem to constitute the very activity of 
responsible reflection, to define the very conditions of what we - some of 
us, anyway - call ethical judgment and action.39 
(RE)embodying Biotechnology charts an example of the continuous attention and 
responsiveness that Hermstein Smith calls for in perpetuating our relations with 
other species on this planet. As I have stated repeatedly throughout this text, I 
am not suggesting that we cease animal research, eating flesh, or domesticating 
39
 Barbara Herrnstein Smith, "Animal Relatives, Difficult Relations," in 
Differences: A Journal of Feminist Cultural Studies Vol.15, No1, 2004. P. 14. 
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and breeding life forms. I am, however, suggesting that we recognize our own 
inherent hypocrisies, particularly the ones that are initially difficult to perceive. I 
suggest we choose to look our meat in the eye - and see ourselves, and 
recognize that we are manipulating, farming, and consuming ourselves when we 
manipulate, and farm, and consume life. 
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BIOTEKNICA \ ORGANIC TISSUE PROTOTYPES \ LABORATORY NOTES 
Jennifer Willet, Unpublished Manuscript, 2004. 
Jan 09/06 
Have been in Australia for three days. 
Stressed about working on the BIOTEKNICA ethics paper for MIT. But 
simultaneously having a hard time mustering enough angst (after so much 
relaxation in Thailand) to accomplish this. 
BIOTEKNICA Ethics Paper 
- Exploring Bioethics from an artistic standpoint. 
I.e. 
Who owns the body? 
digital metaphors / "genohype" 
- We have written about these aspects of our project extensively, and we will 
continue to do so. 
However, in a complex / reciprocal (mobius-strip) based body of research -
rooted in plurality - and phenomenology - and engaging in the very technologies 
it is interested in understanding/critiquing. BIOTEKNICA too is subject to ethical 
evaluation. Often on the part of our viewers, i.e. animal research ethics - and 
misconceptions "cloning". On the part of ourselves, but also on the part of 
academic institutions and research committees. 
Now usually this aspect of an artwork is never discussed in the public sphere. 
How was it made - in terms of who were the participating funding bodies, 
institutional partners, committee chairs. But with a work like BIOTEKNICA 
focused at the very nexus of the technoscoientific complex. This aspect (the 
administrative hurtles and business practices) involved in making this work 
becomes a significant aspect of the artwork itself. And so today - we are not 
going to focus on the ethical rationalization of the biotech industry - but the 
process of ethical rationalization for bioart production through a case study of our 
project: BIOTEKNICA: Organic Tissue Prototypes. 
LAB NOTES: 
First day back at SymbioticA. We returned to the UWA campus - via the salt-
water river - looking for dolphins. It was a beautiful day. So many familiar faces. 
Boo, Jane Coakley, Gary Crass, Oron Catts, lonat Zurr, Guy Ben-Ary. New 
faces Paul Vanouse and an Italian scientist who's name I forgot (Antonio?) 
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The office still has the feel of a club house/tree house. Up on the third story. 
The floor is hollow - so the sound resonates as you walk across the wood. With 
it's sloped ceilings and cranky door/floors. Pets - dolls and assemblages. A 
Barbie in a glass container of mould. 
"Expect the unacceptable" written on the white board. 
I am not sure if I am reading too much into it. But I saw a 'real' researcher in the 
hallway shoot us a disapproving glance - walking by with lonat. 
Lastly: looking around corners for Kira. Kira O'reilly was an artist in residence 
during our first residency. She became a central character in my experience at 
SymbioticA, and although I know consciously that she is a resident of the United 
Kingdom, subconsciously I expect to hear her voice here at any moment. 
Jan. 10/2006 
Walking tour with lonat. 
Check out Opti Cell. 
Cell culture system 
www.opticell.com 
We are encouraged to freeze a sample of all the cells we are working with at an 
early generation. It is described to be as the equivalent of backing up your hard 
drive. 
We meet: 
Dr. Steve Parkinson 
in charge of the tissue culture labs. 




Health and safety 
Check P19 Protocols. 




ATCC The Global Bioresource Centre 
http://www.atcc.org 
ATCC Number: CRL-1825 
Price: $203.00 
Designations: P19 
Depositors: MW McBumey 
Biosafety Level: 1 
Shipped: Frozen 
Medium and Serium: See Propagation 
Growth Properties: adherent 
Organism: Mus muusculus (mouse) 
Morphology: epithelial 
Source: Organ: embryo 
Disease: teratocarcinoma; embryonal carcinoma 
Applications: transfection host 
Cytogenetic Analysis: n=40; XY 
Strain: C3H/He 
Genter: Male 
Comments: The P19 line was derived from an embryonal carcinoma induced in 
a C3H/He mouse. The line can be cloned at high efficiency in medium 
containing 0.1 mM 2-mercaptoethanol. The cells are pluripotential. The cell can 
be induced to differentiate into neural and glial like cells in the presence of 500 
nM retinoic acid. In the presence of 0.5% to 1.0% dimethylsulfoxide (DMSO) the 
cells differentiate to form cardiac and skeletal muscle-like elements, but do not 
form neural or glial like cells. In the presence of both DMSO and retinoic acid, 
the cells differentiate as in the presence of retinoic acid alone. 
Propagation: ATCC Complete Growth Medium: Alpha minimum essential 
medium with ribonucleosides and deoxyribonucleosides, 90%; bovine calf serum, 
7.5%; fetal bovine serum, 2.5% Temperature: 37.0C 
Subculturing: 
Protocol: Do not allow the cells to become confluent. Remove and discard 
culture medium. Briefly rinse the cell layer with 0.25% (w/v) Trypsin- 0.53 mM 
EDTA solution to remove all traces of serum which contains trypsin inhibitor. 
Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an 
inverted microscope until cell layer is dispersed (usually within 5 to 15 
minutes). Note: To avoid clumping do not agitate the cells by hitting or shaking 
the flask while waiting for the cells to detach. Cells that are difficult to detach may 
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be placed at 37°C to facilitate dispersal. Add 6.0 to 8.0 ml of complete growth 
medium and aspirate cells by gently pipetting. Add appropriate aliquots of the 
cell suspension to new culture vessels. Incubate cultures at 37°C. 
Subcultivation ratio: A subcultivation ratio of 1:10 every 2 to 3 days is 
recommended 
Medium renewal: Add fresh medium at least every 48 hours 
Preservation: Freeze medium: Complete growth medium, 95%; DMSO, 5% 
Storage temperature: liquid nitrogen vapor phase 
Related Products: recommended serum: ATCC 30-2020 
recommended serum: ATCC 30-2030 
However, the last time we were here we used another brand of medium (rather 
then ATCC). So I ordered this one instead: 
JRCCatNo51451-500M 
Minimum Essential Medium, Alpha Modification 




Yesterday was our first day in the labs. 
Unlike last time. Day 1, Oron had us trypsinizing cells. Scarring the shit out of 
us. I remember that I pretended that I understood all he was talking about. He 
was playing a number on us. 
This time was less auspicious. We were still lunching with the French at Matilda 
Bay when lonat slipped off to the labs. We caught up with her half an hour later. 
Inventory. SymbioticA does not have any active projects growing at the moment. 
But that is about to change. So we need to make an inventory - and order the 
necessary supplies for ourselves / for the first tissue culture workshop - on next 
Monday and Tuesday / and Chandra, and Boo also just commencing some TC 
lab work. 
lonat calls out: "you passed the test" when I enter the lab. Washing my hands 
immediately upon entering the P2 Certified Laboratory. 
Rummaging through the cupboards and fridge. 
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lonat sits on the floor pulling confused piles of supplies out of the SymbioticA 
cupboard. With her crazy hair - and bright yellow print shirt. She sits cross-
legged with piles of keeps and rejects. Sterile containers. Dissection Kits. All 
over the floor. Miss matched to the austere environment. At the same time a 
"real" in his T-shirt and T-VAS stands nearby tossing old samples into biohazard 
waste containers with great bravado. Like basketball shots - crash / clang / 
bang. Glass vials break. Not the careful laboratory procedure we are advised to 
follow. 
We empty the fridge and cupboard of expired liquids, un-sterile utensils and non-
sterile water. Shawn carefully washes the jugs. We find some of the P19 
medium in the fridge with BIOTEKNICA written on it from our last stay a year and 
a half ago. Cheers! 
Then we meet Steve Parkinson head manager of the 2nd floor tissue culture 
facilities and the same man who lent us his defunct incubator during our last 
residency. He cringed with the notification that two more artists would be 
working in his labs. Insisted that we take health and Safety protocols very 
seriously. 
Upstairs we rooted in the cryogenics fridges. Looking for SymbioticA samples. -
80 C 
We met Greg - in charge of autoclaving. Got balled out by the computer 
technician. 
Evening spent at SIGGRAPH. Lecture by Pill Dench. 3D Scanner. Possible 
BIOTEKNICA opportunity. However, we arrived to find that his mandate was 
pretty corporate (Hollywood movies) and his scanners were actually not that 
great. Ten-year-old technology. I fell asleep, (only for a short while) But we did 
meet Mark Walters. Doctor/Pediatrician who works in plastic surgery to 
reconstruct child cranial deformities. Very Nice Man. He is scanning for Stelark. 
Possibly for us now too. 
Will visit his lab in the next few weeks. 
Missing Bouts terribly. 
Jan. 20/06 
Friday meeting. Preparation for Sydney conference. Lead by Stuart Bunt. 
RISK / Failure / Legitimacy 
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BIOTEKNICA: Soft Experiments from the Laboratory 
Really focused on the fields of art and science. 
Are artists are doing good science? Are scientists are making good art? 
Agreed: pressure on researchers to produce results. Publish. 
Journals - Nature / Science 
Charging Laboratories for publishing. In Nature: photos are more. 
Overall a very didactic discussion. 
"Is bioart helping the field or regressing the field" 
Jan. 21/05 
Nearing the end of the month already. 
This Friday meeting was a discussion lead by Stuart Bunt on 
Risk/Failure/Legitimacy in the art/science environment. It went completely off 
topic. Towards scientists falsifying results. Stuart made a very sexist comment -
which I tried to draw his attention to and everyone ignored. There is an air of 
sexism in the school (in Australia in general) and it is difficult 'feeling like a 
woman' because that is usually not the case for me. I only feel like a woman 
when someone treats me this way. It will have to be a project. 
Otherwise, still not in the lab yet. The workshop begins tomorrow. We are quite 
privileged. 
This weekend has been spent catching up on the website, MIT paper, brochure 
text. Working days / Relaxing nights. 
Last night was quite lovely. We roasted a whole chicken with rosemary and 
twelve dollar stuffing with cranberries and walnuts in it. We got drunk on good 
Australian wine (five judges chardonnay) and danced to Latin music. 
Jan. 23 and 24/06 
Tissue Engineering Workshop for Artists 
(by: Oron Catts, lonat Zurr & Dr.Stuart Hodgetts) 
This is a very exciting opportunity for us. As an extension of the SymbioticA 
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Workshops developed by Oron and Gary Cass - they are now developing a 
specialized two-day workshop in Tissue Engineering for artists (and presumably 
for other cultural workers and non-specialists). I am really interested in this 
series of events as it ties into my arguments supporting non-specialist hands on 
experiential knowledge of biotechnology. This week we are doing a dry run of 
the workshop - to test the curriculum - and make any suggestions/changes for 
future eventsv 
What follows is a transcription of the notes I took during these two days and any 
comments and suggestions I might have in hindsight for the organizers: 
Practical Tissue Culture (TC) / Tissue Engineering (TE) course. 
Safety in the labs. 
Types of contamination: Bacterial / Fungus / Viruses / Spores / Yeast / Micro 
Plasma 
(why is contamination bad? How come all contaminated specimens need to be 
disposed of? Some artists might be interested in contamination? In fact - if I 
were to develop another project with TC in the future - I might intentionally 
contaminate my samples In my own private incubator of course!) 
HEPA Filters - looked at a number of filters. 





Author: Nanci Donacki 
Source: Contributed by Nanci Donacki 
Abstract: Aseptic techniques used by Cell Culture specialists in handling 
products from and/or mammalian cells. 
Date Added: Tue May 14 2002 
Date Modified: Wed Apr 28 2004 
Purpose 
To describe aseptic techniques used by Cell Culture specialists in handling 
products from and/or mammalian cells. 
Safety 
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Protect eyes, mucous membranes, open cuts and wounds from contact with 
biohazard material. Use gloves, goggles, mask, and protective clothing as 
necessary. 
Equipment 




Disinfectant, or quaternary ammonium. 
Alcohol. 70% ethanol. 
Pipets, sterile, of appropriate size. 
Aid-Aid, or equivalent. 
Biohazard waste container. 
Procedure 
Carry out all culturing operation is a laminar flow hood. 
Disinfect all surfaces prior to use with a disinfectant solution. 
Swab down the working surface liberally with 70% ethanol. 
Periodically spread a solution of 70% ethanol over the exterior of gloves to 
minimize contamination. Replace them if torn. 
In case of any spill, spread a solution of 70% alcohol and swab immediately with 
non-linting wipes. 
Discard gloves after use and do not wear them when entering any other lab area. 
Bring into the work area only those items needed for a particular procedure. 
Leave a wide clear space in the center of the hood (not just the front edge) to 
work on. Do not clutter the area to prevent blockage of proper air flow and to 
minimize turbulence. 
Swab with 70% alcohol all glassware (medium bottles, beakers, etc.) before 
placing them inside the hood. 
Arrange the work area to have easy access to all of it without having to reach 
over one item to get at another (especially over an open bottle or flask). 
Use sterile wrapped pipets and discard them after use into a biohazard waste 
container. 
Check that the wrapping of the sterile pipette is not broken or damaged. 
Inspect the vessels to be used: 
T-flask - Must be free from visible contamination or breakage, or lack container 
identification. The plastic covering the flask must be intact. 
Bottles - Check for cracks, expiration dates. 
Spinner flasks - Check for cracks, expiration dates, and proper assembly. 
Discard any biohazard or contaminated material immediately. 
Never perform mouth pipetting. Pipettor must be used. 
When handling sterile containers with caps or lids, place the cap on its side if it 
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must be laid on the work surface. 
Make sure not to touch the tip of the pipette to the rim of any flask or sterile 
bottle. 
Clean the work area when finished by wiping with 70% alcohol. 
Oron started with a social/political/cultural analysis of tissue culture called: 
Tissues, Cultures, Engineering. 
1/ Life as raw material? 
HG Wells 1895 - Life as plastic material. 
Life as a resource. 
Growing gap between cultural understanding of life and scientific understanding 
of life. 
A brief history of TC: 
1913 Alexis Carrell begins a cell line, taken from the heart of a chick embryo, 
which is propagated by Albert H. Ebeling for 34 years 
1885 Wilhelm Roux shows that embryonic chick cells can be maintained alive in 
a saline solution outside the animal body. 
1907 Ross Granville Harrison cultivates amphibian spinal cord in a lymph clot, 
thereby demonstrating that axons are produced as extensions of single nerve 
cells. 
1951-52 George Otto Grey and colleagues establish a continuous line of cells 
derived from a human cervical carcinoma, which later become the well-known 
HeLa cell line. 
Immortalization techniques? Cell lines. 
"The Culture of Organs" by Carrel and Lindenburg 
"Babies in Bottles" Susan Merrill Squier - she postulates a collapse of gender, 
race, species, and time when tissue culturing cells of a variety of sources. 
"The Science of Life: a summery of contemporary knowledge about life and it's 
possibilities." HG Wells. 
Previously tissue culture is a science in and of itself. 
In the 1950's TC serves as a model for the body. 
and burgeoning mover towards "Regenerative Medicine" 
and now we are utilizing TC for non-medical ends. 
Vladimir Mironov. 
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Medical University of South Carolina. 
"organ printing" Rapid prototyping directly with cells. 
Computer aided tissue engineering onto thermo gels and collagen. 
Tissue Culture in Art. 
Paul Perry "The long Voyage" 
Christine Barland "Hela" 
Self-critical of the role of artists in TC and TE. 
Oron says " We believe there is a need for phenomenological experience with 
biology." 
and he tells us a beautiful story about one of his workshop experiences. 
Verena Kaminiarz: As part of their Bioart artist workshop they ask artists to bring 
in a primary cell line source. The plan is to take a dissection from each sample 
and utilize it in the tissue culture component of the workshop. Most people bring 
in a steak. Verena brought a living worm. They discussed as a group what to do 
with the worm. Some said to kill it and take the sample - no questions. Some 
suggested they cut the worm in half - and utilize on half for the experiment - and 
set the other half free. Some suggested they set the worm free. When a 
decision had been reached - they would split the worm in half - Verena brought 
out the worm - and almost on quew - one end of the worm stood up - as if 
acknowledging the crowd. The decision was changed. No one had the heart to 
cut this worm in half - utilizing a portion for an experiment. 
In other words - biology is different in person. 
He also tells us about a company called "New Harvest" who are actually 
interested in tissue engineering protein based food products. They contacted 
Oron and lonat looking for information about their "Victimless Steak". 
Then we move into a more technical description of Tissue Culture and Tissue 
Engineering - and the procedure we will be trying today. I know most of what we 
are talking about - but it is an excellent refresher at the beginning of our second 
residency. In Fact, knowing this was coming up - we held off cell work until today 
- comfortable - like an old friend. 
Three new bits of information: 
Suspension cells. 
Trypsin - is an enzyme found in cow guts. 
Primary Cell Line: Hay Flick Limit - 50 - 55 passages before cells stop dividing. 
Afternoon: Tissue Culture demonstration in the lab! 
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We are using a human cell line Hackett. Some sort of connective tissue. I ask 
Stewart Hodgets about the cell line origin - and he doesn't know what I mean. 
From the freezer? From ATCC? But I mean - what type of tissue specifically -
from whom? Under what circumstances? when? He doesn't know - and looks a 
little puzzled that I am asking. 
Feb. 03/06 
Afternoon: at the large animal facility on UWA Campus. The building is typical 
in it's construction. The main entrance (though hidden off to one side) states 
"Large Animal Facility" for public view. 
The entrance is security locked. We need to be buzzed in. The internal lobby 
looks harmless enough. Contemporary design. Rubber floors. Licenses 
displayed in the front office window. And rows of color-coded garments and 
towels in stacked cubby wholes. The facility maintains a high level of sterility and 
any who wish to pass through the barrier must change all their clothes into the 
appropriately color coded garments. We are not invited past the barrier, and 
therefore do not need to change. 
Busy, colorfully costumed, workers pass up and down the hallways. They look 
tired. 
We congregate in a small lunch/seminar room. 
One half of the class stays here for more discussion - while the other half is 
introduced to some introductory animal handling techniques. We stay for the 
seminar. 
We are introduced to a dowdy British woman who's name I did not catch. She 
specializes in veterinary medicine for research environments; She has never 
worked with companion animals. 
She plans to discuss with us two things; (1) recognition of pain and distress in 
animals, and (2) "Care and use of animals in Scientific Procedures". But mainly 
she refers to the manual, which she asks us all to read, to better understand the 
regulations involved. 
Australian code of practice for the care and use of animals for scientific purposes 7tti edition 2004 
After her introduction, she asked that we play a role-playing game - to better 
understand the concerns of the Animal Ethics Committee (AEC). We were asked 
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to chose to be one of the four type of representatives that is mandated to sit on 
such a committee; (1) Veterinary Medicine practitioners, (2) Scientific Advisors, 
(3) Animal Rights Groups, and (4) lay people. We are asked to select a position 
that is farthest from our usual stance. Everyone jokes that we are all scientists. 
Shawn and I choose Veterinarians. Visitors from another animal facility on 
campus decide to be the scientists, and all the scientists divide themselves 
between lay people, and animal rights activists. 
We are provided with a scenario where we are under pressure from the president 
of the university to pass an application, for research that has already 
commenced, and is about to be presented at a press conference in one hour. 
We read the application. It is poorly, and inaccurately filled out. The researchers 
are developing a new rabbit poison, and wants to test dosages in a natural 
environment. He prefers not to use laboratory grade animals, as his final subject 
is wild rabbits. He wishes to lace a grain with the poison in different dosages, 
and leave it out in the wild. He proposes that a scientist/observer will hide in the 
trees, and observe the prey as they consume the feed. Once the specimens are 
clearly about to die (and the researcher can account for the consumed a fatal 
dose) he/she will sacrifice the rodent with a sniper rifle, preventing any further 
suffering. The carcasses will be buried in the local environment. 
Clearly, this was the most insane Animal Ethics Committee application we could 
possibly imagine. It hardly produced a healthy debate on the subtleties of the 
cost verses benefit ratio in the ethical evaluation of proposed projects. 
Immediately we made a list of reasons why this may be a dangerous and 
unethical research methodology. The scientists joked about having to pretend to 
be "bleeding heart animal rights activists" - and argued aggressively about the 
mistreatment of the research specimens involved. All in all we agreed that we 
would not pass this application. We were assured by the lecturer that we made 
the right decision, and that in real committee situations, there is never pressure 
from upper admin to quickly approve applications. This was a case study in what 
not to do. 
However, at no point did anyone in the room question the larger research goals 
of the proposed project. Why do we want to develop rabbit poison? Are there 
more ethical alternatives. I asked if this might be part of the ethical review 
process. The vet said of course. I asked if there was a rabbit problem in 
Western Australia. They all agreed there was, and it was hurting the farming 
community financially. I asked if economic return was considered a valuable 
attribute in evaluating the ethical status of a particular application. I was told that 
economy, did not contribute to the ethic of a project, but certainly factored into 
the cost/benefit ratio that committees consider. 
We had a coffee break - some cookies, and then it was our turn to gain 
introduction to the animals. Rabbits, Mice, and Rats. Awfully small animals for a 
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large animal facility. 
We enter one of the primary viewing laboratories, and are asked to leave our 
belongings outside in a set of cubicles. It is beautiful green on green design. 
Reminds me of institutional Eastern European design. Three stations are set up 
for the newbies. One table with cloaks and gloves and informational documents. 
One with trays of mice cages, and one with rat trays. We are asked to dawn 
white cloaks, and latex gloves. 
Shawn and I are paired off with two women who manage another animal facility 
on campus. We begin with the rats. The rat handler is a nice young attractive 
man, who immediately tells us he prefers to work with rats as they don't bite as 
much. He immediately begins telling us all about the breed of rats, bread right on 
UWA campus. He lifts one out of a cage by its tail. It squirms. He says to hold 
onto it a third away from the rump, firmly but carefully, as sometimes the tail can 
be ripped off. He states that this can be a very upsetting experience for both the 
rat, and the handler. The rat is placed on his hand, with tail still in grasp. It 
immediately urinates all over his sleeve. Yellow spilling into white cotton. He 
allows the rat to hide its head in the crook of his arm. 
We are taught how to sex the animals. The male's genitals are farther from the 
anus then the females. Two rats are presented to us ass up. Then we are 
introduced to the mother with newborn pups. We are each given a small pup to 
hold. They are translucent, purple and pink skin, with organs, and stomach full of 
milk visible through the shin. The small rat pup splays still in my gloved hands, 
breathing, and heart visibly pumping. Vibrating. Trying to stay still with still 
closed eyes. I am holding life in my hands. Instrumentalized life in the 
biosciences takes on a new more concrete understanding in this moment. I am 
silent; I can't hear anything in the room for a few pregnant moments. I deliver the 
rat back to it's mother quickly, so as not to be bitten - and we are told never to 
handle pups without gloves on as the mother will immediately kill the pup if she 
smells our sent on the animal. 
Next we are greeted by an enthusiastic ausi bloke in charge of rabbit handling. 
He is a very generous man, and clearly enjoys his job, and cares deeply for his 
animals. We are taken into another lab where two stacked rabbit cages present 
themselves beside a handling table covered in green cloth. In the cages are two 
of the most magnificent rabbits I have ever seen in my life. Big, healthy, with 
thick soft fir, and deep red eyes. Albinos. 
This station is most difficult for me, as I had rabbits for pets as a child, 
(companion verses research animals) On the table are a series of syringes, a 
plastic rabbit restraint box and some other implements. The blood drains from 
my face. I am terrified we are going to have to do injections on the rabbits. I feel 
a little dizzy, and begin counting in my head, (a little game my sister taught me 
for when she thinks she might cry but would prefer not to....1.2.3.4.5.4.3.2.1.) 
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I am trying to keep my cool while he describes the breed of rabbit. He takes us 
over to the cages to show us how to hold them, and get them in and out of the 
cage. I don't get close enough - and I think my eyes are getting red. He stops 
talking and asks me if i am okay. Busted. Double agent spy cloak detected. I 
am trying to act as if I truly belong here, and he sees my discomfort. He tells me 
to "come oh over, they won't bite." Shawn makes a joke about my childhood 
pets. Everyone laughs an uncomfortable laugh. He asks about what type of 
animals I will be working with - Rabbits? I explain that we are using tissue 
culture in our work and that I am just here for training purposes. 
We continue with the demo. Taking the rabbits out of the cages. Placing them in 
the box with ears exposed for blood letting (they call it bleeding.) I am still 
terrified he will cut or inject one of the animals, and I convince myself that I will 
faint for sure if this occurs. He tells us about how to kill the rabbits when the 
work is done, and assures us that when the time comes he will help anyone who 
is unsure about the process. He is concerned that we will not do it correctly and 
cause the animal undue suffering. He says that it is the most difficult part of his 
job, but it is important that it is done properly. I like this man very much - he 
understands the two-sided coin. 
I am taught how to pick us the animal by the scruff of the neck - tucking its head 
in the crook of my arm. It is so soft and beautiful. And anxious. He warns that 
these animals are new, and assigned for PAWS training - so they are a little 
skittish this time, but will relax with experience. His voice trails off in describing 
what happened to the last demo rabbits that got a little too old and unruly for 
training purposes. 
He asks me to come to him for extra help if my research ever leans towards the 
use of rabbits. I assure him it won't - but that I would be sure to contact him 
before ever handling a rabbit in a laboratory context. 
We leave the room after 15 min. My head is spinning. I need a drink. 
Last is the Mice. The mouse handler came in to watch the rabbit demo. She is 
eyeing me pretty close. I can tell she is prepared to catch me if I "go down." I 
think this happens some times with new graduate students taking the course in 
preparation for their first animal experiments. 
She is also lovely. In fact they all seem to care deeply for the animals. Very 
reassuring. But strange. How everyone focuses on not causing the animals 
harm, when really their fates usually involve vivisection, injection with all sorts of 
drugs and virus. It seems to be a given that these animals will suffer research 
and disease, but not mishandling. 
The mice demo is very similar to the rat demo. We are taught how to sex the 
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animals. We each hold a baby specimen. Their vulnerability is astonishing. 
Where this differs is in how to hold the animal for injection. The mouse is 
grasped on the back of the neck, pulled tight with head forward, and tail between 
your fingers exposing it's flat belly. The handler shows us three injection sites, in 
actuality performing two in the torso - but leaving tail injections to our 
imagination. 
Before we finish, the handler reminds us that they are here to help us. That we 
can ask all the stupid questions we want, and they will help us with animal 
procedures as much as we like so as not to cause undue harm. I guess in the 
past there was more of a rift between the researchers and animal staff - but they 
are trying to mend that. 
We reach the end of our day. Thank the handlers. And walk back to SymbioticA 
in the hot afternoon sun where the Friday meeting is taking place. Shawn and I 
contribute little to the discussion. Drinking three glasses of wine each, 
contemplating quietly. 
Friday Feb. 10, 2006 
Marie Pier Boucher - a researcher completing her masters degree at University 
of Montreal arrived yesterday. We were not in the city to greet her, but we did 
today. She will be living with us for the first three months of her residency. She 
is enrolled in the communications program where she works with Thierry Bardini 
and Brian Massumi. Her thesis focuses on the grotesque, cancer, the body and 
technology - specifically on the notion of the artificial uterus. She describes her 
purpose here as an anthropologist. I will have to remind her that our personal 
life, though shared with her in the capacity of roommates, is not up for analysis 
and publication. But she can have carte blanche with our professional lives. 
While Oron and lonat are away, they have asked us to meet biweekly with 
Chandra (last name?). I don't know much about his work, and he is rather 
elusive when you ask him, but he seems brilliant. From what I understand he is 
engaged in radical body modification, and he is working as a resident at 
SymbioticA researching how to grow plant and mammalian tissue culture 
together in the same environment. He has just completed six months working 
with Carry Cass in Agricultural Sciences, and now he is beginning his stint in the 
School of Anatomy and Human Biology. 
We descend to the lab with Chandra, his wife, and Marie Pierre in tow. I 
remember my first day in the labs, and I am thrilled to introduce these others. I 
also remember how helpful Kira O'reilly was, and I am happy to pass on the 
favor. 
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There is a lot of prep work to do today. We are out of everything. New medium, 
plus gluta max, and penicillin. Defrost and distribute the FBS into 50 small vials, 
5 ml each. This takes so long, we decide not to trypsinize Chandra's cells. Only 
to feed them. Then we feed our own, and prepare enough medium for next week 
blitz of trypsoinization. HACKET cells. 
Tuesday, Feb. 21, 2006 
Today is Shawn's birthday. We have to feed the cells today. But we have to 
celebrate also. 
I go into the labs in the morning with Marie Pierre. We take the bus, as I don't 
have a driver's license, and she hasn't practiced driving on the wrong side of the 
road yet. It is a beautiful - hot hot hot - Perth summer day. The sky is blue - with 
dynamic white cloud patterns. The River (which looks more like a lake) is a bit 
rough. We look for dolphins on the way in. The bus snakes around the curves of 
the highway/river. I'm starting to think the dolphins are a hoax - or at least an 
aberration. When we arrived in 2004 - everyone told us to look carefully at the 
river - in case we see them. Now, two years later -1 am still looking. To no avail. 
At SymbioticA: no one is there when we arrive. I've been away for a week -
working on our paper for the New Constellations Conference in Sydney. Feeling 
a bit sheepish about my absence - but clear on the necessity of this. I can't write 
in public. Even if there is air-conditioning. 
Oron returns from Spain looking very sick and jet lagged. Jane has taken a few 
days off. We are only in for a couple of hours. 
I love working in the lab alone. No noise - distractions - quietly - systematically -
feeding the cells. It looks so cold in it's representation - but Tissue Culture is a 
lot like cooking in actuality. Oron and lonat often said this to us. However, I 
never really got it. As I have a lot of experience cooking -1 understand the basic 
principles. I enjoy relaxing and cooking. Up until now - TC was so riddled with 
anxiety for me. Fear of fucking up - that I could never see the connection. But 
today - it was like a warm bath. I wanted to put some jazz on. 
I am starting to batch process the vials. Trying to save pipettes. The pipettes 
are beautiful long slender glass tubes with volume indicators down the side. 
They fit into the pipette guns - and allow for the sterile addition and removal of 
fluids from small neck containers with ease and efficiency. The guns are a little 
violent looking - even though they are made of plastic. But the pipettes are only 
elegant. And disposable. Each time you reach down into a single vial - and 
withdraw fluid from the cells' environment - you toss the contaminated pipette into 
the biohazardous garbage. If you were to re use the pipette - even in retracting 
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the fluid from an identical tissue culture sample - the chances of spreading 
contamination is high. So for every action the pipette is tossed. Hundreds a day 
for every lab - all over the world. So, when I am feeling confident - I often try to 
batch process the feeding - filling the pipette almost full - and carefully without 
touching the neck of any of the flasks - depositing the new nutrient solution into a 
number at one time. Saving a few pipettes a day. 
The cells are incredibly healthy. Confluent. Will have to trypsinize them on 
Friday. 
I'm off to the beach. 
Tuesday, Feb. 28, 2006 
Donor Calf Bovine Serum 
If we are going to work with the P19's we need a different mix of serums in the 
nutrient fluid. We ordered a bottle of Donor Calf Bovine Serum. It is the color of 
a good beef stock. I spent hours alone in the lab today. Defrosting the serum 
and dividing it into 7.5 ml dosages. Enough to make 100 ml of prepared nutrient 
solution (along with 5 mil of the usual fetal bovine serum. Serum is an interesting 
thing. It is the blood of the calf or fetus with all the cells and platelets removed. 
Horrific actually. And also interesting, we are postulating the ability to grow cells 
outside of the body - but how much of the body to we need to bring into the lab to 
create a hospitable 'artificial' environment for the cells to proliferate. 
... if I cut of my hand, you say me and my hand. 
If I cut off my leg, you say me and my leg. 
If I take out my kidney, liver and intestines, you say me and my 
intestines.. .intestines. 
But if I cut off my head, do you say me and my head or me and my body?... 
loosely remembered from Roman Polanski's The Tenant. 
additionally, I trypsonized the HACAT cells again. No contamination. We now 
have twelve healthy vials. Some will be frozen. Some will be utilized in lonat's 
Bioart class for the tissue culture demo - and some will serve as our first test 
cells in the bioreactor environment. 
I filmed the entire procedure today. Filled a DV mini tape. However, what I am 
really hoping for - is a capture of the conversations going on around me. Though 
I was working alone, two senior graduate students were teaching a new recruit 
tissue culture protocols in the next hood over. It was very interesting. The new 
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student is from Germany. He speaks with a thick accent. I introduced myself, 
and explained a bit of what I was doing. He seemed very interested. Asking all 
sorts of questions. The new guy doesn't know the politics yet. Don't mix with the 
artists. 
I have become good friends with another PhD Candidate, Maria. She is also 
from Europe, Portugal. She is very open to artists working in the labs. She says 
that in Europe artists are a valuable part of society. She attends all the Friday 
meetings at SymbioticA. She was over at our house last weekend, and we 
spoke about her experiences at the UWA. I think she is having a lot of problems. 
Not a good mix. One of the points she addressed - was distrust on the part of 
her fellow students for her involvement with SymbioticA. They feel it is a waste 
of her time and dangerous. It seems the group is ostracizing her. I am sure it is 
for other reasons as well - but her involvement with the artists is frowned apron. 
Anyways.... 
Monday March 06, 2006 
National Holiday - Labor Day. Not working at the university today. But spent 8 
hours in the sweltering heat responding to emails. Growing frustrated with the 
business distracting me from the writing. 
Three dead frogs today. I think I might have killed them. We have a fishpond in 
the front courtyard. Shawn and I have taken to the fish. We feed them twice a 
week - keep the water aerated, and top it up when it evaporates too much. Paul 
told us that the sign of a healthy pond is the frogs. We have had frogs since we 
arrived. They make rumbling noises all night long. Guy says they keep him up a 
night. I like them. They serve as a foil for the work we are doing in the labs. 
Care. So yesterday I topped up the pond - with added de-chlorinator. We did it a 
month ago and it was fine. This morning - three floaters. Dead Frogs. I am 
ashamed. 
Thursday March 09, 2006 
Defrosting P19 cells. 
1 - immediately start to defrost vial of cells in warm water. 
2 - Prepare a vial with melted cells - top up to 5ml with PBS. 
3 - Make a twin vial with 5 ml of water, (make sure both vials have exactly the 
same amount of fluid in them to balance the centrifuge) 
4 - Set Centrifuge - 36 degrees Celsius -1600 rpm - 5 min. 
5 - with the pipette remove as much fluid as possible without disturbing the pellet 
of cells. 
6 - then refill to 5 mil with medium. 
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7 - repeat centrifuge process two more times, each time replacing the medium in 
the vial. 
8 - pipette final cells into TC dish, and top up with medium. 
9 - place in incubator. 
Thursday March 30,2006 
Their fate seems sealed. Oron escorts us down to the labs. Marie Pier asks if 
she can come. We say no. "There will be nothing to photograph." But what I 
really mean is -1 might cry. And I'm not sure I want the visiting anthropologist to 
document our failures. It's not a crisis - just the usual mid residency artist slump. 
I happens to everyone. 
Oron confirms our concerns. Not only are the P19 not really establishing 
themselves - but they seem contaminated as well. 
Three months of work - and we have little to show for it, 
Plan B: Defrost the last vial of P19 from Marlyin - and purchase some more for 
back up (and to replace the ones we are borrowing) from ATCC.org. 
Tuesday April 4, 2006 
I stayed home working on my job applications. Bad news from the labs though. 
Shawn trypsinized the cells without diluting the trypsin. Hackett. They came off 
in sheets. Cell death. We really have nothing now. 
Friday April 7,2006. 
Death and rebirth. Today I disposed of all the old dead cells. A small ceremony 
was watched by the science students. They think I am a bit strange. I drew 
dead stick men on the flasks, and did a photo shoot in the lab. On the floor - in 
the hood. They turned out beautifully - only in hind sight I should have drawn a 
dead mouse on the P19 cells. More accurate - less anthropomorphizing. 
We also defrosted the last vial of P19 cells in the school, lonat came along for 
emotional support. Oron ridiculed us from afar all day - until I asked him to stop. 
All in jest - but it hit a cord. 
So we were in the freezer room - waiting for Marlyin - and I started to 
hyperventilate a bit. A bit nervous - and hung over from last nights activities, 
lonat was touched that I was upset about the cells - rather then the exhibition 
etc... Downstairs - Shawn performed the task - I was jumpy, but took amazing 
photographs to document the dead rising. Or the seeping awaking. 
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Tuesday April 18, 2006. 
Easter weekend is over. 
We come into SymbioticA after a beautiful long weekend. Primarily working in 
the office. Website update is taking a long time, and a major investment on 
Shawn's part. Oron sitting in the corner - taking jabs at us. "aren't you going to 
check your cells" again, again, again. 
We say yah, yah, we'll get to it. Of course he has already checked them himself. 
Nearly all dead. Four days is too long. 
Thursday April 20, 2006. 
A beautiful day in the labs. 
Today we worked with Paul Thomas. He is a lovely man - an art professor from 
Edith Cowan University and artistic Director for BEEP (Biennial Electronic Arts 
Perth). He is a very tall man - with very fair skin - a dermis transplantation on his 
forehead - and very British. Though he can seem imposing when you first meet 
him - he is actually a very kind, gentle, self-effacing man - and a good friend. 
Paul has been working for years on the human/technology interface in his art 
practice. Today he is interested in seeding some cells in fabric so that he can 
photograph with electron microscopy the area of adherence between cell and 
fabric in the dish. He has four pieces of silk that have been autoclaved, and 
soaked in 70% ethanol for some time. I think they are silk rose petals. Oron 
asks us if we can donate some of our Hackett cells - and help Paul with the 
process. 
We take him downstairs. Though he has observed before - it is his first time 
working hands on in the lab. He is very nervous - and does not appreciate the 
audience. 
We wash the petals four times in PBS (Phosphate Buffered Solution) 
Wash the Petri dish with 70%ethanol. 
Soak the petal sin prepared nutrient solution. 
Transfer petals to Petri dish. 
Trypsonize the Hackett cells placing 1/3 in the dish. 
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Place dish in the incubator for 24 hours. 
Shawn Starts first. Washing the Petri dish. I talk to him about his family - to 
distract him/ relax him. Take a few pictures. Then it is Paul's turn. We are very 
careful to discuss conditions for maintaining sterility. He is a bit wobbly - but 
excellent. We are all a bit wobbly the first time - with sweat running down the 
back of your sneck. He rinses the petals - and soaks it in prepared nutrient 
solution. 
I think he touches the outer edge of the NS container twice. This is probably 
grounds for contamination. I want to be supportive - but when it comes time to 
trytpsonize the cells - we switch back to steady hand Shawn and I throw out the 
remains of the solution. I tried to do it casual - but Shawn held me up - asking 
why I was disposing of perfectly good (and very expensive solution). I have to 
say I think it might be contaminated - and Paul's feelings are hurt. I feel bad. I 
give him the camera, and he takes a few shots while Shawn works. 
It was a funny passaging. The Hackett cells took 10 minutes to come off the 
dish. 
We complete the protocol - and I take some lovely photographs of Paul with the 
wide-angle lens. 
Moments later - after Paul has left we trypsonize the P19's - they peal off in 20 
seconds. Shawn is running to neutralize the process in time. He thinks he has 
caught it - but as always we are feeling haggard - and excitement - and 
adrenalin. You'd think we were competing in a sporting event - the way tension 
rises - and pulses flair. Nothing to do but wait till tomorrow to see the results. 
Cultivating life is hard. Oron makes it look so easy - and teases us almost cruelly 
when we slip up - but balancing administrative responsibilities, artistic impulses, 
international travel, with an extremely delicate and sensitive scientific protocol - is 
a treacherous and exhausting undertaking. I'm sleeping this weekend for sure. 
FridayApril21,2006. 
Funny afternoon. Double lab duty. 
Shawn is working on the website. I go in to the labs to check cells. Beautiful. 
Absolutely Beautiful. Trypsinization was very successful! Each flask (both p19 
and Hackett) has approximately 50% coverage of adherent cells. I decide to 
feed the P19's only a day after trypsinization. The solution looks depleted in 
color, and as we are coddling them - trying not to kill them again. It will be three 
days before we can get to them again. 
It seems I have just enough of almost everything to accomplish this. Just enough 
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pipettes - ten drops of bleach, and the last of prepared P19 nutrient solution. I 
take all steps - humming a little - glad the cells are thriving in four flasks. (The 
first trypsinization in the most crucial - the move from one flask - to two, or three, 
or four, greatly enhances your chances of successful proliferation. This way you 
have back ups. You can freeze some cells - for another day. You can maintain 
multiple flasks, in case some are contaminated, and so on.) But as I reach the 
end of the protocol -1 realize that I am a few milliliters short of prepared nutrient 
solution. Two flasks get three milliliters (rather then five). I close up - It's Friday 
and I want to get on to the meeting, 
Upstairs, I mention to Shawn the low levels of nutrient solution. He reminds me 
that the cells will have to last three days - and we have experienced cell death 
before. I should open shop - and over fill each flask. I already knew this - and 
the goose chase begins. 
Replacement pipettes down from SymbioticA office. 
Hunt down bleach (mental note bleach and ethariol are stored by the sink in the 
autoclave room). 
Print out P19 Protocols. 
Defrost Fetal Bovine Serum, and Donor Calf Serum. 
Prepare two 50 mil vials of P19 Nutrient Solution. 
Then top up each vial with a few extra mils of new solution. 
I'm twenty minutes late for the meeting. Too bad it was interesting. 
Monday April 24, 2006. 
Heading into the labs. Testing to see if our new P19 strategy is working. They 
prefer to be fed every 48 hours. This is not really possible over the weekend -
Though we are considering signing up for after hours access. On Friday I gave 
them an abundance of nutrient solution - and hoped for the best. So coming in 
today and seeing then healthy and confluent is a relief. There is some debris 
floating in the solution - but I seen 90% adherence rate - nuclei in full view. I love 
the microscope. It is amazing - that with the intervention of a mediating device, I 
can observe my cells more closely - and in fact feel more connected and in tune 
with the cells - then if I only related to them with my eye. I confidently feed the 
cells - and wrap up quickly. 
Now that we have four healthy flasks - we are ready to start microscopy 
protocols. I head over to the IAAF and meet with Guy's replacement. I must get 
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her name. She agrees to help us with both still and time laps microscopic 
photography of the P19's. I make an appointment for Thursday - 1:30 - and two 
weeks in advance for the video work. 
We are still behind - but moving ahead. Life is a slow process. 
Thursday April 27, 2006 
IAAF - or whatever it is called - Image Analysis and Acquisition Facility -
Renamed: Cell Central. 
Today we are doing still optical microscopy - with digital documentation. 
I did this last time in 2004 - but have forgotten everything. A complicated 
procedure - but strangely familiar - with our experience in scanning and digital 
photography. 
Friday April 28, 2006 
Feeding, feeding, feeding. "Feed me Seymour, feed Me!" 
The cells are always hungry. Particularly the P19 - every 48 hours at the latest -
But that is just too much over the weekend. We missed on Wednesday - they 
went three days - a little worse for ware because of that. Lots of dead clumps. 
So Today I take a look - enough still living - and top each vial up to 7ml. 
I wish microscopy had been today - yesterday held little life. 
I am always surprised by how dirty the labs are. Do they have cleaning staff? 
Everything is dusty - implements everywhere - pipette tips strayed from the 
garbage, litter the floor - and stains, bleach, ethanol, and something brown - that 
looks like rust.... Someone leaves these very old very dirty looking containers in 
the fume hood. How is this sterile? My kitchen is cleaner? - (well not really). 
Hope they make it through the weekend. 
May 03, 2006. 
Lab Fatigue. That is the only way to describe it. The fatigue that one 
experiences when working in the laboratory for more then a couple hours a 
session - particularly linked to ongoing laboratory work - day in and day out for 
several months (if not years) in a row. The laboratory is not a hospitable place 
for human beings. I can only describe our lab, and my experiences there - but 
most can liken it to working intensely on a computer for several hours - so that 
the back seizes - the eyes dry - and the user is struck with a pangs of an 
emergency bathroom trip - as they have been so engrossed in their work - that all 
early warning signs of a full bladder and possibly even bowel movement have 
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been ignored. I am frequently experiencing migraines during this residency. (If I 
think back I did as well last time - though I had dismissed these symptoms as 
resulting from personal stress - rather then directly related to my work here.) 
Often after a day in the lab I go home to a hot bath, dark room, and varying 
quantities of Advil. My migraines are stress related - though I also have some 
dietary triggers (i.e. red wine). In that I experience migraines after moments of 
extreme concentration - performance - stress. The migraine never interferes with 
my ability to perform, but comes at the moment after the stress is removed, and 
my body relaxes, quickly expanding the veins in my head and neck, bringing on 
full visuals and crippling pain. 
Lab Fatigue. 
That is how I feel today. 
Last night was a two-hour conference call until midnight with my doctoral 
committee. Though leaving that experience elated - the performance was 
exhausting - and a bad start for a busy day in the labs with Shawn. 
The light in room is distinctly yellow. There is continual low-level noise - a hum, 
and rhythmic hydraulic sighs coming from the incubator. Today Luis is in 
introducing a new German graduate student to a tissue culture protocol. Though 
I have only heard Luis speaking rarely - it has always been in English. The flow 
of German utterances is very comforting in a soundscape dominated by 
machinery. The room is kept very dry - this is excellent in retarding the spread of 
bacteria - but hard on the body. 
Additionally, we feel a bit surveyed in this environment. Not in the penal sense -
but in the sense that we understand our place in the labs is open to opposition. 
When working along side scientists - I find myself constantly apologizing and 
asking if we are in the way. This probably has more to do with my own 
insecurities then a requirement of our residency. However, what is real, is an 
expectation that we will work quietly, respectfully - and not disturb 'real' research 
with our antics/amateurism. I am terrified of dropping a vial on the floor - or 
leaving the microscope lamp on - or somehow contaminating others research 
because of my inexperience. On the other hand - as I gain more experience -
that is less likely to happen, and I am becoming more confident in my actions. 
This said. Strange mistake today - and still fearing the consequences. The fluid 
in the pipette touched the filter during an extraction. If this fluid passed the 
pipette filter - and entered the filter in the gun - it is a very expensive 
replacement. We have no way of telling. So we tell no one. This could prove 
fine - or contaminate the entire lab's experiments. Hold our breath - and see on 
Friday. I tend to overreact to these things - and Shawn assures me that the 
liquid did not enter the pipette gun. 
We did a lot of work today. Probably too much. 
We ran out of everything. Started stocking the lab with tissue culture flasks, 
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pipettes, bleach, and 70% ethanol. Defrosted three vials of trypsin, and one 
Fetal Bovine Serum. Calf Serum was already available in the fridge. Then I 
prepared the new nutrient solution batches. 100 ml for the P19's - and 100 ml for 
the Hackett cells. This involves measuring out small amounts of the serums in 
vials - and topping up with 45 ml of Nutrient solution. Making two 50 ml vials of 
prepared solution. This solution exhausts itself over time and with exposure to 
light. So we only prepare 100 ml at a time - lasting anywhere from one week to 
one month depending on the volume and number of flasks one is maintaining. 
We were low on PBS - and needed to subdivide a large glass container into a 
couple more BIOTEKNICA vials. 
Then we needed to trypsonize all the cells - four vials of P19 - into 12 flasks - and 
two vials of Hackett into six. Lastly we plated three small circular sheets of glass 
with p19 cells in Petri dishes - reducing the final number of flasks to 9. 
We were working with the small hood. And once we got everything in there (15 
flasks, three Petri dishes, several sterilized implements bags, pipettes, the 
pipette gun, bleach, two containers of nutrient solution (one for each cell type), 
several small vials containing serums, and several large vials for prepared 
nutrient solution, three vials of trypsin, the large PBS container - and three large 
vials of PBS... I think that's it) the fume hood was so full - that it was difficult to 
work. 
Shawn trypsonized the Hackett cells first. 
Once that was completed we prepared the glass plates for video microscopy. 
This is a delicate process. The plates are very fine, and very fragile. They have 
been sterilized and stored in a sealed paper bag. So have various implements. 
Shawn uses sterile tweezers to place a glass plate in the centre of each Petri 
dish. Then we trypsonize one vial of P19's - dividing the suspended cells into 
three and seeding them on the plate of glass. Then each Petri dish is topped up. 
Of course we were doing a photo shoot at the time - adding to the tension. The 
dishes don't seal up like the vials - so they are very awkward - and prone to 
spillage and contamination. The dishes are documented and stored in the 
incubator. We trypsonize the remaining P19's. They were very confluent - and 
starting to die as they were clumping up in the vials. 
Hours later - on the way home in the car - raging migraine. And three friends are 
having an opening. It would be dismissive of their work not to attend. I make an 
appearance - and return home early for a long sleep. 
Friday, May 05, 2006 
Video Microscopy. 
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A good day! Two days ago we seeded glass plates with our p19 cells. Now we 
will insert them into a heated chamber with nutrient solution and leave them in 
the microscope for the weekend. Every ten minutes - a photograph will be taken, 
making a data set of stop motion video stills. 
Guy is still away at his Atlanta residency - so we will do the procedure with his 
temporary replacement Mika. 
We had no idea she was so inexperienced. She was very nervous. She had 
seen the procedure performed once before - and collected a protocol from Guy -
but she was pretty much flying solo with no experience. 
We headed into the TC labs together and I could tell immediately that something 
was off. She had no knowledge of sterility procedures. And kept opening the 
autoclaved packages up outside of the hood. Even dropped one component on 
the laboratory floor - which we subsequently cleaned with 70% ethanol. She had 
difficulty operating the pipette gun - waiving it wildly through the air - touching the 
tip to random surfaces. Hands shaking. 
Assembling the infrastructure is a delicate process. Each piece is autoclaved, 
and stored in the protective paper pockets. The pockets are brought down to the 
lab - and the undercarriage is assembled in the sterile hood. Then one of the 
seeded glass plates is inserted into the carriage (utilizing tweezers, so as not to 
contaminate the cells.) - and the negative space filled with new medium. There 
are external flow pipes built into the infrastructure to allow for constant 
replenishment of media - however IAAF dose not have the facilities to support 
this function - and we plug up the pipes with plastic caps. Mika - sweating visibly 
- is finding it difficult to fill the carriage with medium - sealing it without air 
bubbles. We are trying to calm her down. We live with the bubbles. 
Once the device is fully assembled - we walk it over to the IAAF. 
There is a bit of a struggle attaching it to the microscope - but not as much. Mika 
is a young talented technician. She is really at her best with the microscope. 
She was just nervous - doing a complicated protocol for the first time, with an 
audience to boot. 
We get the settings straight. I am taking pictures all the time. This entire trip is 
marked by photography. 
Cross our fingers and wait till Monday to see what we get. 
Monday, May 8 2006. 
Cell death. That's all we captured. 
Guy mentioned that he had been having some problems with the focus. 
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Apparently - setting the focus is contingent on the room temperature. 
Thursday, May 18, 2006. 
waiting, waiting, waiting.... 
We come in today - to feed the cells, prepare the trypsin - and seed Paul 
Thomas's mika. He is doing an electron microscopy project - taking very detailed 
images of the bonds between cells and inanimate objects. 
No luck with any of this. 
It is Shawn's turn to feed the cells. But he is pretty tired, entertaining my folks -
and obsessively engaged in his genealogy research. So I finally concede - I'll 
feed the cells. I head down to the lab to find it entirely full. Two students working 
- one at each hood - and Luis - forming a third station at the counter. Hushed 
discussion - they are at a critical point. It has never been explicitly said to me, 
but I know to - "stay out of the way of the scientists." 
I head down to the second floor lab every half an hour - peaking my head 
through the porthole window - only to find they are still there. 5:00 rolls around -
Jane is leaving soon - the school is about to go into lockdown. I never picked up 
an identification card - so I have to borrow Jane's - to make it through the 
security doors after hours. 6:45. The lab clears out. No time for monkey 
business. Trypsin and Paul's cells are left to another day. 
Only feeding. With a small set back. We have run out of medium - and Jane has 
forgot to order more. Only expired medium left from our last visit. It expired Jan 
2005. I am nervous about using this serum. I rely heavily on the current batch. 
With three vials remaining of P19 - I mark the canisters with (old medium) and 
use the expired stock. 
We'll see how it goes. 
The cells are looking fairly haggard. They are to be fed every 48 hours. 4 mil. I 
do that on Monday, Wednesday, and Friday. Over the weekend - I give then 
each 7 mil - to make it over the third day. Only this week. On Wednesday - we 
were so tired - from having visitors - we skipped that feeding - only allowing for 4 
mill of nutrient solution over three days. Are we delinquent parents? 
Irresponsible artists? Tired? Who knows? But we are loosing cells like crazy 
these days. I hope we can keep a full stock until the end of our residency. 
Friday, May 19, 2006. 
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Visitors. 
My dad and his wife Teala have been visiting. Worlds collide - and not. Strange 
it has been a pleasure to meet in a foreign country - where warren is not a father 
- and I am not a daughter. We were able to meet as friends. Today is the day -
To finally introduce my family to the exactitude of what I do. I imagine they will 
be impressed - but you never know. 
Stuart gives an excellent demonstration of the School of Anatomy and Human 
Biology. Only I feel bad - first day back after dual trips to Dubai and Adelaide. 
He seems a bit haggard. He takes us through the labs - explaining all the 
technology - showing us TC&A art works, and discussing the evolution of their art 
production. He explains the nature of pure aesthetic engagement in the 
biological sciences - illustrative approaches, and embedded critical approaches. 
He explains the difficult terrain of sci/art exhibition - and the dangers of 'science 
education' in the gallery. It is a beautiful talk. 
We head down to the labs at 2:00 - and unfortunately we run into the same 
problem as yesterday. Mass lab production! I am going to cry. Dad and Teala 
have traveled all this way - and it is their last day - and I might not be able to 
show them our lab work! I check and check again and again. No luck. Finally, I 
ask the scientists if I can bring some visitors bye - and show them our cells under 
the microscope. They agree - and the problem is half solved. They look through 
the lens - and see. Teals is surprised - she can't see the cells moving. 
An hour later Shawn is presenting his copyright lecture at the Friday meeting -
and I slip away unnoticed - to feed the cells. Bad timing. Only 30 minutes 
difference and they could have seen it all. 
The entire school is closed at 5:00 pm today. Locked until 9 am. They are 
cutting off power to the phone lines (as part of the new small animal facility 
construction). And health and safety says people are not allowed to work in the 
building if the phones are out. They have the most rigorous health and safety I 
have ever encountered. 
Thursday, May 25, 2006. 
Working at home today. Growing more concerned about our inability to generate 
a digital 3D prototype in the remaining five weeks. So we agree to move to plan 
B. Cast meat sculptures. We are having a hard time accessing the necessary 
technology to complete this aspect of the work here in Perth. We tried opening 
the 3D files we generated in Adelaide on Oron's computer a few weeks ago. It is 
too old and slow. We bought new Lightwave software (ironically they had a copy 
laying around the shop that someone ordered two years ago and never picked 
up. ha ha ha It was Shawn. He ordered it last time we were here and then we 
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ran out of funds so he never picked it up. So Oron wandered over asking if they 
could order in a copy - and they gave him this one at a vastly reduced price.) 
Unfortunately the computer they have driving the 3D printer is far too slow to deal 
with the new software - and the huge file sizes of the scans. So my thought is 
that we will make the digital prototypes upon our return to Montreal. We have 
excellent 3D rapid prototyping facilities affiliated with Hexagram. 
We purchase the meat today - and I was going to get right on it - however I also 
got a bit fanatic looking for my lost notebook. Finally found it under my 
suitcase??? I've been looking for that for two weeks - and I was starting to think 
it was really gone. So a new path... Transcribe all my lab notes into digital copy. 
I am afraid of loosing the book again - with all this precious information. Plus it is 
fun going back over our residency. Most of the lab notes were entered directly 
into the computer after work. But sometimes I took notes on the spot - and they 
are all in my book. 
Stressed. Not going to finish all our plans in time. 5 weeks left! I am starting to 
have that sick to my stomach feeling - like this might be the last time I do this... or 
that. But I am also getting really home sick. 
Friday June, 09, 2006. 
Having a hard time keeping up with the notes. So much is happening so fast - I 
am running out of time. Three weeks left!!!! 
Today is packed. Tagny's first day at the lab. What a pleasure/privilege to be 
able to introduce her to this place. I can see the wonder/excitement - and feel it 
again myself. 
We come in for the afternoon. Check in with Guy to see how our last microscopy 
has gone. Strange - well. It seems that the cells we thought were dying - are 
transforming. We have captured this process in our last movie. It is very 
interesting - strange. 
The P19 cells seem to be reacting poorly with the process/carriage needed for 
microscopy. Every time we insert the plate into the apparatus - we look down the 
lens to see them "dying." They begin all healthy and stretched out. Then 
immediately begin to shrink up - ball up - as if they are being trypsonized -
wiggling. We kept thinking the cells were dying - until one day last week Stewart 
Hodgets happened to come into the lab while we were looking at the video. He 
suggested that they were not dead at all. That they were transforming. He said 
the P19 cell line is not inherently cancerous. That a process of transformation is 
required. 
Monday, June 12, 2006. 
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Very strung out today. Incredibly busy weekend. Shannon Bell is in town. We 
went to parties - had dim sum meetings - and went to the beach. 
Tagny came in early with me today. 8:30 am arrival. Still sleeping. Lost keys -
locked out of SymbioticA. So we coffeed - and talked - and cried we were 
laughing so hard. It is a pleasure to have such a close friend here - and to see 
SymbioticA through her eyes. 
Then early start. Guy was on the move. Another run at the P19's in video 
microscopy. Guy is a pro. He has the entire carriage assembled in two minutes. 
And under the lamp. I say I am to tired to take pictures - and Tagny offers to 
document - then I do the documentation. The pictures are good. 
But more interesting. Oron and I meet to take the next step with the polymers. 
On Friday - Shawn poured the silicon over the wax moulds. Today it is set. Oron 
pulls them out of the mould - beautiful white rubbery - fleshy constructs. The 
teratomas are beautiful. The molds took well. Well enough. Each one had a 
small bubble. But it only adds to the design - so we decide to move ahead on 
them. 
Before we get started - we take another teratoma sculpture out of the freezer -
and get it started on the 3D scanner. A little frozen piece of meet - stuck in play 
dough - placed carefully on a moving surface. It should stink. But it doesn't. It is 
beautiful. 
Then we prepare the polymers. 
We are using the P4HB polymer. A bioasorbable polymer. Apparently it is 
produced by a genetically modified organism. Strange how interconnected all 
the biotech products are. You can't trace every connection - ethical reflexitivity is 
impossible - we are working in another universe - with protocols and materials of 
a different order. 
This polymer is carefully measured out. 5% polymer - 95% acetone. 
The scale is extremely precise. 
The dilution is made - and sealed in a glass bottle. And warmed in a dish of hot 
water. The warming allows for the dissolve reaction to occur. 
This afternoon - we will start pouring the polymers - and feeding cells - and 
plating more cells for Microscopy. 
Tonight - Lecture at SIGGRAPH. 
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Appendix 2 
BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | PROTOCALLS 
Tissue Culture Laboratory Protocols - Passaging (3T3 Mouse Fibroblast 
Cells) 
SymbioticA - The University of Western Australia 
Jennifer Willet 
June 01, 2004 
The following information was gathered during demonstrations and work 
sessions with Oron Catts and lonat Zurr from SymbioticA in the School of 
Anatomy & Human Biology at The University of Western Australia. 
General Safety Information 
01 Wash hands carefully when entering or exiting the laboratory 
02 Wear disposable lab coat, and latex gloves when working with 
biological materials 
03 Assume all biological materials are hazardous 
04 No eating, drinking, smoking, or kissing in the laboratory 
05 Clean all work surfaces with 70% ethanol solution before and after all 
work 
06 All waste should be disposed of properly (i.e. Autoclave disposal) 
07 All liquid wasted should be treated with bleach before disposal 
08 Wash gloved hands with 70%ethanol solution before working in fume 
hood environments 
Work Station Preparation (Level II Fume Hood) 
01 Turn on UV Light for twenty minutes in advance of utilizing fume hood 
02 Turn off UV Light 
03 Open Hood 
04 Turn on light and air flow 
05 Clean work space with 70% ethanol solution 
General Pipette procedure information 
01 never directly touch the pipette unless it is for disposal purposes 
02 Open one end of sterile packaging and insert pipette into gun before 
fully removing package 
03 Never over fill a pipette allowing liquids to enter into the gun filter 
04 Pre-loosen all caps of containers, careful not to touch the inside of any 
cap 
05 Do not allow pipette to touch external surfaces of any containers used 
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06 Do not cross-contaminate with pipette, use a new pipette for every 
solution 
Preparation of Nutrient Solution for Storage 
With all forms of tissue culture a nutrient solution must be prepared to maintain 
the nutrient needs of dividing cell lines. 
01 Prepare work station with the following materials 
500ml Bottle of DMEM Dulbecco's Modified Eagle's Medium 
5ml Gluta Max (Amino Acid) 
5ml Penicillin 
Pipettes, and disinfected pipette gun 
Permanent Markers 
Bleach Solution 
02 With Pipette add 5ml Gluta Max to DMEM 
03 With new pipette add 5ml of Penicillin to DMEM 
04 Write your name on the bottle 
05 Store in refrigerator when not in use 
Preparation of Nutrient Solution for Dailey Use 
01 Prepare work station with the following materials 
500ml of DMEM + Glu and P/S 
5ml vial of FBS Fetal Bovine Serum 
Pipettes, and disinfected pipette gun 
Styrofoam vial holder - disinfected with 70% ethanol 
Sterilized 50ml vials 
Permanent Markers 
Bleach Solution 
02 With Pipette deposit 5ml of FBS in a sterilized 50ml vial 
03 With a new pipette add 45ml of Prepared Nutrient solution 
04 Mark Vial as 10% FBS, date, and your name 
05 Store in Refrigerator when not in use, but only for a short time 
Passaging (Stage I: From Primary Cell Line Container) 
3T3 - Mouse Fibroblast 
Connective tissue cell line established in early 1970's from a Swiss mouse 
Passaging is the protocol where a healthy cell population is further divided into a 
larger number of containers, encouraging the cells to further divide and grow in 
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numbers. The basic premise being, that healthy cells will continue to divide until 
they become confluent (flowing together, overlapping, fully populated). Once the 
entire surface within the tissue culture flask is confluent with 3T3 Cells -
passaging will allow you to divide those cells among three identical flasks, 
ostensively tripling your cell population. 
01 Prepare the workstation with the following materials 
50 ml prepared Nutrient Solution 
10 ml defrosted Trypsim 
Bottle of PBS Cleaning Solution 
Pipettes, and disinfected pipette gun 
Styrofoam vial holder - disinfected with 70% ethanol 
Sterilized culture flasks 
Permanent Markers 
Bleach Solution 
02 With pipet remove depleted nutrient solution from tissue culture flask, 
and dispose in bleach solution. 
03 With a new pipette draw 5 mills of PBS solution, and deposit in Tissue 
Culture Flask. Swish the solution along the bottom of flask ensuring 
full cellular coverage. Remove PBS Solution and deposit in bleach. 
04 Repeat step two again with a new pipette. 
05 With a new pipette, draw 3 mills of Trypsin (an amino acid) and deposit 
in Tissue Culture Flask. This will break down the cellular bonds. 
06 Place flask in the incubator for one minute (or less). 
07 Check under microscope to see that cells are freed from the flask 
surface, and floating in the Trypsin. 
08 If not agitate the flask 
09 Once the cells are free floating, with a new pipette add a 
predetermined amount of prepared nutrient solution. (Amount 
depends on the number of flasks you are dividing to.) (These last 
three steps should be done quickly; as if you over expose your cells to 
Trypsim they will die.) 
10 Use a new pipette to stir cells into the nutrient solution. 
11 Divide the final solution into designated number of flasks. 
12 Return flasks to incubator. 
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Appendix 3 
Concordia University - Human Research Ethics Application 




x j / U N I V E R S I T Y 
Summary Protocol Form 
For faculty and staff research: Submit to the University Human Research Ethics Committee 
(UHREC). do the Office of Research. GM J 000. 
For graduate or undergraduate research: 
* For projects covered under a faculty member's previously approved SPF, no new 
SPF is required. 
• For new projects which are supported by external (e.g. Tri-council) or internal (e.g. 
CASA or FRDl'j funds, the supervising faculty member must submit a new SPF on 
behalf of the student to the UHREC. c/o the Office of Research, CM 1000. 
» For new projects which are NOT supported by external (e.g. Tri-council) or internal 
(e.g. CASA or FRDP) funds, the student must submit a new SPF to the relevant 
^SE^^cnla^ ^J^u!i^lf^L^~£2m!!3i!yS^. _ 
For more, information on the above, set hi!K^aaia>IlfflR$i!JiaiKliOMlliUl..K.SSaKi!.stlillll, 
If using the MS Word form, please lab between fields (do not use (he enler key j asxl click on check boxes. 
If not using the MS Word form, please TYPE your responses and submit on a separate sheet. 
Date: May 28.2004 
What type of review do you recommend thai this form receive"' Expedited O or Full £*] 
Part One: Basic Information 
I • N<iniejJiLRj'searc]\ers: 
Principal Investigator. Shawn Anhur Bailey. Associate Professor. 
Department/Program: Studio Arts, Faculty of Fine Arts »• 
Office address: VA Building 
Telephone number: 4647 E-mail address: sabailey@alcor.coneordia.ca 
Names and details for all other researchers involved (e.g.. co-investigators, collaborators, 
research associates, research assistants, supervisors- please specify role): 
Jennifer Willet 
BIOTEKNICA Co-Investigator, Collaborator 
Part Time Faculty Member, Studio Arts, Concordia University 
4758 Des Erables Ave. 
Montreal, Quebec CANADA 
H2H2C9 
jwi!let@sympatico.ca 
Jennifer Willet is a professional artist, a part time faculty member in Studio Arts at 
Concordia University, and a PhD student in the interdisciplinary humanities program at the 
< >OR Smnmiin i'!,n.icnl i unit /»Vv n) ifh-ceni/ter yit/3) 
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same institution. She completed a BFA at The University of Calgary in 1997 and a MFA at 
The University of Guetph in 1999. Her work explores notions of self and subjectivity in 
relation to biomedical, bioinformatics, and digital technologies with an emphasis on social 
and political criticism. She has traveled, exhibited, and presented her research extensively 
across Canada and internationally. 
Oron Catts 
Director, SymbioticA Research Group 
The School of Anatomy and Human Biology 
Mailbag Delivery Point M309 
The University of Western Australia 




SymbioticA is a research facility located in The School of Anatomy & Human Biology at 
The University of Western Australia that is dedicated to artistic inquiry into new 
knowledge and biomedical technologies. Groups and individuals who are interested in 
exploring new possibilities neglected by mainstream science or art are conducting the 
research at SymbioticA. In order to facilitate the research SymbioticA has created a 
Research Group (SARG), which consists of the core researchers in Symbiotica and artist-
researchers who are invited exclusively on project-by-project basis. 
For the purposes of the University of Western Australia's internal ethical approval process 
Professor Catts will be listed as principle investigator. This is necessary due to internal 
regulations. 
Xilk.of„Kese?vriJiPtoject: 
Biotekniea: 3D Organic Tissue Protoiyjjes: Soft Sculptures 
Granting Agency, Grant Number and Title OR Contractor and Contract Title (if applic): 
Hexagram - Itistitut De Recherche & Creation En Arts & Technologies. 
Grant Account Number: QH0022 
Project Peroicl: April 0 1 . 2004 - March 31,2005 
Brief Description of Research: 
For funded research, please include one-page summary; otherwise, include a brief overall 
description. Include a statement of the benefits likely to be derived from project. You can address 
these questions by including the summary page from the gram proposal. 
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BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | ABSTRACT 
BIOTEKNICA is a five-year artistic/scientrfic/research project, currently in its third year, conducted 
between collaborators, Jennifer Willet and Shawn Bailey. BIOTEKNICA is a fictitious corporation, which 
explores notions of reproduction and self/other distinctions in relation to evolving biotechnologies. 
BIOTEKNICA projects its viewers into the future, where within our virtual laboratory designer organisms 
are generated on demand. However, the organisms produced by BIOTEKNICA do not adhere to the 
structures and functionality normally manifest in nature. Similar to mutations depicted In The Fly and 
Aliens our specimens are irrational and grotesque. They are modeled on the Teratoma, an unusual 
cancerous growth containing multiple human tissues like hair, skin and teeth. Monstrous as this seems, 
scientists today are conducting research on the Teratoma with the goal of developing future therapeutic 
cloning technologies BIOTEKNICA both embraces and critiques these technologies, considering the 
contradictions and deep underlying complexities of contemporary biotechnologies role in the future of 
humanity 
In the past. BIOTEKNICA has been a Multimedia production, however, we seek to bring our theoretical 
specimens out of their virtual environment. We are currently working as Research Fellows at the 
Symbiotica Art/Science Laboratories at The University of Western Australia over the summer of 2004.. 
where we will grow organic prototypes that will serve as new representations of our product line. We 
seek to develop soft sculptures that tip the scales between representation and reality, based on tissues 
cultivated under the supervision of biotechnologists and geneticists further contributing to the fascinating 
complexities and social discourses that arise from our project. 
BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | STATEMENT OF BENEFITS 
BioArt and GeneArt (Transgenic) forms are an emerging field Of contemporary art production where the 
artistic media is organic cell structures, and where the boundaries between art and science are 
permanently blurred. In April 2003, we presented BIOTEKNICA at The European Media Art Festival 
congress (which was entirely dedicated to BioArt practices) where we met some of the most successful 
and provocative contemporary BioArtists including: Eduardo Kac (Chicago Art Institute), Joe Davis (MIT 
Media Lab), and the SymbioticA Research Group (University of Western Australia). There is a very 
pressing need for artists to engage innovative new technologies. Contemporary technological evolution is 
often dependant upon the potential for commercial development, particularly with expensive new 
technologies whose ethical and cultural application is uncertain Artists are increasingly the leaders in 
exploring new technologies, and creating social and cultural discourses around their application, 
BIOTEKNICA mobilizes an array of specialized technologies (both biological and computational) for 
purposes, which they were not originally intended: It creates a site for cross-disciplinary communication 
between artists, new media specialists, and scientists - spanning international borders and making 
connections between several reputable universities and research centers, 
BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | SIGNIFICANCE 
We see the proposed BIOTEKNICA Organic Prototypes as engaging in several critical social and 
theoretical terrains These include: redefining notions of self/other, reproduction, representation, gender 
and genetic identity, self-experimentation, reality and the virtual, ethics and the bioseiences, and 
interdisciplinary - or cross specialization in contemporary research Upon completion, the BIOTEKNICA 
Organic Prototypes will be presented in conjunction with a series of papers and presentations providing a 
complex analytic context for interpretation. 
Symbiotica is of particular interest to us as a venue where non-scientists can enter the laboratory and 
contribute intellectually to the application of contemporary tissue engineering technologies. 
BIOTEKNICA is directly concerned with creating a site for non-specialists to participate in (virtual) 
scientific investigations To bring BIOTEKNICA researchers - and thus BIOTEKNICA content - into a 
functional laboratory will only heighten our original intentions with this project. 
< ><)R Stmmian I'nmici-t i unit tier. Hi i.lnmiorv jD'Ur 
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Scholarly Review of Proposed Research: 
Complete the Scholarly Review Form (SRF) if you are conducting non-funded or-contract bio-
medical research or any other non-funded or contract research involving more than minimal levels 
of risk. 
N/A. Project is fully funded and housed within appropriate facilities designed for such 
purposes. 
Fart Two: Research Participants 
I. Simple JBf_Ee£&ffi§Jfi. bfi_S.toligd: 
Shawn Bailey has volunteered to donate a sample of his own tissue to the BIOTEKNICA 
Project, and the sample wi l l be submitted to the SymbioticA Organic Tissue Database for 
future art/science research purposes as part of an artist tissue database. The donation on our 
part is entirely voluntary and involves very minor surgical procedure (skin tissue samples). In 
no way would we be denied access to the SymbioticA facilities, if we chose not to make a 
contribution. This procedure is minimally invasive and carried out by medical professionals. 
Al l protocols wi l l be conducted in accord with level 2 safety and under direct supervision by, 
and medical advice will be sought if necessary after the biopsy. Cultures wil l be maintained 
and documented but following the research they wil l be fixed or frozen (according to existing 
cryogenic or plastination protocols) and archived for documentation purposes in a safe and 
legally transportable format. 
The artists (Bailey, Wiliet) are licensed by the University of Western Australia to practice 
human anatomy research within the school, and are currently undergoing training in animal 
ethic protocols for the purpose of enhancing sensitivity to animal care and tissue cultivation 
protocols involving the use of animal cellular culture lines. Both artists are receiving training 
in tissue cultivation techniques utilizing existing "immortal" cell lines drawn from animal 
research trials. No animals are utilized or harmed in the research conducted by Wiliet and 
Bailey. 
jyk'hod PJLR^enmrnerii of Pajlidpjjtts: 
The artist and principle investigator has volunteered to undergo this clinical procedure. 
No other human subjects will be involved in the proposed research. 
OOH Snniu:urv I'rtfhut'i f on» AVr. ,'0 i.liWiiarv JH'Ut 
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3. Treatment of Participants in the Course of the Research: 
A brief summary of procedure, as well an account of the training of researchers/assistants; 
SHAVE BIOPOSY PROCEDURE: 
A shave biopsy is a quick and simple method for removing appropriate Karitonitye cells from a 
healthy subject characterized by fast-healing, minimal pain and minimal risk of infection. The tissue 
will only be sampled through to the dermis with a maximum surface area of 5 mm X 3 mm to a depth 
of 1.5 mm. 
Procedure for Excisionat Biopsy (Shave Biopsy): 
1 The skin will be infiltrated with anaesthetic to raise a wheal under the area to be excised. A 
30-gauge 1/2-inch needle is ideal. The skin will be cleaned with an appropriate disinfectant. 
2 A razor blade or scalpel will remove a split-thickness graft to a maximum depth of dermis 
sample. 
The sample will be packed in dry ice under sterile conditions and transported from the plastic 
surgeons office to the University of Westerns Australia for subsequent tissue cultivation 
Techniques. 
Instructions for Wound Care after a Skin Biopsy: 
1. Remove the Band-Aid after 24 hours. 
2. Clean the site daily with soap and water. Apply a small amount of Polysporin and cover with 
fresh Band-Aid. 
3. Do not allow a scab to form. Do not expose the wound to direct air, as this will delay 
healing. 
4. Continue wound care until healed, approx. 5-7 days, 
5. If any problems are encountered the plastic surgeon will be contacted. 
Source: The Yale Dermatologic Surgery Unit. 
Part Three: Fthica! Concerns 
Indicaie briefly how research plan deals with the following potential ethical concents: 
i Informed Consent: 
Wriiien consent form or written draft of oral protocols must be attached: see instructions and 
sample. 
Please see attached signed consent forms. 
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2. Deception: 
The researcher must both describe the nature of any deception and provide a rationale regarding 
why it must be used to address the research question - i.e., is it absolutely necessary for the design? 
Deception may include the following: deliberate presentation of false 'information; suppression of 
material information: selection of information designed to mislead: and selective disclosure. 
There will be no deception involved in the gathering of tissue samples for the purposes of 
completing the BIOTEKNICA tissue culture sculptures. 
3. Freedom to Discontinue: 
The artist/researcher acknowledges that he is free to discontinue the procedure at any time of 
his choosing, 
4. Assessment of Risks to Subjects' Physical WeHbeing, Psychological Welfare, and/or 
Repjittation: 
This includes low-level risk or any form of discomfort resulting from the research procedure and 
how it will be dealt with. When it is called for. you should indicate arrangements that have been 
made to ascertain that subjects are in "healthy" enough condition to undergo the intended research 
procedures. Yoti should be able to indicate clearly the kinds of risks that may be involved and the 
action to be taken if someone is unexpectedly put at risk as part of the research efforts. 
ft is the view of the artist/researcher that the minor discomfort resulting from the procedure 
is akin to standard and socially acceptable consensual procedures, such as biopsies on healthy 
athletes, routine cosmetic surgery procedures, and a host of "cosmetic" appearance enhancing 
procedures such as tattooing, body piercing or other mainstream "cultural" body modification 
art forms. In the case of muscle biopsies on healthy athletes to examine elite performance, the 
risk from the minor surgical procedure is far greater than from a simple cutaneous skin biopsy 
proposed in this instance. 
A full medical history will be obtained by the surgeon before the skin biopsy is performed, and 
the primary risk involved is minor infection. A follow up visit with the doctor will ensure that no 
complications have arisen, and if any complications do arise, medical advice will be sought 
immediately. 
5. Protecting and/or Addressing Participant "At Risk" Situations: 
The primary '"at risk" situation that arises from the proposed research is the risk of infection 
from the surgical procedure. The artist will seek appropriate medical counselling in the event 
that the routine procedure for caring for the surface wound results in infection. 
The psychological aspects of this work are of central interest to the researchers in this project 
and careful documentation from a scientific and subjective perspective will be an integral part of 
exhibited dissemination materials. The research project seeks to highlight the ethical, social 
and political impact of new technologies applied to the human body. Both Willet and Bailey 
have been extremely involved in the discussion of new art forms relating to Biotechnologies, 
contemporary art practices, and the exhibition of works utilizing these protocols. 
Both Willet and Bailey have lectured extensively and internationally on these topics. 
OOH Siiimiiiirv / V n t e v ; /.>;-;« Rev. i'l i.hinuon- JiinJ) 
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6. Post-Research Explanation and/or Debriefing: 
This will not be necessary, as the researcher /subject is intrinsically involved in developing 
the research protocols and therefore will possess full knowledge of the research intentions 
before any procedure is enacted. The subject is free at any time to discontinue the project. 
7. Cia>ilskiiiiaU^Lst..8es.u!ls: 
The research will be presented in public forums and the subject has consented to have his 
name attached to the artworks with full credit for his participation. 
8 • iiiyilianyJing; 
Please describe the path of your data from collection to storage to its eventual destruction/disposal. 
Include specific details on data handling, data storage (format and location), who will have access. 
and disposal/destruction method. 
At all stages of production we will he documenting the laboratory processes with digital 
and microscopic photography, and digital video with the intention of producing a series of 
oversized digital prints, a documentary video and an intensive website programmed in 
multimedia authoring software. 
Primary cells and generated tissue cultures will be stored at the Department of Human Anatomy 
and Biology at The University of western Australia, in a Level II Laboratory with 
appropiate incubation, fume hood, and waste disposal sen ices (autoclavcd waste disposal, 
and approved liquid waste disposal). Access to this labatory is restricted to approved 
faculty and graduate students. Upon Completion, the tissue sculptures will be documented 
with digital microscopic cameras, available in the same facility, and properly stored in 
containment units called bioreactors (as developed at 1 he University of western Australia). 
These bioreactors protect the sculptures from external contamination, and are suitable to 
present in gallery settings. The Organic Prototypes pose no threat whatsoever to external 
enviroments. or people. The greatist risk of contamination in fact lies with the sculptures 
themselves - so vunerable to external eontingiencies. We have confirmed exhibition 
venues in Western Australia for this work, however we may also make inquiries with the 
Canadian Department of Foreign affairs for possible future laboratory - to - laboratory 
shipping of final sculpture to a university venue in Canada. However, this aspect is 
unconfirmed, and would require further research and development. 
Cultures will be maintained and documented but following the research they will be fixed or frozen 
(according to existing cryogenic protocols) and archived for documentation purposes at 
The University of Western Australia. 
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9. Other Comments: 
Bearing in mind the ethical guidelines of your academic and/or professional association, please 
comment on any other ethical concerns: which may arise in the course of this research (e.g., 
responsibility to subjects beyond the purposes of this study). 
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We have no other comments at this time. Thank you for your time and attention in this matter. 
Please feel free to contact us if you require further information. 
Signature of Principal Investigator: 
Bate: .Tune 1.2004 
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CONSENT FORM TO PARTICIPATE IN RESEARCH 
This is to state that I agree to participate in a program of research entitled BIOTEKiNlCA, being 
conducted by Shawn Bailey, Associate Professor of Studio arts of Concordia University 
(514.848.2424 (4647) email w»bajj.c^:^aJcojjXM3.0Jr .^.ca). in conjunction with his collaborator 
Jennifer Willet, Part Time Professor of Studio Arts at Concordia University, and The 
SymbioticA Research Group in the School of Anatomy and Human Biology at The University of 
Western Australia. 
A. PURPOSE 
BIOTEKNICA is a five-year creative project, currently in its third year, conducted between 
collaborators. Jennifer Willet and Shawn Bailey. BIOTEKNICA is a fictitious corporation. 
which explores notions of reproduction and self/other distinctions in relation to evolving 
biotechnologies. In conjunction with SymbioticA Art/Science Laboratories at The University of 
Western Australia we will grow organic prototypes through approved tissue culture protocols 
that will serve as new representations of our BIOTEKNICA product line. 
1 have been informed that the purpose of the research is to donate a skin sample through biopsy 
procedures with local anesthetic under clinical settings at a designated and licensed plastic 
surgeon in Perth. Western Australia. The tissue sample will subsequently undergo passaging and 
cellular division and introduced into 3d polymer scaffolds at the Department of Medicine and 
Human Anatomy at the University of Western Australia. 
For the purposes of BIOTEKNICA Research and Creation you are donating, of your own free 
will, and without financial or other remuneration, a dermal tissue sample that will be cultivated 
in the tissue engineering laboratory of The University of Western Australia and later exhibited in 
life and reproduction as a component of the BIOTEKNICA project. 
You are free at any time to withdraw consent to further participation without prejudice in any 
way. You need give neither reason nor justification for such a decision. In such cases, any record 
of you as a participant is to be destroyed, unless otherwise agreed by you. 
I (the participant) have read the Dinformation provided and any questions i have asked have 
been answered to my satisfaction. I agree to participate in this activity, realizing that I may 
withdraw at any time without reason and without prejudice. (Or where applicable - without 
prejudice to my future medical treatment). 
I have been advised as to what data is being collected, what the purpose is. and what will be 
done with the data upon completion of the research. 
I agree that research generated from my donation may be published and exhibited by ;"' 
BIOTEKNICA researchers in both academic and artistic settings. 
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B. PROCEDURES 
Indicate in this section where the research will he conducted and describe in non-technical terms 
what the subjects will be required to do: the lime required to do it; any risks or discomfort 
involved; and any special safeguards being taken to protect the confidentiality or well being of 
the subject 
The skin sample will be collected in a plastic surgeon's office local to Perth and The University 
of Western Australia. The Subject will be required to spend about 30 minutes at the doctor's 
office, with a follow up examination seven days later. The subject will undergo local anesthetic. 
and minor surgery in the buttocks or upper thigh region; A sample less then one square 
centimeter will be obtained through shaved biopsy procedure. (Please see attached description of 
this procedure.) 
Qualified scientific directors of the institute will conduct all laboratory protocols in accord with 
level 2 biological handling safety categorization under Australian law and exclusively under 
direct supervision. Medical advice will be sought immediately if the procedure results in any 
infection or serious discomfort. Cultures will be maintained and documented but following the 
completion of laboratory research they will be fixed or frozen (according to existing cryogenic or 
plastination protocols) and archived for documentation purposes, 
C. CONDITIONS OF PARTICIPATION 
• I understand that I am free to withdraw my consent and discontinue my participation at 
anytime without negative consequences. 
• 1 understand that my participation in this study is: 
VOLUNTARY and NON-CONFIDENTIAL (my identity will be revealed in study results) 
• 1 understand that the data from this study will be published in a variety of artistic and 
academic formats. 
I HAVE CAREFULLY STUDIED THE ABOVE AND UNDERSTAND THIS AGREEMENT. 
I FREELY CONSENT AND VOLUNTARILY AGREE TO PARTICIPATE IN THIS STUDY , 
NAME (please print) ,____ . ^ 
SIGNATURE 
If at any time you hove questions about your rights us a research participant, please contact 
Adefa Reid, Research Ethics and Compliance Officer. Concordia University, at (514) S4H 74HI 
or by email at arnd^Lwii'E^i^n'lukisji. 
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BIOTEKNICA | PHASE III: 3D Organic Tissue Prototypes (Soft Sculptures) 
Application to Undertake Research Involving Human Subjects 
BIOTEKNICA | PHASE III: ABSTRACT 
BIOTEKNICA is a five-year creative project, currently in its third year, conducted 
between collaborators, Jennifer Willet and Shawn Bailey. BIOTEKNICA is an 
art/science collaboration, which explores notions of reproduction and self/other 
distinctions in relation to evolving biotechnologies. 
BIOTEKNICA projects its Viewers into the future, where within our virtual laboratory 
designer organisms are generated on demand. However, the organisms produced by 
BIOTEKNICA do not adhere to the structures and functionality normally manifest in 
nature. Similar to mutations depicted in The Fly and Aliens our specimens are irrational 
and grotesque. They are modeled on the Teratoma, an unusual cancerous growth 
containing multiple human tissues like hair, skin and teeth. Monstrous as this seems, 
scientists today are conducting research on the Teratoma with the goal of developing 
future therapeutic cloning technologies, BIOTEKNICA both embraces and critiques 
these technologies, considering the contradictions and deep underlying complexities of 
contemporary biotechnologies role in the future of humanity 
In the past, BIOTEKNICA has been a Multimedia production, however, we seek to bring 
our theoretical specimens out of their virtual environment. We have been invited to work 
as Research Fellows at the Symbiotica Art/Science Laboratories at The University of 
Western Australia in the summer of 2004, where we will grow organic prototypes that will 
serve as new representations of our product line. BIOTEKNICA purports to be engaged 
in growing specimens through cloning protocols. However, we as artists have no 
intention of engaging in these technologies. Instead we wish to develop soft sculptures 
that tip the scales between representation and reality, based on tissues cultivated under 
the supervision of biotechnologists and geneticists further contributing to the fascinating 
complexities and social discourses that arise from our project. 
BIOTEKNICA | PHASE III: RESEARCHERS 
Shawn Bailey is a practicing artist working with digital print media, video and 
installation. His current research explores notions of authority, control structures, media 
and international biotech and pharmaceutical policies. He completed a BFA at The 
University of Calgary in 1997 and a MFA at York University (Toronto) in 1999. He has 
lectured and exhibited internationally. He is currently an Assistant Professor at 
Concordia University in the Print Media programme in Studio Arts and an artist-
researcher with the Hexagram Institute. He lives and works in Montreal, Canada. 
Jennifer Willet is a professional artist, a part time faculty member in Studio Arts at 
Concordia University, and a PhD student in the interdisciplinary humanities program at 
the same institution. She completed a BFA at The University of Calgary in 1997 and a 
MFA at The University of Guelph in 1999 Her work explores notions of self and 
subjectivity in relation to biomedical, biomformatics, and digital technologies with an 
emphasis on social and political criticism. She has traveled, exhibited, and presented her 
research extensively across Canada and internationally 
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SymbioticA is a research facility located in The School of Anatomy & Human Biology at 
The University of Western Australia that is dedicated to artistic inquiry into new 
knowledge and biomedical technologies. Groups and individuals who are interested in 
exploring new possibilities neglected by mainstream science or art are conducting the 
research at SymbioticA. In order to facilitate the research SymbioticA has created a 
Research Group (SARG), which consists of the core researchers in Symbiotica and 
artist-researchers who are invited exclusively on project-by-project basis. 
BIOTEKNICA | PHASE III ORGANIC TISSUE PROTOTYPES | OBJECTIVES 
We see four sets of objectives related to Phase III of BIOTEKNICA: 
(1) Theoretically, our goal is to provide a site of critical and artistic contemplation where 
the ramifications of biologically enhanced forms of reproduction can be addressed and 
redefined collaboratively by individuals both within and outside of the scientific 
community. 
(2) In terms of cross-disciplinary experimentation, BIOTEKNICA would like to produce a 
series of six organic prototypes in conjunction with The Symbiotica Laboratory at The 
University of Western Australia. 
(3) In terms of new media production, BIOTECKNICA Phase III will result in the 
development of a series of digital images, web based production, and an interactive 
installation documenting the organic prototypes. 
(4) Professionally, and in terms of dissemination, we aim to present BIOTEKNICA both 
within Canada and internationally with a series of exhibitions, lectures, conference 
presentations, and print and web based publications. 
BIOTEKNtCA j PHASE III: ORGANIC TISSUE PROTOTYPES j SPECIFICATIONS 
We are proposing a series of six three-dimensional prototypes that possesses some 
likeness and qualities with our virtual specimens modeled on the teratoma. We see 
these prototypes as organic sculptures that could be exhibited in Perth, and possibly in 
Montreal at a McGill University or Concordia University laboratory venues. In addition to 
the exhibition of the prototypes, we intend to present photographic and video 
representation of the laboratory procedures and resulting prototypes in the gallery 
context, as well as web and CDROM dissemination. All forms of dissemination will 
overtly acknowledge the collaborative contribution of Symbiotica and The University of 
Western Australia and other supporting institutions. 
Prototype Attributes: 
1) Our prototypes will exist in three dimensions 
2) They will possess a permanent (non-degradable) internal three-dimensional structure 
This structure will be based on scans of Willet and Bailey's bodies, then digitally altered, 
manipulated and mutated, and output as a three dimensional rapid prototypes We 
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project these structures could be made of Poly HEMA hydrogel - the same material 
Symbiotica used in "The Stone Age of Biology" artwork. 
4) We are proposing the growth of human skin tissue. We propose to use tissues 
donated by Shawn Bailey with the intention of growing both within the framework of the 
scaffold structure. 
BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | PROCESS 
With BIOTEKNICA Organic Tissue Prototypes we are proposing a dynamic and 
alternative use of advanced imaging technologies, 3D rapid prototyping, and tissue 
engineering technologies. To complete this phase we will first compile three-
dimensional scans of both Willet's and Bailey's bodies These scans will be manipulated 
in AutoCAD to create the structural dimensions of each of the six organic prototypes. 
These structures will then be outsourced as three-dimensional prototypes in a non-
biodegradable material called Poly HEMA hydrogel. This will serve as the dense inner 
structure for our prototypes. 
At this point Shawn Bailey will undergo a shaved skin biopsy with a certified plastic 
surgeon. The biopsy will be processed in the laboratory where we will isolate a number 
of uncontaminated cells, and proliferate them in the laboratory setting through the 
passaging process. These cells will then be placed in the three-dimensional scaffolds 
and chemically treated to induce prolonged cellular division. This entire process will be 
executed under the supervision of scientists and technicians at the SymbioticA 
Laboratories. 
The tissue engineering processes involved in our project are very safe, and extremely 
commonplace in contemporary bioscience circles The cultivation of human tissue celts 
has been an ongoing scientific and medical activity for over thirty years. Related 
processes are taught as cellular biology curriculum in institutions worldwide. What 
makes BIOTEKNICAs prototypes significant is the use of such technologies in the 
production of art, and the critical demystification of specialized scientific practices in the 
public sphere. In the last eight years, several international artists have worked with 
SymbioticA in this capacity. 
At all stages of production we will be documenting the laboratory processes with digital 
microscopic photography, and digital video with the intention of producing a series of 
oversized digital prints, a documentary video and an intensive website programmed in 
multimedia authoring software. 
BIOTEKNICA | PHASE III: ORGANIC TISSUE PROTOTYPES | SIGNIFICANCE 
We see the proposed BIOTEKNICA Organic Prototypes as engaging in several critical 
social and theoretical terrains. These include: redefining notions of self/other, 
reproduction, representation, gender and genetic identity, self-experimentation, reality 
and the virtual, ethics and the biosciences, and interdisciplinary - or cross specialization 
in contemporary research Upon completion, the BIOTEKNICA Organic Prototypes will 
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be presented in conjunction with a series of papers and presentations providing a 
complex analytic context for interpretation. 
Symbiotica is of particular interest to us as a venue where non-scientists can enter the 
laboratory and contribute intellectually to the application of contemporary tissue 
engineering technologies. BIOTEKNICA is directly concerned with creating a site for 
non-specialists to participate in (virtual) scientific investigations. To bring BIOTEKNICA 
researchers - and thus BIOTEKNICA content - into a functional laboratory will only 
heighten our original intentions with this project. 
BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | ETHICAL ISSUES 
Contemporary Art offers a multitude of subjective narratives, often representing 
disenfranchised viewpoints or uncomfortable truths that are given public voice. In art, 
compelling social issues become public and contribute to a shared community, political 
discourse, and cultural dialogue where they did not exist before, Artwork that is 
compelling, provocative and controversial is a necessary condition for the play of 
individual subjectivity in a postmodern society whose laws and mores are increasingly 
focused on capital exchange to the exclusion of non-privileged members of society. 
BIOTEKNICA explores notions of reproduction, transformation and self/other distinctions 
in conjunction with recent biotechnological developments. Our project is founded in an 
exploration of the relationships between aesthetics and ethics. BIOTEKNICA research is 
a timely meditation on the ultimate fragility of the natural body. 
BIOTEKNICA is a unique artistic endeavor in that it requires ethical approval from both 
Universities on the grounds that it utilizes human biological products in its creation. We 
will be integrating the ethical exploration inherent in our project, as well as our publishing 
and dissemination programme in order to raise and address critical issues surrounding 
contemporary biotechnologies in the realm of non-specialists. All relevant Ethical 
approval by Concordia University will be sought and confirmed prior to the use of any 
human tissues. The University of Western Australia has already approved similar 
projects within the SymbioticA Research Group, and has offered to approve our project 
under a larger umbrella application It is absolutely essential that our proposed-
programme is scrutinized and found to be consistent with standardized scientific 
approaches, and contributes to the emerging definition and debate concerning art-
science research in Canada and abroad 
BIOTEKNICA conforms to all scientific protocols and international laws related to 
our project Licensed specialists in the field will train us in established laboratory 
protocol and supervise the research. The organic structures that we create will lack 
a functional nervous and immune system. They are not cognitive or aware on any 
level, whatsoever. The structures that we grow in the laboratory are less complex 
on a structural level than simple plant or fungal life forms. They are self-contained, 
and removal from the very specialized environment they are grown in, results in 
immediate destruction of the fragile artwork. They can only be exhibited in 
laboratory environments. Ironically, it is the gallery-goers who actually present the 
real risk of contamination and destruction to the extremely delicate artwork. 
Shawn Bailey has volunteered to donate a sample of his own tissue to the BIOTEKNICA 
Project, and will be submitted to the SymbioticA Organic Tissue Database for future 
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art/science research purposes. The donation on our part is entirely voluntary and 
involves very minor surgical procedure (skin tissue samples). In no way would we be 
denied access to the SymbioticA facilities, if we chose not to make a contribution. This 
procedure is minimally invasive and carried out by medical professionals, All protocols 
will be conducted in accord with level 2 safety and under supervision, and medical 
advice will be sought if necessary after the biopsy. Cultures will be maintained and 
documented but following the research they will be fixed or frozen (according to existing 
cryogenic protocols) and archived for documentation purposes. 
Additionally, all other biological materials (I.e. Fetal Bovine Syrum) used in our 
project are recycled from external approved scientific experiments occurring at the 
department of Anatomy and Medicine at the University of Western Australia. 
BIOTEKNICA | ORGANIC TISSUE PROTOTYPES | INNOVATION 
BioArt and GeneArt is an emerging field of contemporary art production where the 
artistic media is organic cell structures, and where the boundaries between art and 
science are permanently blurred. In April 2003. we presented BIOTEKNICA at The 
European Media Art Festival congress (which was entirely dedicated to BioArt practices) 
where we met some of the most successful and provocative contemporary BioArtists 
including: Eduardo Kac (Chicago Art Institute), Joe Davis (MIT Media Lab), and the 
SymbioticA Research Group (University of Western Australia). There is a very pressing 
need for artists to engage innovative new technologies. Contemporary technological 
evolution is often dependant upon the potential for commercial development, particularly 
with expensive new technologies whose ethical and cultural application is uncertain 
Artists are increasingly the leaders in exploring new technologies, and creating social 
and cultural discourses around their application. BIOTEKNICA mobilizes an array of 
specialized technologies (both biological and computational) for purposes, which they 
were not originally intended. It creates a site for cross-disciplinary communication 
between artists, new media specialists, and scientists - spanning international borders 
and making connections between several reputable universities and research centers. 
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